CHK1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S22 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | SKSEsPKEPEQLRKLFIGGLsFEtTDESLRSHFEQWGTLTD |
| A0A2R8Y4L2 | T25 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | EsPKEPEQLRKLFIGGLsFEtTDESLRSHFEQWGTLTDCVV |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| O00231 | S298 | Sugiyama | PSMD11 | RYAGRQTEALKCVAQASKNRsLADFEKALTDYRAELRDDPI |
| O00273 | S28 | Sugiyama | DFFA DFF1 DFF45 H13 | GVPESGEIRTLKPCLLRRNysREQHGVAAsCLEDLRSKACD |
| O00716 | S124 | SIGNOR|EPSD|PSP | E2F3 KIAA0075 | HGPSSRAGLLQQPPALGRGGsGGGGGPPAKRRLELGESGHQ |
| O14618 | S245 | Sugiyama | CCS | LACGIIARSAGLFQNPKQICsCDGLTIWEERGRPIAGKGRK |
| O14757 | S147 | Sugiyama | CHEK1 CHK1 | THRDIKPENLLLDERDNLKIsDFGLAtVFRYNNRERLLNKM |
| O14757 | S280 | Sugiyama | CHEK1 CHK1 | KKDRWYNKPLKKGAKRPRVtsGGVsEsPsGFsKHIQsNLDF |
| O14757 | S284 | Sugiyama | CHEK1 CHK1 | WYNKPLKKGAKRPRVtsGGVsEsPsGFsKHIQsNLDFsPVN |
| O14757 | S286 | Sugiyama | CHEK1 CHK1 | NKPLKKGAKRPRVtsGGVsEsPsGFsKHIQsNLDFsPVNsA |
| O14757 | S288 | Sugiyama | CHEK1 CHK1 | PLKKGAKRPRVtsGGVsEsPsGFsKHIQsNLDFsPVNsAss |
| O14757 | S291 | EPSD|PSP|Sugiyama | CHEK1 CHK1 | KGAKRPRVtsGGVsEsPsGFsKHIQsNLDFsPVNsAssEEN |
| O14757 | S296 | SIGNOR|EPSD|PSP|Sugiyama | CHEK1 CHK1 | PRVtsGGVsEsPsGFsKHIQsNLDFsPVNsAssEENVKYss |
| O14757 | S305 | Sugiyama | CHEK1 CHK1 | EsPsGFsKHIQsNLDFsPVNsAssEENVKYsssQPEPRTGL |
| O14757 | S316 | EPSD|PSP | CHEK1 CHK1 | sNLDFsPVNsAssEENVKYsssQPEPRTGLsLWDtsPsYID |
| O14757 | S326 | Sugiyama | CHEK1 CHK1 | AssEENVKYsssQPEPRTGLsLWDtsPsYIDKLVQGISFsQ |
| O14757 | S331 | Sugiyama | CHEK1 CHK1 | NVKYsssQPEPRTGLsLWDtsPsYIDKLVQGISFsQPTCPD |
| O14757 | S333 | Sugiyama | CHEK1 CHK1 | KYsssQPEPRTGLsLWDtsPsYIDKLVQGISFsQPTCPDHM |
| O14757 | S467 | Sugiyama | CHEK1 CHK1 | DGLEFKRHFLKIKGKLIDIVssQKIWLPAT___________ |
| O14757 | T153 | Sugiyama | CHEK1 CHK1 | PENLLLDERDNLKIsDFGLAtVFRYNNRERLLNKMCGtLPy |
| O14757 | T170 | Sugiyama | CHEK1 CHK1 | GLAtVFRYNNRERLLNKMCGtLPyVAPELLKRREFHAEPVD |
| O14757 | T279 | Sugiyama | CHEK1 CHK1 | IKKDRWYNKPLKKGAKRPRVtsGGVsEsPsGFsKHIQsNLD |
| O14757 | T330 | Sugiyama | CHEK1 CHK1 | ENVKYsssQPEPRTGLsLWDtsPsYIDKLVQGISFsQPTCP |
| O14757 | T378 | PSP | CHEK1 CHK1 | QLLGTPGSSQNPWQRLVKRMtRFFtKLDADKSyQCLKETCE |
| O14757 | T382 | PSP | CHEK1 CHK1 | TPGSSQNPWQRLVKRMtRFFtKLDADKSyQCLKETCEKLGy |
| O14757 | T413 | Sugiyama | CHEK1 CHK1 | LKETCEKLGyQWKKSCMNQVtISTTDRRNNKLIFKVNLLEM |
| O14757 | Y173 | Sugiyama | CHEK1 CHK1 | tVFRYNNRERLLNKMCGtLPyVAPELLKRREFHAEPVDVWS |
| O14757 | Y402 | Sugiyama | CHEK1 CHK1 | tKLDADKSyQCLKETCEKLGyQWKKSCMNQVtISTTDRRNN |
| O14974 | S20 | SIGNOR | PPP1R12A MBS MYPT1 | _MKMADAKQKRNEQLKRWIGsEtDLEPPVVKRQKTKVKFDD |
| O15067 | S215 | Sugiyama | PFAS KIAA0361 | LDSWDLDFYTKRFQELQRNPstVEAFDLAQsNsEHSRHWFF |
| O15151 | S342 | SIGNOR|iPTMNet|EPSD|PSP | MDM4 MDMX | RCWALRKDWYSDCSKLtHsLstsDItAIPEKENEGNDVPDC |
| O15151 | S367 | SIGNOR|iPTMNet|EPSD|PSP | MDM4 MDMX | tAIPEKENEGNDVPDCRRtIsAPVVRPKDAYIKKENSKLFD |
| O15226 | S618 | Sugiyama | NKRF ITBA4 NRF | VNKIAKRDIEQIIRNYARsEsHtDLtFsRELTNDERKQIHQ |
| O15294 | S20 | EPSD|PSP | OGT | _MAssVGNVADSTEPTKRMLsFQGLAELAHREYQAGDFEAA |
| O15350 | S47 | SIGNOR|ELM|EPSD|PSP | TP73 P73 | tyFDLPQSSRGNNEVVGGTDssMDVFHLEGMTTSVMAQFNL |
| O43390 | T429 | Sugiyama | HNRNPR HNRPR | AKPPDKKRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGR |
| O43390 | Y431 | Sugiyama | HNRNPR HNRPR | PPDKKRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGR |
| O43395 | S161 | EPSD|PSP | PRPF3 HPRP3 PRP3 | QIKQMMEAATRQIEERKKQLsFIsPPtPQPKtPsssQPERL |
| O43660 | S119 | EPSD|PSP | PLRG1 | PYPPGPGVALTADTKIQRMPsEsAAQSLAVALPLQTKADAN |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O43852 | S44 | Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O43852 | S69 | Sugiyama | CALU | HDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKDGFVt |
| O43852 | T196 | Sugiyama | CALU | FtAFLHPEEyDyMKDIVVQEtMEDIDKNADGFIDLEEyIGD |
| O43852 | T65 | Sugiyama | CALU | FDyDHDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKD |
| O60343 | S485 | EPSD|PSP | TBC1D4 AS160 KIAA0603 | CERIEGLYPPRAKLVIQRHLssLtDNEQADIFERVQKMKPV |
| O60343 | S588 | EPSD|PSP | TBC1D4 AS160 KIAA0603 | tssLENIFSRGANRMRGRLGsVDsFERsNsLASEKDYsPGD |
| O60506 | S359 | Sugiyama | SYNCRIP HNRPQ NSAP1 | VLFVRNLANtVTEEILEKAFsQFGKLERVKKLKDyAFIHFD |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | S183 | Sugiyama | EIF5B IF2 KIAA0741 | GsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKN |
| O75151 | S929 | EPSD|PSP | PHF2 CENP-35 KIAA0662 | RVGPSVPRQDRPVREGTRVAsIETGLAAAAAKLsQQEEQKS |
| O75461 | S12 | SIGNOR|EPSD|PSP | E2F6 | _________MSQQRPARKLPsLLLDPTEETVRRRCRDPINV |
| O75461 | S52 | SIGNOR|EPSD|PSP | E2F6 | VEGLLPSKIRINLEDNVQYVsMRKALKVKRPRFDVSLVYLT |
| O75494 | S133 | Sugiyama | SRSF10 FUSIP1 FUSIP2 SFRS13A TASR | yDRYRRSRSRSYERRRsRsRsFDyNYRRsYsPRNSRPTGRP |
| O75592 | S3478 | PSP | MYCBP2 KIAA0916 PAM | ETSPITDTDLAKRTVFQRSYsVVASEYDKQHSILPARVKAI |
| O94779 | T494 | Sugiyama | CNTN5 | KILASAPTFALNQLKKTIIVtKDQEVVIECKPQGSPKPTIS |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| O95625 | S511 | EPSD|PSP | ZBTB11 | TAKTDFGPDDDTYRSRLRQRsVNEGAYIRLHKGMEKKLQKR |
| O95625 | S537 | EPSD|PSP | ZBTB11 | YIRLHKGMEKKLQKRKAVPKsAVQQVAQKLVQRGKKMKQPK |
| O95707 | S10 | EPSD|PSP | POP4 RPP29 | ___________MKSVIyHALsQKEANDsDVQPSGAQRAEAF |
| O95757 | S599 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | sIDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERND |
| O95785 | S1129 | EPSD|PSP | WIZ ZNF803 | ALAKMMGGAGPGssLEARsPsDLHIsPLAKKLPPPPGsPLG |
| O95816 | S208 | Sugiyama | BAG2 | IKLLEHSKGAGSKTLQQNAEsRFN_________________ |
| O95817 | T124 | Sugiyama | BAG3 BIS | ENRQVHPFHVYPQPGMQRFRtEAAAAAPQRsQsPLRGMPEt |
| P00338 | S105 | Sugiyama | LDHA PIG19 | VTANsKLVIItAGARQQEGEsRLNLVQRNVNIFKFIIPNVV |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00338 | Y172 | Sugiyama | LDHA PIG19 | GFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHGWVLGE |
| P00491 | S176 | Sugiyama | PNP NP | GDRFPAMsDAyDRtMRQRALstWKQMGEQRELQEGTYVMVA |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P02545 | S307 | EPSD|PSP | LMNA LMN1 | AAHEELQQsRIRIDsLsAQLsQLQKQLAAKEAKLRDLEDsL |
| P04075 | S17 | Sugiyama | ALDOA ALDA | ____MPyQyPALtPEQKKELsDIAHRIVAPGKGILAADEst |
| P04075 | S176 | Sugiyama | ALDOA ALDA | EHtPsALAIMENANVLARyAsICQQNGIVPIVEPEILPDGD |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04083 | S189 | Sugiyama | ANXA1 ANX1 LPC1 | tsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsDARALyEA |
| P04181 | T33 | Sugiyama | OAT | VLSRGVHSSVASATSVATKKtVQGPPtSDDIFEREyKyGAH |
| P04181 | T39 | Sugiyama | OAT | HSSVASATSVATKKtVQGPPtSDDIFEREyKyGAHNyHPLP |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | S312 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | sstFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMA |
| P04406 | S321 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE______ |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04637 | S15 | SIGNOR|iPTMNet|EPSD|PSP | TP53 P53 | ______MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPL |
| P04637 | S20 | SIGNOR|ELM|iPTMNet|EPSD|PSP | TP53 P53 | _MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPLPsQAM |
| P04637 | S366 | SIGNOR | TP53 P53 | EALELKDAQAGKEPGGSRAHssHLKsKKGQstsRHKKLMFK |
| P04637 | S37 | SIGNOR|iPTMNet|EPSD|PSP | TP53 P53 | EtFsDLWKLLPENNVLsPLPsQAMDDLMLsPDDIEQWFtED |
| P04637 | S378 | SIGNOR|EPSD|PSP | TP53 P53 | EPGGSRAHssHLKsKKGQstsRHKKLMFKtEGPDsD_____ |
| P04637 | T18 | SIGNOR|EPSD|PSP | TP53 P53 | ___MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPLPsQ |
| P04637 | T387 | SIGNOR|EPSD|PSP | TP53 P53 | sHLKsKKGQstsRHKKLMFKtEGPDsD______________ |
| P04792 | S187 | Sugiyama | HSPB1 HSP27 HSP28 | APMPKLAtQsNEItIPVtFEsRAQLGGPEAAKsDETAAK__ |
| P04792 | S78 | Sugiyama | HSPB1 HSP27 HSP28 | LPPAAIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVs |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | S83 | Sugiyama | HSPB1 HSP27 HSP28 | IEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNH |
| P04792 | S86 | Sugiyama | HSPB1 HSP27 HSP28 | PAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNHFAP |
| P04792 | T174 | Sugiyama | HSPB1 HSP27 HSP28 | SSsLsPEGtLTVEAPMPKLAtQsNEItIPVtFEsRAQLGGP |
| P04792 | T184 | Sugiyama | HSPB1 HSP27 HSP28 | TVEAPMPKLAtQsNEItIPVtFEsRAQLGGPEAAKsDETAA |
| P05198 | T279 | Sugiyama | EIF2S1 EIF2A | KEKIEEKRGVFNVQMEPKVVtDtDEtELARQMERLERENAE |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05388 | S307 | Sugiyama | RPLP0 | AAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD__________ |
| P05455 | S94 | Sugiyama | SSB | KSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRsVY |
| P05455 | T302 | Sugiyama | SSB | ALGKAKDANNGNLQLRNKEVtWEVLEGEVEKEALKKIIEDQ |
| P05783 | S93 | Sugiyama | KRT18 CYK18 PIG46 | GMGGIQNEKETMQsLNDRLAsyLDRVRSLETENRRLESKIR |
| P06400 | S612 | SIGNOR|EPSD|PSP | RB1 | LNLPLQNNHtAADMyLsPVRsPKKKGSTTRVNstANAETQA |
| P06493 | S208 | EPSD|PSP | CDK1 CDC2 CDC28A CDKN1 P34CDC2 | WSIGTIFAELATKKPLFHGDsEIDQLFRIFRALGtPNNEVW |
| P06733 | S291 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IsPDQLADLyKsFIKDyPVVsIEDPFDQDDWGAWQKFtAsA |
| P06733 | S37 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NPtVEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRY |
| P06733 | S40 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGK |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P07195 | S106 | Sugiyama | LDHB | VtANSKIVVVtAGVRQQEGEsRLNLVQRNVNVFKFIIPQIV |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | S427 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | WDKLGEtyKDHENIVIAKMDstANEVEAVKVHsFPtLKFFP |
| P07437 | S115 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | sGAGNNWAKGHytEGAELVDsVLDVVRKEAESCDCLQGFQL |
| P07437 | T107 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAESC |
| P07602 | S29 | Sugiyama | PSAP GLBA SAP1 | SLLGAALAGPVLGLKECtRGsAVWCQNVKTASDCGAVKHCL |
| P07814 | S910 | EPSD|PSP | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | NsEPAGLEtPEAKVLFDKVAsQGEVVRKLKTEKAPKDQVDI |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P07900 | T467 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKEN |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S460 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQ |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | T459 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEt |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08631 | Y411 | EPSD|PSP | HCK | ASLVCKIADFGLARVIEDNEytAREGAKFPIKWTAPEAINF |
| P08758 | S116 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | LKHALKGAGTNEKVLtEIIAsRtPEELRAIKQVyEEEyGss |
| P08758 | T111 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | yDAyELKHALKGAGTNEKVLtEIIAsRtPEELRAIKQVyEE |
| P09104 | S37 | Sugiyama | ENO2 | NPtVEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRY |
| P09104 | S40 | Sugiyama | ENO2 | VEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGK |
| P09104 | T41 | Sugiyama | ENO2 | EVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKG |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09651 | S22 | Sugiyama | HNRNPA1 HNRPA1 | sKsEsPKEPEQLRKLFIGGLsFEtTDESLRSHFEQWGTLTD |
| P09651 | T25 | Sugiyama | HNRNPA1 HNRPA1 | EsPKEPEQLRKLFIGGLsFEtTDESLRSHFEQWGTLTDCVV |
| P09661 | S226 | Sugiyama | SNRPA1 | NAIANAstLAEVERLKGLLQsGQIPGRERRsGPtDDGEEEM |
| P09972 | S176 | Sugiyama | ALDOC ALDC | ERTPSALAILENANVLARyAsICQQNGIVPIVEPEILPDGD |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P0DPH7 | S54 | Sugiyama | TUBA3C TUBA2 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10412 | S89 | Sugiyama | H1-4 H1F4 HIST1H1E | AGyDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P10412 | T92 | Sugiyama | H1-4 H1F4 HIST1H1E | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P11047 | T258 | EPSD|PSP | LAMC1 LAMB2 | PVLQEWVTATDIRVTLNRLNtFGDEVFNDPKVLKSYyyAIS |
| P11142 | S85 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | NtVFDAKRLIGRRFDDAVVQsDMKHWPFMVVNDAGRPKVQV |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11940 | T191 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | GRFKSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLF |
| P11940 | T379 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | AtKPLyVALAQRKEERQAHLtNQyMQRMASVRAVPNPVINP |
| P11940 | Y194 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLFGKF |
| P12268 | S159 | Sugiyama | IMPDH2 IMPD2 | FCGIPITDtGRMGSRLVGIIssRDIDFLKEEEHDCFLEEIM |
| P12268 | S416 | Sugiyama | IMPDH2 IMPD2 | APGEYFFSDGIRLKKyRGMGsLDAMDKHLssQNRyFsEADK |
| P12931 | S51 | PSP | SRC SRC1 | AFPAsQtPsKPAsADGHRGPsAAFAPAAAEPKLFGGFNssD |
| P12931 | Y419 | EPSD|PSP | SRC SRC1 | ENLVCKVADFGLARLIEDNEytARQGAKFPIKWTAPEAALy |
| P12931 | Y530 | EPSD|PSP | SRC SRC1 | PTFEYLQAFLEDyFtstEPQyQPGENL______________ |
| P12956 | S477 | EPSD|PSP | XRCC6 G22P1 | EQVGKMKAIVEKLRFtYRsDsFENPVLQQHFRNLEALALDL |
| P13489 | S178 | Sugiyama | RNH1 PRI RNH | SCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKDSP |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P13929 | S37 | Sugiyama | ENO3 | NPtVEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRY |
| P13929 | S40 | Sugiyama | ENO3 | VEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGK |
| P13929 | T41 | Sugiyama | ENO3 | EVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKG |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14314 | S451 | Sugiyama | PRKCSH G19P1 | KLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSAMKyEQGtGC |
| P14314 | S478 | Sugiyama | PRKCSH G19P1 | DKFSAMKyEQGtGCWQGPNRstTVRLLCGKEtMVtStTEPS |
| P14314 | T444 | Sugiyama | PRKCSH G19P1 | VYRLCPFKLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSAMK |
| P14618 | S97 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sHGtHEyHAEtIKNVRtAtEsFAsDPILyRPVAVALDTKGP |
| P14618 | T95 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | NFsHGtHEyHAEtIKNVRtAtEsFAsDPILyRPVAVALDTK |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | S515 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQ |
| P14625 | T150 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | EELTVKIKCDKEKNLLHVtDtGVGMtREELVKNLGTIAKsG |
| P14625 | T155 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | KIKCDKEKNLLHVtDtGVGMtREELVKNLGTIAKsGtsEFL |
| P14625 | T519 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | DHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIy |
| P14649 | T101 | Sugiyama | MYL6B MLC1SA | DGKILysQCGDVMRALGQNPtNAEVLKVLGNPKsDELKSRR |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P15822 | S1749 | EPSD|PSP | HIVEP1 ZNF40 | ISVGRLsPQQEsSASSKRMLsPANsLDIAMEKHQKRAKDEN |
| P15880 | T232 | Sugiyama | RPS2 RPS4 | KLLMMAGIDDCytsARGCtAtLGNFAKATFDAISKTysyLt |
| P15880 | T278 | Sugiyama | RPS2 RPS4 | EtVFtKsPyQEFtDHLVKtHtRVsVQRtQAPAVATt_____ |
| P15880 | T285 | Sugiyama | RPS2 RPS4 | PyQEFtDHLVKtHtRVsVQRtQAPAVATt____________ |
| P16401 | S92 | Sugiyama | H1-5 H1F5 HIST1H1B | GGYDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P16401 | T95 | Sugiyama | H1-5 H1F5 HIST1H1B | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16402 | S90 | Sugiyama | H1-3 H1F3 HIST1H1D | AGyDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P16402 | T93 | Sugiyama | H1-3 H1F3 HIST1H1D | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S89 | Sugiyama | H1-2 H1F2 HIST1H1C | AGyDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P16403 | T92 | Sugiyama | H1-2 H1F2 HIST1H1C | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16989 | T112 | EPSD|PSP | YBX3 CSDA DBPA | LGTVKWFNVRNGYGFINRNDtKEDVFVHQtAIKKNNPRKYL |
| P18124 | T170 | Sugiyama | RPL7 | VNELIyKRGYGKINKKRIALtDNALIARSLGKyGIICMEDL |
| P18615 | S115 | Sugiyama | NELFE RD RDBP | KLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLyEs |
| P18615 | S165 | Sugiyama | NELFE RD RDBP | ELGPDGEEAEGPGAGDGPPRsFDWGyEERSGAHSsAsPPRs |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18669 | S14 | Sugiyama | PGAM1 PGAMA CDABP0006 | _______MAAYKLVLIRHGEsAWNLENRFsGWyDADLsPAG |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P18669 | S155 | Sugiyama | PGAM1 PGAMA CDABP0006 | NIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQI |
| P18754 | S90 | Sugiyama | RCC1 CHC1 | VQAEAGGMHTVCLSKsGQVysFGCNDEGALGRDtsVEGSEM |
| P18858 | S76 | EPSD|PSP | LIG1 | PGRKAARVLGsEGEEEDEALsPAKGQKPALDCsQVsPPRPA |
| P19338 | S356 | Sugiyama | NCL | LAVVDVRIGMTRKFGyVDFEsAEDLEKALELtGLKVFGNEI |
| P19338 | S532 | Sugiyama | NCL | IKVPQNQNGKSKGyAFIEFAsFEDAKEALNSCNKREIEGRA |
| P19338 | Y525 | Sugiyama | NCL | VFEKATFIKVPQNQNGKSKGyAFIEFAsFEDAKEALNSCNK |
| P19838 | S328 | SIGNOR|EPSD|PSP | NFKB1 | QFAIVFKTPKYKDINITKPAsVFVQLRRKsDLETSEPKPFL |
| P20042 | S67 | Sugiyama | EIF2S2 EIF2B | EPtEDKDLEADEEDTRKKDAsDDLDDLNFFNQKKKKKKTKK |
| P20674 | S104 | Sugiyama | COX5A | PEPKIIDAALRACRRLNDFAstVRILEVVKDKAGPHKEIYP |
| P21108 | S11 | Sugiyama | PRPS1L1 PRPS3 PRPSL | __________MPNIKIFsGssHQDLSQKIADRLGLELGKVV |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22090 | T141 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | YKLCKVRKITVGVKGIPHLVtHDARTIRYPDPVIKVNDTVQ |
| P22314 | S46 | Sugiyama | UBA1 A1S9T UBE1 | AQsVLsEVPSVPTNGMAKNGsEADIDEGLysRQLyVLGHEA |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P22626 | S225 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNFGFGDsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyN |
| P22626 | T159 | EPSD|PSP | HNRNPA2B1 HNRPA2B1 | DtIEIItDRQsGKKRGFGFVtFDDHDPVDKIVLQKyHtING |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P23588 | S131 | Sugiyama | EIF4B | SIKEFFRGLNIsAVRLPREPsNPERLKGFGyAEFEDLDSLL |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P23588 | T205 | Sugiyama | EIF4B | GRDRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYR |
| P25205 | S160 | EPSD|PSP | MCM3 | KVVRSVHYCPATKKTIERRysDLttLVAFPSSSVYPTKDEE |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26038 | T526 | Sugiyama | MSN | EERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHA |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | T107 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | HKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILF |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26373 | T170 | EPSD|PSP | RPL13 BBC1 OK/SW-cl.46 | LtGPVMPVRNVYKKEKARVItEEEKNFKAFAsLRMARANAR |
| P26447 | S60 | Sugiyama | S100A4 CAPL MTS1 | RELPSFLGKRTDEAAFQKLMsNLDSNRDNEVDFQEYCVFLS |
| P27708 | S1859 | Sugiyama | CAD | RGIPGLPDGRFHLPPRIHRAsDPGLPAEEPKEKSSRKVAEP |
| P27797 | S35 | Sugiyama | CALR CRTC | AVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssGK |
| P27797 | S40 | Sugiyama | CALR CRTC | AVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssGKFyGDE |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27816 | T521 | SIGNOR | MAP4 | GLLKDMsPLsEtEMALGKDVtPPPEtEVVLIKNVCLPPEME |
| P27816 | T925 | EPSD|PSP | MAP4 | DKKPTSAKPssttPRLSRLAtNtsAPDLKNVRsKVGstENI |
| P27824 | S554 | Sugiyama | CANX | EKDKGDEEEEGEEKLEEKQKsDAEEDGGtVsQEEEDRKPKA |
| P29401 | S105 | Sugiyama | TKT | VWAEAGFLAEAELLNLRKIssDLDGHPVPKQAFtDVATGsL |
| P29401 | S332 | Sugiyama | TKT | GDKIATRKAYGQALAKLGHAsDRIIALDGDtKNstFsEIFK |
| P29401 | T442 | Sugiyama | TKT | GEDGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAA |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P29692 | S64 | Sugiyama | EEF1D EF1D | sVILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRI |
| P29692 | S86 | Sugiyama | EEF1D EF1D | GPGAssGtsGDHGELVVRIAsLEVENQsLRGVVQELQQAIs |
| P29692 | T129 | Sugiyama | EEF1D EF1D | EARLNVLEKssPGHRAtAPQtQHVsPMRQVEPPAKKPAtPA |
| P30043 | T190 | Sugiyama | BLVRB FLR SCAN | RGPSRVISKHDLGHFMLRCLttDEyDGHstyPsHQyQ____ |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P30085 | S180 | Sugiyama | CMPK1 CMK CMPK UCK UMK UMPK | KPIIDLyEEMGKVKKIDASKsVDEVFDEVVQIFDKEG____ |
| P30086 | S139 | Sugiyama | PEBP1 PBP PEBP | RyVWLVyEQDRPLKCDEPILsNRsGDHRGKFKVAsFRKKyE |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30086 | T167 | Sugiyama | PEBP1 PBP PEBP | GKFKVAsFRKKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK |
| P30101 | S474 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yFsPANKKLNPKKyEGGRELsDFIsyLQREAtNPPVIQEEK |
| P30101 | S478 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | ANKKLNPKKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKK |
| P30101 | S98 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | VPLAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAyDGP |
| P30101 | T102 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAyDGPRtAD |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P30101 | Y100 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAyDGPRt |
| P30304 | S124 | SIGNOR|ELM|iPTMNet|EPSD|PSP | CDC25A | RIHsLPQKLLGCsPALKRSHsDSLDHDIFQLIDPDENKENE |
| P30304 | S178 | SIGNOR|ELM|EPSD|PSP | CDC25A | GCLHSHGLQEGKDLFTQRQNsAPARMLsSNERDSSEPGNFI |
| P30304 | S239 | iPTMNet | CDC25A | VDLLDGENLKNEEETPSCMAsLWTAPLVMRTTNLDNRCKLF |
| P30304 | S279 | SIGNOR|ELM|EPSD|PSP | CDC25A | FDsPsLCssSTRSVLKRPERsQEEsPPGSTKRRKsMsGASP |
| P30304 | S293 | SIGNOR|ELM|EPSD|PSP | CDC25A | LKRPERsQEEsPPGSTKRRKsMsGASPKESTNPEKAHETLH |
| P30304 | S76 | SIGNOR|ELM|EPSD|PSP | CDC25A | GSDyEQPLEVKNNSNLQRMGsSEstDsGFCLDsPGPLDSKE |
| P30304 | T507 | SIGNOR|ELM|EPSD|PSP | CDC25A | RPMHHEDFKEDLKKFRTKSRtWAGEKsKREMYsRLKKL___ |
| P30305 | S230 | SIGNOR|ELM|EPSD|PSP | CDC25B CDC25HU2 | STHALAEWAsRREAFAQRPssAPDLMCLsPDRKMEVEELsP |
| P30305 | S563 | EPSD|PSP | CDC25B CDC25HU2 | RPMNHEAFKDELKTFRLKTRsWAGERSRRELCSRLQDQ___ |
| P30307 | S216 | SIGNOR|iPTMNet|EPSD|PSP | CDC25C | EFsLKDQEAKVSRsGLYRsPsMPENLNRPRLKQVEKFKDNt |
| P30533 | S230 | Sugiyama | LRPAP1 A2MRAP | SDIKGSVLHSRHTELKEKLRsINQGLDRLRRVsHQGystEA |
| P30533 | T134 | Sugiyama | LRPAP1 A2MRAP | NLNVILAKYGLDGKKDARQVtsNsLsGtQEDGLDDPRLEKL |
| P30533 | T248 | Sugiyama | LRPAP1 A2MRAP | LRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWDLAQSAN |
| P30533 | Y246 | Sugiyama | LRPAP1 A2MRAP | EKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWDLAQS |
| P31327 | S564 | Sugiyama | CPS1 | TEDRQLFSDKLNEINEKIAPsFAVEsIEDALKAADTIGyPV |
| P31327 | S569 | Sugiyama | CPS1 | LFSDKLNEINEKIAPsFAVEsIEDALKAADTIGyPVMIRSA |
| P31327 | S835 | Sugiyama | CPS1 | MCHPsIEGFTPRLPMNKEWPsNLDLRKELSEPSsTRIyAIA |
| P31327 | T45 | Sugiyama | CPS1 | AHQKWKFSRPGIRLLSVKAQtAHIVLEDGtKMKGYSFGHPS |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P33991 | S54 | GPS6|ELM|EPSD | MCM4 CDC21 | sQRRRGEDSTSTGELQPMPtsPGVDLQSPAAQDVLFSsPPQ |
| P33992 | T633 | EPSD|PSP | MCM5 CDC46 | LEAIVRIAEALSKMKLQPFAtEADVEEALRLFQVSTLDAAL |
| P34932 | S363 | Sugiyama | HSPA4 APG2 HSPH2 | GATRIPAVKEKISKFFGKELsttLNADEAVTRGCALQCAIL |
| P34932 | S76 | Sugiyama | HSPA4 APG2 HSPH2 | VISNAKNTVQGFKRFHGRAFsDPFVEAEKSNLAYDIVQLPT |
| P35269 | T154 | Sugiyama | GTF2F1 RAP74 | AFEAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHF |
| P35579 | S1304 | Sugiyama | MYH9 | NVtGLLsQsDSKSSKLTKDFsALEsQLQDtQELLQEENRQK |
| P35579 | S1308 | Sugiyama | MYH9 | LLsQsDSKSSKLTKDFsALEsQLQDtQELLQEENRQKLsLs |
| P35579 | S1915 | Sugiyama | MYH9 | KLQRELEDAtEtADAMNREVssLKNKLRRGDLPFVVPRRMA |
| P35579 | T1906 | Sugiyama | MYH9 | AQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRGDL |
| P35611 | S726 | EPSD|PSP | ADD1 ADDA | GsDGSPGKSPsKKKKKFRtPsFLKKSKKKSDS_________ |
| P35612 | S713 | EPSD|PSP | ADD2 ADDB | sPEGsPsKsPsKKKKKFRTPsFLKKSKKKEKVEs_______ |
| P35637 | S462 | Sugiyama | FUS TLS | NECNQCKAPKPDGPGGGPGGsHMGGNyGDDRRGGRGGYDRG |
| P36507 | T59 | EPSD|PSP | MAP2K2 MEK2 MKK2 PRKMK2 | KKLEELELDEQQKKRLEAFLtQKAKVGELKDDDFERIsELG |
| P36578 | S272 | Sugiyama | RPL4 RPL1 | WtEsAFRKLDELyGtWRKAAsLKsNyNLPMHKMINtDLsRI |
| P36578 | S275 | Sugiyama | RPL4 RPL1 | sAFRKLDELyGtWRKAAsLKsNyNLPMHKMINtDLsRILKs |
| P36578 | S365 | Sugiyama | RPL4 RPL1 | RNHKLRVDKAAAAAAALQAKsDEKAAVAGKKPVVGKKGKKA |
| P36578 | S55 | Sugiyama | RPL4 RPL1 | DIVNFVHTNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVAR |
| P36578 | S63 | Sugiyama | RPL4 RPL1 | NLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGG |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T62 | Sugiyama | RPL4 RPL1 | TNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGG |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P36578 | Y277 | Sugiyama | RPL4 RPL1 | FRKLDELyGtWRKAAsLKsNyNLPMHKMINtDLsRILKsPE |
| P37108 | T45 | Sugiyama | SRP14 | sVyItLKKYDGRTKPIPKKGtVEGFEPADNKCLLRATDGKK |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P38646 | S549 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | IVHVSAKDKGTGREQQIVIQssGGLsKDDIENMVKNAEKYA |
| P38646 | S554 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | AKDKGTGREQQIVIQssGGLsKDDIENMVKNAEKYAEEDRR |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P39019 | S59 | Sugiyama | RPS19 | LAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIY |
| P39019 | S93 | Sugiyama | RPS19 | GsMTKIYGGRQRNGVMPsHFsRGsKsVARRVLQALEGLKMV |
| P39019 | T55 | Sugiyama | RPS19 | DtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsM |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P39023 | T305 | Sugiyama | RPL3 OK/SW-cl.32 | YKIGQGyLIKDGKLIKNNAstDyDLSDKSINPLGGFVHYGE |
| P39748 | S255 | Sugiyama | FEN1 RAD2 | CESIRGIGPKRAVDLIQKHKsIEEIVRRLDPNKYPVPENWL |
| P39748 | T195 | EPSD|PSP | FEN1 RAD2 | AATEDMDCLTFGsPVLMRHLtASEAKKLPIQEFHLsRILQE |
| P40227 | S301 | Sugiyama | CCT6A CCT6 CCTZ | VCGDSDKGFVVINQKGIDPFsLDALsKEGIVALRRAKRRNM |
| P40227 | S306 | Sugiyama | CCT6A CCT6 CCTZ | DKGFVVINQKGIDPFsLDALsKEGIVALRRAKRRNMERLTL |
| P40429 | T153 | Sugiyama | RPL13A | RKFAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQ |
| P40429 | T155 | Sugiyama | RPL13A | FAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQLM |
| P40926 | S309 | Sugiyama | MDH2 | sTPLLLGKKGIEKNLGIGKVssFEEKMIsDAIPELKASIKK |
| P40926 | S310 | Sugiyama | MDH2 | TPLLLGKKGIEKNLGIGKVssFEEKMIsDAIPELKASIKKG |
| P41236 | T22 | Sugiyama | PPP1R2 IPP2 | AASTAsHRPIKGILKNKtsttssMVAsAEQPRGNVDEELSK |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43243 | S195 | EPSD|PSP | MATR3 KIAA0723 | RDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyD |
| P43243 | S4 | EPSD|PSP | MATR3 KIAA0723 | _________________MsKsFQQssLsRDsQGHGRDLsAA |
| P43243 | T150 | EPSD|PSP | MATR3 KIAA0723 | EDKItPENLPQILLQLKRRRtEEGPtLsyGRDGRsAtREPP |
| P43405 | S295 | SIGNOR|EPSD|PSP | SYK | QLPGSHPATWSAGGIISRIKsysFPKPGHRKssPAQGNRQE |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P43490 | S472 | Sugiyama | NAMPT PBEF PBEF1 | EYGQDLLHTVFKNGKVTKsysFDEIRKNAQLNIELEAAHH_ |
| P46013 | T1764 | EPSD|PSP | MKI67 | LVDtPtssKPQPKRSLRKADtEEEFLAFRKQTPSAGKAMHt |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46776 | Y52 | Sugiyama | RPL27A | RGNAGGLHHHRINFDKyHPGyFGKVGMKHYHLKRNQsFCPt |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46777 | Y210 | Sugiyama | RPL5 MSTP030 | FNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyIKNs |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P47914 | S142 | Sugiyama | RPL29 | KAKAKAKAKDQTKAQAAAPAsVPAQAPKRtQAPtKAsE___ |
| P47914 | Y98 | Sugiyama | RPL29 | PKEVKPKIPKGVSRKLDRLAyIAHPKLGKRARARIAKGLRL |
| P48730 | S181 | GPS6 | CSNK1D HCKID | tHQHIPYRENKNLtGtARYAsINtHLGIEQsRRDDLESLGY |
| P48730 | T161 | GPS6 | CSNK1D HCKID | KGNLVyIIDFGLAKKyRDARtHQHIPYRENKNLtGtARYAs |
| P48730 | T174 | GPS6 | CSNK1D HCKID | KKyRDARtHQHIPYRENKNLtGtARYAsINtHLGIEQsRRD |
| P48730 | T176 | GPS6 | CSNK1D HCKID | yRDARtHQHIPYRENKNLtGtARYAsINtHLGIEQsRRDDL |
| P49327 | S265 | Sugiyama | FASN FAS | TILNAGTNTDGFKEQGVtFPsGDIQEQLIRSLyQsAGVAPE |
| P49327 | T2215 | Sugiyama | FASN FAS | DEAsELACPtPKEDGLAQQQtQLNLRSLLVNPEGPtLMRLN |
| P49588 | S775 | Sugiyama | AARS1 AARS | VTGAEAQKALRKAESLKKCLsVMEAKVKAQTAPNKDVQREI |
| P49790 | S297 | EPSD|PSP | NUP153 | KLRNtPYQAPVRRQMKAKQLsAQSYGVTSstARRILQsLEK |
| P49790 | S330 | EPSD|PSP | NUP153 | RILQsLEKMSsPLADAKRIPsIVssPLNsPLDRsGIDItDF |
| P49792 | T1098 | EPSD|PSP | RANBP2 NUP358 | GDGYsGAKPIPGGQTIGPRNtFNFGSKNVsGIsFtENMGss |
| P50454 | S132 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | GELLRSLSNSTARNVTWKLGsRLyGPssVsFADDFVRssKQ |
| P50454 | S138 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | LSNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEH |
| P50454 | S139 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | SNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHS |
| P50454 | S141 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | STARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHSKI |
| P50454 | Y135 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | LRSLSNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYN |
| P50914 | S16 | Sugiyama | RPL14 | _____MVFRRFVEVGRVAyVsFGPHAGKLVAIVDVIDQNRA |
| P50990 | S23 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | LHVPKAPGFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTT |
| P51587 | T3387 | GPS6|EPSD | BRCA2 FACD FANCD1 | ESTRTAPTSSEDYLRLKRRCtTSLIKEQESSQASTEECEKN |
| P51858 | S69 | Sugiyama | HDGF HMG1L2 | FFGTHETAFLGPKDLFPyEEsKEKFGKPNKRKGFsEGLWEI |
| P52272 | S432 | EPSD|PSP | HNRNPM HNRPM NAGR1 | GGAGMERMGAGLGHGMDRVGsEIERMGLVMDRMGsVERMGs |
| P52292 | S54 | EPSD|PSP | KPNA2 RCH1 SRP1 | VNVELRKAKKDDQMLKRRNVssFPDDAtsPLQENRNNQGtV |
| P52294 | S18 | EPSD|PSP | KPNA1 RCH2 | ___MttPGKENFRLKSYKNKsLNPDEMRRRREEEGLQLRKQ |
| P53350 | S137 | PSP | PLK1 PLK | HGFFEDNDFVFVVLELCRRRsLLELHKRRKALTEPEARYYL |
| P53350 | S529 | SIGNOR | PLK1 PLK | PYLRTWFRTRSAIILHLSNGsVQINFFQDHtKLILCPLMAA |
| P53350 | T210 | PSP | PLK1 PLK | VKIGDFGLATKVEYDGERKKtLCGtPNyIAPEVLSKKGHSF |
| P53350 | T539 | SIGNOR | PLK1 PLK | SAIILHLSNGsVQINFFQDHtKLILCPLMAAVTYIDEKRDF |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53396 | S656 | Sugiyama | ACLY | IGNTGGMLDNILASKLyRPGsVAyVSRsGGMsNELNNIISR |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54132 | S502 | PSP | BLM RECQ2 RECQL3 | TRKNLFERPLFNTHLQKsFVsSNWAEtPRLGKKNEsSYFPG |
| P54132 | S539 | EPSD|PSP | BLM RECQ2 RECQL3 | YFPGNVLtstAVKDQNKHTAsINDLERETQPSYDIDNFDID |
| P54132 | S646 | SIGNOR|EPSD|PSP | BLM RECQ2 RECQL3 | YTDKSAQNLASRNLKHERFQsLSFPHTKEMMKIFHKKFGLH |
| P54132 | T182 | SIGNOR|EPSD|PSP | BLM RECQ2 RECQL3 | TSETSKsFVtPPQsHFVRVStAQKSKKGKRNFFKAQLYTTN |
| P55039 | S72 | EPSD|PSP | DRG2 | GEGFDVMKSGDARVALIGFPsVGKSTFLSLMTSTASEAASY |
| P55735 | S184 | Sugiyama | SEC13 D3S1231E SEC13A SEC13L1 SEC13R | PGsLIDHPSGQKPNYIKRFAsGGCDNLIKLWKEEEDGQWKE |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P60174 | S198 | Sugiyama | TPI1 TPI | TPQQAQEVHEKLRGWLKsNVsDAVAQstRIIyGGsVtGAtC |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60660 | T44 | Sugiyama | MYL6 | DGKILysQCGDVMRALGQNPtNAEVLKVLGNPKsDEMNVKV |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T201 | Sugiyama | ACTB | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P60709 | T202 | Sugiyama | ACTB | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P60891 | S11 | Sugiyama | PRPS1 | __________MPNIKIFsGssHQDLSQKIADRLGLELGKVV |
| P61221 | Y594 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | RPRINKLNsIKDVEQKKsGNyFFLDD_______________ |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61313 | S118 | Sugiyama | RPL15 EC45 TCBAP0781 | LQsVAEERAGRHCGALRVLNsyWVGEDSTyKFFEVILIDPF |
| P61353 | S86 | Sugiyama | RPL27 | SKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPAL |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61978 | Y72 | Sugiyama | HNRNPK HNRPK | KNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISA |
| P62081 | S174 | Sugiyama | RPS7 | IKVHLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEFQL |
| P62081 | T172 | Sugiyama | RPS7 | RLIKVHLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEF |
| P62241 | S160 | Sugiyama | RPS8 OK/SW-cl.83 | KRSKKIQKKYDERKKNAKIssLLEEQFQQGKLLACIASRPG |
| P62241 | S4 | Sugiyama | RPS8 OK/SW-cl.83 | _________________MGIsRDNWHKRRKTGGKRKPYHKK |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62266 | S45 | Sugiyama | RPS23 | KQYKKAHLGtALKANPFGGAsHAKGIVLEKVGVEAKQPNSA |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62316 | T40 | Sugiyama | SNRPD2 SNRPD1 | EEEEFNtGPLsVLtQsVKNNtQVLINCRNNKKLLGRVKAFD |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62701 | T141 | Sugiyama | RPS4X CCG2 RPS4 SCAR | YKLCKVRKIFVGTKGIPHLVtHDARTIRYPDPLIKVNDtIQ |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62753 | S53 | Sugiyama | RPS6 OK/SW-cl.2 | AtEVAADALGEEWKGYVVRIsGGNDKQGFPMKQGVLTHGRV |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62826 | T32 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KLVLVGDGGtGKttFVKRHLtGEFEKKyVATLGVEVHPLVF |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62899 | T104 | Sugiyama | RPL31 | IRVRLSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDE |
| P62899 | T107 | Sugiyama | RPL31 | RLSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN__ |
| P62899 | T112 | Sugiyama | RPL31 | RNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN_______ |
| P62899 | T22 | Sugiyama | RPL31 | APAKKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRA |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62899 | Y108 | Sugiyama | RPL31 | LSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN___ |
| P62906 | S113 | Sugiyama | RPL10A NEDD6 | LNKNKKLVKKLAKKyDAFLAsEsLIKQIPRILGPGLNKAGK |
| P62906 | S115 | Sugiyama | RPL10A NEDD6 | KNKKLVKKLAKKyDAFLAsEsLIKQIPRILGPGLNKAGKFP |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S138 | Sugiyama | RPL8 | EKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVI |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62937 | S51 | Sugiyama | PPIA CYPA | KtAENFRALSTGEKGFGYKGsCFHRIIPGFMCQGGDFtRHN |
| P62979 | S123 | Sugiyama | RPS27A UBA80 UBCEP1 | LKYYKVDENGKIsRLRRECPsDECGAGVFMAsHFDRHyCGK |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P63104 | S145 | Sugiyama | YWHAZ | YYRyLAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHP |
| P63104 | S156 | Sugiyama | YWHAZ | DDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLGLALNFSV |
| P63104 | Y149 | Sugiyama | YWHAZ | LAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLG |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63220 | S65 | Sugiyama | RPS21 | RFNGQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF__ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T201 | Sugiyama | ACTG1 ACTG | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P63261 | T202 | Sugiyama | ACTG1 ACTG | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | T80 | EPSD|PSP|Sugiyama | YBX1 NSEP1 YB1 | LGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIKKNNPRKyL |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P67870 | T213 | EPSD|PSP | CSNK2B CK2N G5A | HPMAYQLQLQAAsNFKsPVKtIR__________________ |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68104 | T23 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | KEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFE |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68363 | S54 | Sugiyama | TUBA1B | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P68363 | T82 | Sugiyama | TUBA1B | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P68431 | T12 | GPS6|EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | _________MARtKQtARKstGGKAPRKQLATKAARKsAPA |
| P68431 | T46 | Sugiyama | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | S7 | Sugiyama | RPL24 | ______________MKVELCsFsGyKIYPGHGRRYARTDGK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S12 | EPSD|PSP|Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84098 | S122 | Sugiyama | RPL19 | LRRLLRRYRESKKIDRHMyHsLyLKVKGNVFKNKRILMEHI |
| P84098 | S13 | Sugiyama | RPL19 | ________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEIA |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| P84098 | T56 | EPSD|PSP | RPL19 | NsRQQIRKLIKDGLIIRKPVtVHsRARCRKNTLARRKGRHM |
| P84098 | Y124 | Sugiyama | RPL19 | RLLRRYRESKKIDRHMyHsLyLKVKGNVFKNKRILMEHIHK |
| P84243 | S32 | EPSD | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | tGGKAPRKQLATKAARKsAPsTGGVKKPHRyRPGtVALREI |
| P84243 | T12 | SIGNOR | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | _________MARtKQTARKstGGKAPRKQLATKAARKsAPs |
| P84243 | T46 | Sugiyama | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | ARKsAPsTGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P85299 | S240 | EPSD|PSP | PRR5 PROTOR1 PP610 | SEGPFTHSCILEKRLLRRsRsGDVLAKNPVVRsKsYNtPLL |
| Q00341 | T8 | EPSD|PSP | HDLBP HBP VGL | _____________MssVAVLtQEsFAEHRSGLVPQQIKVAt |
| Q00610 | S147 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | VYHWSMEGESQPVKMFDRHssLAGCQIINYRTDAKQKWLLL |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01650 | S31 | Sugiyama | SLC7A5 CD98LC LAT1 MPE16 | LAAPAAEEKEEAREKMLAAKsADGsAPAGEGEGVtLQRNIT |
| Q02539 | S92 | Sugiyama | H1-1 H1F1 HIST1H1A | AGyDVEKNNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNK |
| Q02539 | T95 | Sugiyama | H1-1 H1F1 HIST1H1A | DVEKNNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNKKAS |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q02543 | T101 | Sugiyama | RPL18A | WLRYDsRSGtHNMYREyRDLttAGAVtQCyRDMGARHRARA |
| Q02543 | T107 | Sugiyama | RPL18A | RSGtHNMYREyRDLttAGAVtQCyRDMGARHRARAHsIQIM |
| Q02543 | Y97 | Sugiyama | RPL18A | NFGIWLRYDsRSGtHNMYREyRDLttAGAVtQCyRDMGARH |
| Q02750 | T55 | EPSD|PSP | MAP2K1 MEK1 PRKMK1 | KKLEELELDEQQRKRLEAFLtQKQKVGELKDDDFEKIsELG |
| Q02878 | T213 | Sugiyama | RPL6 TXREB1 | FVIAtsTKIDISNVKIPKHLtDAyFKKKKLRKPRHQEGEIF |
| Q04206 | T505 | EPSD|PSP | RELA NFKB3 | APHTTEPMLMEYPEAITRLVtGAQRPPDPAPAPLGAPGLPN |
| Q04837 | S67 | EPSD|PSP | SSBP1 SSBP | QVEGKNPVTIFSLATNEMWRsGDsEVyQLGDVsQKTTWHRI |
| Q04917 | T31 | Sugiyama | YWHAH YWHA1 | ARLAEQAERyDDMAsAMKAVtELNEPLsNEDRNLLsVAyKN |
| Q05639 | T23 | Sugiyama | EEF1A2 EEF1AL STN | KEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFE |
| Q06609 | T309 | SIGNOR|EPSD|PSP | RAD51 RAD51A RECA | GNIIAHASTTRLYLRKGRGEtRICKIyDSPCLPEAEAMFAI |
| Q06830 | S152 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | IIDDKGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEV |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q06830 | T156 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | KGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEVCPAG |
| Q07020 | S140 | Sugiyama | RPL18 | ILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAPGtPH |
| Q07020 | S41 | Sugiyama | RPL18 | QDIyLRLLVKLYRFLARRtNstFNQVVLKRLFMSRtNRPPL |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07020 | T42 | Sugiyama | RPL18 | DIyLRLLVKLYRFLARRtNstFNQVVLKRLFMSRtNRPPLs |
| Q07666 | S20 | Sugiyama | KHDRBS1 SAM68 | _MQRRDDPAARMsRssGRsGsMDPsGAHPsVRQtPsRQPPL |
| Q07955 | S182 | Sugiyama | SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3 | FVRKEDMTYAVRKLDNTKFRsHEGEtAyIRVKVDGPRsPsy |
| Q08AD1 | S464 | EPSD|PSP | CAMSAP2 CAMSAP1L1 KIAA1078 | FDKEDSVQRstPNRGITRsIsNEGLtLNNsHVsKHIRKNLS |
| Q08J23 | S593 | Sugiyama | NSUN2 SAKI TRM4 | NNSEKMKVINTGIKVWCRNNsGEEFDCAFRLAQEGIYTLYP |
| Q09028 | S146 | Sugiyama | RBBP4 RBAP48 | EVNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGE |
| Q12789 | S667 | EPSD|PSP | GTF3C1 | QEGVSTKCCKKSIVRLVRNLsEEGLLRLYRTTVIQDGIKKK |
| Q12888 | S1678 | EPSD|PSP | TP53BP1 | RAsMGVLsGKRKLItsEEERsPAKRGRKSAtVKPGAVGAGE |
| Q12965 | S1002 | Sugiyama | MYO1E MYO1C | RSNQKSLyTsMARPPLPRQQstssDRVsQtPEsLDFLKVPD |
| Q13043 | T340 | EPSD|PSP | STK4 KRS2 MST1 | sEEDEMDsGtMVRAVGDEMGtVRVASTMTDGANtMIEHDDT |
| Q13242 | S172 | Sugiyama | SRSF9 SFRS9 SRP30C | yLRKEDMEYALRKLDDTKFRsHEGEtsYIRVYPERstsYGY |
| Q13243 | S153 | Sugiyama | SRSF5 HRS SFRS5 SRP40 | EVTFADAHRPKLNEGVVEFAsYGDLKNAIEKLSGKEINGRK |
| Q13257 | S185 | EPSD|PSP | MAD2L1 MAD2 | EKWEEsGPQFITNsEEVRLRsFtTTIHKVNsMVAYKIPVND |
| Q13257 | T187 | EPSD|PSP | MAD2L1 MAD2 | WEEsGPQFITNsEEVRLRsFtTTIHKVNsMVAYKIPVND__ |
| Q13263 | S473 | EPSD|PSP|Sugiyama | TRIM28 KAP1 RNF96 TIF1B | sGDDPyssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERL |
| Q13283 | S362 | Sugiyama | G3BP1 G3BP | LFIGNLPHEVDKSELKDFFQsyGNVVELRINsGGKLPNFGF |
| Q13283 | S67 | Sugiyama | G3BP1 G3BP | sNGKPADAVyGQKEIHRKVMsQNFtNCHTKIRHVDAHATLN |
| Q13310 | T191 | Sugiyama | PABPC4 APP1 PABP4 | GRFKSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELF |
| Q13310 | Y194 | Sugiyama | PABPC4 APP1 PABP4 | KSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELFsQF |
| Q13439 | S71 | EPSD|PSP | GOLGA4 | PNRESGDTQSFAQKLQLRVPsVEsLFRsPIKESLFRsssKE |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q13442 | T18 | Sugiyama | PDAP1 HASPP28 | ___MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEE |
| Q13470 | S502 | EPSD|PSP | TNK1 | PPARGQRRNMPLERMKGIsRsLEsVLsLGPRPtGGGssPPE |
| Q13509 | S115 | Sugiyama | TUBB3 TUBB4 | SGAGNNWAKGHytEGAELVDsVLDVVRKECENCDCLQGFQL |
| Q13509 | T107 | Sugiyama | TUBB3 TUBB4 | PDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECENC |
| Q13885 | S115 | Sugiyama | TUBB2A TUBB2 | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q13885 | T107 | Sugiyama | TUBB2A TUBB2 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q13907 | S55 | EPSD|PSP | IDI1 | TKKNCHLNENIEKGLLHRAFsVFLFNTENKLLLQQRSDAKI |
| Q14004 | S437 | EPSD|PSP | CDK13 CDC2L CDC2L5 CHED KIAA1791 | SRHSRSRSRHRLSRSRSRHssIsPsTLTLKSSLAAELNKNK |
| Q14152 | S1256 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EDRFRRPRDEGGWRRGPAEEsssWRDssRRDDRDRDDRRRE |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14186 | S23 | EPSD|PSP | TFDP1 DP1 | KDAGLIEANGELKVFIDQNLsPGKGVVsLVAVHPSTVNPLG |
| Q14247 | S298 | EPSD|PSP | CTTN EMS1 | ERQDsAAVGFDyKEKLAKHEsQQDySKGFGGKyGVQKDRMD |
| Q14498 | S334 | Sugiyama | RBM39 HCC1 RNPC2 | FELAGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtT |
| Q14498 | S337 | Sugiyama | RBM39 HCC1 RNPC2 | AGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtTGRL |
| Q14498 | T330 | Sugiyama | RBM39 HCC1 RNPC2 | QLNGFELAGRPMKVGHVTERtDAssAssFLDsDELERtGID |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14669 | S1078 | EPSD|PSP | TRIP12 KIAA0045 ULF | NSNNIEPARTAGGSGLARAAsKDTISNNREKIKGWIKEQAH |
| Q14676 | T523 | EPSD|PSP | MDC1 KIAA0170 NFBD1 | KssPGIHLERsQAsttVDINtQVEKEVPPGSAIIHIKKHQV |
| Q14738 | S60 | EPSD|PSP | PPP2R5D | PQPQPQPQAQSQPPSSNKRPsNstPPPTQLSKIKYsGGPQI |
| Q14966 | S375 | EPSD|PSP | ZNF638 NP220 ZFML | PVINSSNVHVGsRGsKKNYQsQADIPIRsPFGIVKASWLPK |
| Q15084 | S389 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | FALLKGsFsEQGINEFLRELsFGRGstAPVGGGAFPtIVER |
| Q15181 | S248 | Sugiyama | PPA1 IOPPP PP | KALVTKKTNGKGIsCMNttLsEsPFKCDPDAARAIVDALPP |
| Q15181 | T245 | Sugiyama | PPA1 IOPPP PP | DHWKALVTKKTNGKGIsCMNttLsEsPFKCDPDAARAIVDA |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15185 | S82 | Sugiyama | PTGES3 P23 TEBP | NDsKHKRtDRsILCCLRKGEsGQsWPRLTKERAKLNWLsVD |
| Q15642 | S296 | Sugiyama | TRIP10 CIP4 STOT STP | FARPGDVEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRS |
| Q15648 | T704 | EPSD|PSP | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | sNKTKKKKSSRLPPEKPKHQtEDDFQRELFSMDVDSQNPIF |
| Q16143 | Y127 | SIGNOR|EPSD|PSP | SNCB | LIEPLMEPEGEsYEDPPQEEyQEYEPEA_____________ |
| Q16181 | T228 | EPSD|PSP | SEPTIN7 CDC10 SEPT7 | KKQIMKEIQEHKIKIyEFPEtDDEEENKLVKKIKDRLPLAV |
| Q16204 | S240 | EPSD|PSP | CCDC6 D10S170 TST1 | RMDKLEAEKRILQEKLDQPVsAPPsPRDIsMEIDsPENMMR |
| Q16204 | S244 | EPSD|PSP | CCDC6 D10S170 TST1 | LEAEKRILQEKLDQPVsAPPsPRDIsMEIDsPENMMRHIRF |
| Q16576 | S145 | Sugiyama | RBBP7 RBAP46 | EVNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGE |
| Q16695 | T46 | Sugiyama | H3-4 H3FT HIST3H3 | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q27J81 | S574 | EPSD|PSP | INF2 C14orf151 C14orf173 | HRRVNPPtLRMKKLNWQKLPsNVAREHNsMWAsLssPDAEA |
| Q32P44 | S176 | EPSD|PSP | EML3 | sSssssPSERPRQKLSRKAIssANLLVRsGstESRGGKDPL |
| Q32P51 | S22 | Sugiyama | HNRNPA1L2 HNRNPA1L | SKSASPKEPEQLRKLFIGGLsFEtTDESLRSHFEQWGTLTD |
| Q32P51 | T25 | Sugiyama | HNRNPA1L2 HNRNPA1L | ASPKEPEQLRKLFIGGLsFEtTDESLRSHFEQWGTLTDCVV |
| Q53F19 | S100 | EPSD|PSP | NCBP3 C17orf85 | VTSKEAIEKKEQRAKRFHFRsEVNLAQRNVALDRDMMKKAI |
| Q53H47 | S508 | SIGNOR|EPSD|PSP | SETMAR | FLDRIVTCDEKWILYDNRRRsAQWLDQEEAPKHFPKPILHP |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q5JSZ5 | S166 | EPSD|PSP | PRRC2B BAT2L BAT2L1 KIAA0515 | QLNGKPVGHEGGLRGSSRLLsFsPEEFPTLKAAGGQDKAGK |
| Q5JTH9 | S1049 | EPSD|PSP | RRP12 KIAA0690 | HRVLVNIRKAEARAKRHRALsQAAVEEEEEEEEEEEPAQGK |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5T5Y3 | S1398 | Sugiyama | CAMSAP1 | sCSDsGTKCSSTPDNLSRtQsGssLsLAsAAttEPESVHSG |
| Q5T8P6 | T839 | EPSD|PSP | RBM26 C13orf10 PRO1777 | LDLyKKMQAGEEVTELRRKYtELQLEAAKRGILSSGRGRGI |
| Q5UIP0 | S2205 | EPSD|PSP | RIF1 | GLKRsQEDEIssPVNKVRRVsFADPIYQAGLADDIDRRCSI |
| Q5VTE0 | T23 | Sugiyama | EEF1A1P5 EEF1AL3 | KEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFE |
| Q6NXT2 | T45 | Sugiyama | H3-5 H3F3C | AARKSTPSTCGVKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q6PD62 | S1081 | EPSD|PSP | CTR9 KIAA0155 SH2BP1 | ENQNKSGsEAGsPRRPRRQRsDQDsDsDQPSRKRRPsGsEQ |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PEY2 | S54 | Sugiyama | TUBA3E | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q6PKG0 | T747 | Sugiyama | LARP1 KIAA0731 LARP | PPVDPNQEVPPGPPRFQQVPtDALANKLFGAPEPstIARsL |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6T4R5 | T401 | EPSD|PSP | NHS | CSLVHSQsVLQRRRKLRRRKtISGIPRRVQQEIDsDEsPVA |
| Q6UB98 | S76 | EPSD | ANKRD12 ANCO2 KIAA0874 | SSMKRKLPFTISPSRNEERDsDTDSDPGHTSENWGERLISS |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q71DI3 | T46 | Sugiyama | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71U36 | S54 | Sugiyama | TUBA1A TUBA3 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q71U36 | T82 | Sugiyama | TUBA1A TUBA3 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q7KZF4 | S150 | Sugiyama | SND1 TDRD11 | EGLAtRREGMRANNPEQNRLsECEEQAKAAKKGMWSEGNGS |
| Q7Z2Z1 | S1045 | EPSD|PSP | TICRR C15orf42 | HsASFYSVSQPKSRSVQRVHsFQQDKSDQRENsPVQsIRsP |
| Q7Z2Z1 | S1115 | PSP | TICRR C15orf42 | LDSEVPAAyQtPKKSHQKSLsFSKTTPRRIsHtPQtPLYtP |
| Q7Z2Z1 | S1894 | EPSD|PSP | TICRR C15orf42 | LPstVEDsPFSRAFSRRRPIsRTYtRKKLMGTWLEDL____ |
| Q7Z2Z1 | S865 | EPSD|PSP | TICRR C15orf42 | QELRTRSAKKRRKNALIRHKsIAEVSQNLRQIEIPKVSKRA |
| Q7Z2Z1 | T1898 | EPSD|PSP | TICRR C15orf42 | VEDsPFSRAFSRRRPIsRTYtRKKLMGTWLEDL________ |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z4V5 | S300 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | AEKPLPKPRGRKPKPERPPSssSSDSDSDEVDRISEWKRRD |
| Q7Z4V5 | S395 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | REDDEPVKKRGRKGRGRGPPsssDsEPEAELEREAKKSAKK |
| Q7Z4V5 | S454 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | VRPEEKQQAKPVKVERTRKRsEGFsMDRKVEKKKEPSVEEK |
| Q86UE8 | S686 | EPSD|PSP | TLK2 | SVGVIFYQCLYGRKPFGHNQsQQDILQENtILKATEVQFPP |
| Q86UE8 | S750 | SIGNOR | TLK2 | IDVQQLACDPYLLPHIRKsVstssPAGAAIAstsGAsNNss |
| Q86WB0 | T84 | EPSD|PSP | ZC3HC1 NIPA HSPC216 | QAEQPSLESTSKEAFFSRVEtFSsLKWAGKPFELSPLVCAK |
| Q86WR7 | S43 | EPSD|PSP | PROSER2 C10orf47 | LRAFsRGGsLESRSSSSRsRsFtLDDEsLKYLTHEEKDVLL |
| Q8N201 | S495 | Sugiyama | INTS1 KIAA1440 UNQ1821/PRO3434 | KFLAMVFQDLLTNKDDYLRAsRALLREIIKQTKHEINFQAF |
| Q8N4C8 | T280 | EPSD|PSP | MINK1 B55 MAP4K6 MINK YSK2 ZC3 | KKFIDFIDTCLIKTYLSRPPtEQLLKFPFIRDQPTERQVRI |
| Q8N8S7 | S125 | Sugiyama | ENAH MENA | MHALEVLNSQETGPTLPRQNsQLPAQVQNGPSQEELEIQRR |
| Q8NBJ7 | S281 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | ADGsANHRARVttRMGNtPDsAsDNLGFRCAADAGRPPGEL |
| Q8NBJ7 | S283 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | GsANHRARVttRMGNtPDsAsDNLGFRCAADAGRPPGEL__ |
| Q8NBS9 | S426 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | KKVSEHSGGRDLDSLHRFVLsQAKDEL______________ |
| Q8NG66 | S273 | SIGNOR|EPSD|PSP | NEK11 | PERYPKELNAIMESMLNKNPsLRPSAIEILKIPYLDEQLQN |
| Q8NHW5 | S307 | Sugiyama | RPLP0P6 | AAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD__________ |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TD47 | T141 | Sugiyama | RPS4Y2 RPS4Y2P | YKLCKVRKITVGTKGIPHLVtHDARTIRYPDPLIKVNDTVQ |
| Q8WWI1 | S1510 | EPSD|PSP | LMO7 FBX20 FBXO20 KIAA0858 | RsAsVNKEPVSLPGIMRRGEsLDNLDsPRSNSWRQPPWLNQ |
| Q8WX93 | S479 | Sugiyama | PALLD KIAA0992 CGI-151 | VLECRVRGAPPLQVQWFRQGsEIQDsPDFRILQKKPRSTAE |
| Q92974 | S172 | EPSD|PSP | ARHGEF2 KIAA0651 LFP40 | ttNIAGHFNDEsPLGLRRILsQstDsLNMRNRTLsVESLID |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q96E09 | S37 | SIGNOR|PSP | PABIR1 C9orf42 FAM122A | GGsPAEGGGSGGGGGLRRsNsAPLIHGLsDtsPVFQAEAPS |
| Q96GD4 | S331 | SIGNOR|EPSD|PSP | AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 | NPSERLPLAQVSAHPWVRANsRRVLPPSALQSVA_______ |
| Q96PK6 | S618 | EPSD|PSP | RBM14 SIP | MSKRYGSDRRLAELsDYRRLsEsQLsFRRsPtKSSLDYRRL |
| Q96PK6 | S627 | EPSD|PSP | RBM14 SIP | RLAELsDYRRLsEsQLsFRRsPtKSSLDYRRLPDAHsDyAR |
| Q96PK6 | T629 | EPSD|PSP | RBM14 SIP | AELsDYRRLsEsQLsFRRsPtKSSLDYRRLPDAHsDyARYs |
| Q96QD9 | T205 | EPSD|PSP | FYTTD1 UIF | DTRQATFLFRRGLKVQAQLNtEQLLDDVVAKRTRQWRTSTT |
| Q96RL1 | S627 | EPSD|PSP | UIMC1 RAP80 RXRIP110 | KWQQRLKNPKEKGHSEGRLLsFLEQSEHKTSDADIKSSETG |
| Q96ST3 | T434 | EPSD|PSP | SIN3A | NNKPQRPsQNGCQIRRHPTGttPPVKKKPKLLNLKDsSMAD |
| Q96T58 | T1059 | EPSD|PSP | SPEN KIAA0929 MINT SHARP | PVRKEILKRESKKIKLDRLNtVAsPKDCQELASISVGsGSR |
| Q99590 | S1127 | EPSD|PSP | SCAF11 CASP11 SFRS2IP SIP1 SRSF2IP | sNssGsEsFKFVEQQSYKRKsEQEFSFDtPADRSGWTSASS |
| Q99613 | S638 | Sugiyama | EIF3C EIF3S8 | ICAFRQGLTKDAHNALLDIQssGRAKELLGQGLLLRSLQER |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99848 | T182 | EPSD|PSP | EBNA1BP2 EBP2 | ERSEKAKQLRALRKYGKKVQtEVLQKRQQEKAHMMNAIKKY |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BQE3 | S54 | Sugiyama | TUBA1C TUBA6 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BQE3 | T82 | Sugiyama | TUBA1C TUBA6 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BQG0 | S1310 | EPSD|PSP | MYBBP1A P160 | sPLsALARKKARLsLVIRSPsLLQSGAKKKAQVRKAGKP__ |
| Q9BRD0 | S18 | EPSD|PSP | BUD13 | ___MAAAPPLSKAEYLKRYLsGADAGVDRGsESGRKRRKKR |
| Q9BTD8 | S406 | EPSD|PSP | RBM42 | GDLGNEVNDDILARAFSRFPsFLKAKVIRDKRTGKTKGyGF |
| Q9BVA1 | S115 | Sugiyama | TUBB2B | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q9BVA1 | T107 | Sugiyama | TUBB2B | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q9BW19 | S26 | EPSD|PSP | KIFC1 HSET KNSL2 | sPLLEVKGNIELKRPLIKAPsQLPLsGsRLKRRPDQMEDGL |
| Q9BXB4 | S189 | EPSD|PSP | OSBPL11 ORP11 OSBP12 | KsRsFsLAsssNsPIsQRRPsQNAIsFFNVGHSKLQSLSKR |
| Q9BXW9 | S331 | SIGNOR|EPSD|PSP | FANCD2 FACD | VLPSRLQAsQVKLKSKGRAsssGNQEssGQSCIILLFDVIK |
| Q9BY77 | S63 | EPSD|PSP | POLDIP3 KIAA1649 PDIP46 | QstRTATFQQRFDARQKIGLsDARLKLGVKDAREKLLQKDA |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BZI7 | T169 | Sugiyama | UPF3B RENT3B UPF3X | TKVGtIDDDPEyRKFLEsyAtDNEKMTstPEtLLEEIEAKN |
| Q9GZR7 | S82 | EPSD|PSP | DDX24 | AKNPSsLFsKEAPKRKAQAVsEEEEEEEGKsssPKKKIKLK |
| Q9H0H5 | S203 | EPSD|PSP | RACGAP1 KIAA1478 MGCRACGAP | RRstsRQFVDGPPGPVKKtRsIGsAVDQGNEsIVAKTTVTV |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9H788 | Y131 | Sugiyama | SH2D4A PPP1R38 SH2A | EEPRKTHsEEFTNsLKTKsQyHDLQAPDNQQtKDIWKKVAE |
| Q9H8G2 | S203 | EPSD|PSP | CAAP1 C9orf82 CAAP | LELLSEKKILKILEGDNGMDsDMEEEADDGSKMGSDLVSQQ |
| Q9H8N7 | S447 | EPSD|PSP | ZNF395 HDBP2 PBF | SVSWAAAPSAACSLSPVRSRsLsFsEPQQPAPAMKSHLIVt |
| Q9HAW4 | T916 | SIGNOR|iPTMNet|EPSD|PSP | CLSPN | LASMDENAMDANMDELLDLCtGKFTSQAEKHLPRKSDKKEN |
| Q9HB96 | S374 | SIGNOR|EPSD|PSP | FANCE FACE | DLSLSNATVLTRSLFLGRILsLTSSASRLLTTALTSFCAKY |
| Q9HB96 | T346 | SIGNOR|EPSD|PSP | FANCE FACE | LLCAQLQLPQLSDLGLLRLCtWLLALSPDLSLSNATVLTRS |
| Q9HC62 | S344 | EPSD|PSP | SENP2 KIAA1331 | EVSARLRLGsGSNGLLRRKVsIIETKEKNCSGKERDRRTDD |
| Q9NP61 | S366 | Sugiyama | ARFGAP3 ARFGAP1 | DDsyFTSSSSYFDEPVELRsssFssWDDssDSyWKKETSKD |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NRL2 | S1320 | EPSD|PSP | BAZ1A ACF1 WCRF180 HSPC317 | QstPKTTVSSKTGRSLRKINsAPPtETKSLRIASRSTRHsH |
| Q9NRM7 | S408 | EPSD|PSP | LATS2 KPM | APPRAHVAFRPDCPVPSRTNsFNSHQPRPGPPGKAEPSLPA |
| Q9NRM7 | S835 | EPSD|PSP | LATS2 KPM | GFRWTHNSKYYQKGsHVRQDsMEPsDLWDDVsNCRCGDRLK |
| Q9NS23 | S188 | SIGNOR | RASSF1 RDA32 | IKVQLKLVRPVsVPSSKKPPsLQDARRGPGRGTSVRRRtsF |
| Q9NS23 | T38 | PSP | RASSF1 RDA32 | RAGKGRTRLERANALRIARGtACNPtRQLVPGRGHRFQPAG |
| Q9NS23 | T43 | PSP | RASSF1 RDA32 | RTRLERANALRIARGtACNPtRQLVPGRGHRFQPAGPATHT |
| Q9NUU7 | S92 | EPSD|PSP | DDX19A DDX19L | NtNQVEVLQRDPNsPLysVKsFEELRLKPQLLQGVYAMGFN |
| Q9NVU7 | T552 | Sugiyama | SDAD1 NUC130 | SMPMEERKAKAAAISTSRVLtQEDFQKIRMAQMRKELDAAP |
| Q9NW13 | S122 | PSP | RBM28 | PKAKKAKVADKKARLIIRNLsFKCSEDDLKTVFAQFGAVLE |
| Q9NWH9 | S748 | EPSD|PSP | SLTM MET | RPRDVDHRRDDPYWsENKKLsLDTDARFGHGSDYSRQQNRF |
| Q9NWH9 | S815 | EPSD|PSP | SLTM MET | RFVGQsEGKKARPTARREDPsFERYPKNFSDSRRNEPPPPR |
| Q9NXE8 | S337 | EPSD|PSP | CWC25 CCDC49 | PSPKKEVYQRRHAPGYTRKLsAEELERKRQEMMENAKWREE |
| Q9NYB9 | S22 | Sugiyama | ABI2 ARGBPIA | AELQMLLEEEIPGGRRALFDsytNLERVADyCENNyIQSAD |
| Q9P2D1 | T1227 | EPSD|PSP | CHD7 KIAA1416 | EVELTNIQKKYYRAILEKNFtFLSKGGGQANVPNLLNTMME |
| Q9UEY8 | S693 | EPSD|PSP | ADD3 ADDL | sPEGsPsKsPsKKKKKFRTPsFLKKNKKKEKVEA_______ |
| Q9UGV2 | S331 | Sugiyama | NDRG3 | QGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQ |
| Q9UGV2 | T329 | Sugiyama | NDRG3 | FLQGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVts |
| Q9UGY1 | S21 | Sugiyama | NOL12 | MGRNKKKKRDGDDRRPRLVLsFDEEKRREyLTGFHKRKVER |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UII2 | S63 | Sugiyama | ATP5IF1 ATPI ATPIF1 | AGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEIVHHKK |
| Q9UJM3 | S251 | SIGNOR|EPSD|PSP | ERRFI1 MIG6 | GVPDPNPPPPQTHRRLRRsHsGPAGsFNKPAIRIsNCCIHR |
| Q9UJM3 | S302 | EPSD|PSP | ERRFI1 MIG6 | EVPPRVPIPPRPVKPDYRRWsAEVTSSTYSDEDRPPKVPPR |
| Q9UKI8 | S679 | EPSD|PSP | TLK1 KIAA0137 | SVGVIFFQCLYGRKPFGHNQsQQDILQENtILKATEVQFPV |
| Q9UKI8 | S743 | SIGNOR|ELM|EPSD|PSP | TLK1 KIAA0137 | FDVHQLANDPYLLPHMRRsNssGNLHMAGLtAsPTPPssSI |
| Q9UKM9 | T160 | EPSD|PSP | RALY HNRPCL2 P542 | PRAVPVKRPRVTVPLVRRVKtNVPVKLFARSTAVTTssAKI |
| Q9UMR2 | S93 | EPSD|PSP | DDX19B DBP5 DDX19 TDBP | NtNQVEVLQRDPNsPLysVKsFEELRLKPQLLQGVYAMGFN |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UNZ2 | S192 | Sugiyama | NSFL1C UBXN2C | KRQHssQDVHVVLKLWKsGFsLDNGELRSyQDPsNAQFLEs |
| Q9UPP1 | S904 | EPSD|PSP | PHF8 KIAA1111 ZNF422 | RVTPTLPKQDRPVREGTRVAsIETGLAAAAAKLAQQELQKA |
| Q9UQ35 | S1455 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | PsRRsRsGssPGLRDGsGtPsRHsLsGssPGMKDIPRtPSR |
| Q9UQ35 | S1497 | EPSD|PSP | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | RsECDssPEPKALPQtPRPRsRsPssPELNNKCLtPQRERs |
| Q9UQ35 | S1499 | EPSD|PSP | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ECDssPEPKALPQtPRPRsRsPssPELNNKCLtPQRERsGs |
| Q9UQ35 | S1539 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sEssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEs |
| Q9UQ35 | S1541 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDs |
| Q9UQ35 | S2280 | EPSD|PSP | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | RtPAAAAAMNLAsPRtAVAPsAVNLADPRtPtAPAVNLAGA |
| Q9UQ35 | S2388 | EPSD|PSP | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sARMAPALsGANLtsPRVPLsAyERVsGRtsPPLLDRARsR |
| Q9UQ35 | T2252 | EPSD|PSP | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | IPAAsAAAMNLAsARtPAIPtAVNLADsRtPAAAAAMNLAs |
| Q9UQ80 | S267 | Sugiyama | PA2G4 EBP1 | YKRDPSKQYGLKMKtSRAFFsEVERRFDAMPFtLRAFEDEK |
| Q9UQ84 | S746 | PSP | EXO1 EXOI HEX1 | HFSKKDTPLRNKVPGLYKSSsADSLSTTKIKPLGPARASGL |
| Q9Y294 | S166 | SIGNOR|PSP | ASF1A CGI-98 HSPC146 | VTRFHINWEDNtEKLEDAEssNPNLQsLLstDALPsAsKGW |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2T7 | S137 | Sugiyama | YBX2 CSDA3 MSY2 | EDVFVHQtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEA |
| Q9Y2T7 | T115 | EPSD|PSP|Sugiyama | YBX2 CSDA3 MSY2 | LGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIKRNNPRKFL |
| Q9Y2T7 | T143 | Sugiyama | YBX2 CSDA3 MSY2 | QtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEATNVTGP |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y3Y2 | T212 | EPSD|PSP | CHTOP C1orf77 FOP HT031 PP7704 | FGGRGRGRGRGRGALARPVLtKEQLDNQLDAYMSKTKGHLD |
| Q9Y4F5 | S655 | EPSD|PSP | CEP170B FAM68C KIAA0284 | ASRPLGAAPQAEHQGLPVPGsPGGQKWVSRWASLADsYsDP |
| Q9Y520 | S661 | EPSD|PSP | PRRC2C BAT2D1 BAT2L2 KIAA1096 XTP2 | tPVVHEtEPEsGsQPRPAVLsGYFKQFQKSLPPRFQRQQEQ |
| Q9Y570 | S15 | EPSD|PSP | PPME1 PME1 PP2593 PRO0750 | ______MSALEKSMHLGRLPsRPPLPGsGGsQsGAKMRMGP |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y696 | T222 | Sugiyama | CLIC4 | AKKYRNFDIPKEMTGIWRYLtNAysRDEFtNtCPsDKEVEI |
| Q9Y696 | Y225 | Sugiyama | CLIC4 | YRNFDIPKEMTGIWRYLtNAysRDEFtNtCPsDKEVEIAys |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 1.712630e-12 | 11.766 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.032909e-10 | 9.986 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 6.454097e-10 | 9.190 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.847793e-09 | 8.545 | 1 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.040232e-09 | 8.298 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.576863e-08 | 7.802 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.773509e-08 | 7.557 | 1 | 0 |
| HSF1 activation | R-HSA-3371511 | 4.497597e-08 | 7.347 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.027074e-07 | 6.988 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.497894e-07 | 6.602 | 1 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.948543e-07 | 6.306 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.948543e-07 | 6.306 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.578614e-06 | 5.589 | 1 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.320894e-06 | 5.364 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.671614e-06 | 5.331 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 6.145750e-06 | 5.211 | 0 | 0 |
| M Phase | R-HSA-68886 | 6.338121e-06 | 5.198 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 9.033809e-06 | 5.044 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.208833e-05 | 4.918 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.297097e-05 | 4.887 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.947909e-05 | 4.530 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.138379e-05 | 4.503 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.448817e-05 | 4.352 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.448817e-05 | 4.352 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.953420e-05 | 4.305 | 1 | 1 |
| Mitotic Anaphase | R-HSA-68882 | 6.192615e-05 | 4.208 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 6.309471e-05 | 4.200 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.543422e-05 | 4.184 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.647991e-05 | 4.177 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.975468e-05 | 4.156 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.125268e-04 | 3.949 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.276723e-04 | 3.894 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.415623e-04 | 3.849 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.539508e-04 | 3.813 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.620038e-04 | 3.790 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.714248e-04 | 3.766 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.029917e-04 | 3.693 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.029917e-04 | 3.693 | 1 | 1 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.299790e-04 | 3.638 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.550542e-04 | 3.593 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.812429e-04 | 3.551 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.283674e-04 | 3.484 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.013287e-04 | 3.396 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 4.424658e-04 | 3.354 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.468899e-04 | 3.350 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 5.739594e-04 | 3.241 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.492930e-04 | 3.188 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 6.997596e-04 | 3.155 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 8.197766e-04 | 3.086 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 8.401295e-04 | 3.076 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 8.410518e-04 | 3.075 | 1 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 8.401295e-04 | 3.076 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 9.080929e-04 | 3.042 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 9.759564e-04 | 3.011 | 1 | 1 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.087703e-03 | 2.963 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.075255e-03 | 2.968 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.075255e-03 | 2.968 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.075255e-03 | 2.968 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.075255e-03 | 2.968 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.075255e-03 | 2.968 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.067236e-03 | 2.972 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.125005e-03 | 2.949 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.181399e-03 | 2.928 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.181399e-03 | 2.928 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.296971e-03 | 2.887 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.295544e-03 | 2.888 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.470050e-03 | 2.833 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.491584e-03 | 2.826 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.495203e-03 | 2.825 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.521539e-03 | 2.818 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.586701e-03 | 2.800 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.527346e-03 | 2.816 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.536809e-03 | 2.813 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.703960e-03 | 2.769 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.716067e-03 | 2.765 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.703960e-03 | 2.769 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.787536e-03 | 2.748 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.940417e-03 | 2.712 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.940417e-03 | 2.712 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.990236e-03 | 2.701 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.995593e-03 | 2.700 | 1 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.069028e-03 | 2.684 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.397038e-03 | 2.620 | 1 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.490167e-03 | 2.604 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.509248e-03 | 2.600 | 1 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.559187e-03 | 2.592 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.881064e-03 | 2.540 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.888766e-03 | 2.539 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.894393e-03 | 2.538 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.010569e-03 | 2.521 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.069889e-03 | 2.513 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.912044e-03 | 2.536 | 1 | 1 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.881064e-03 | 2.540 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.069889e-03 | 2.513 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.069889e-03 | 2.513 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.194702e-03 | 2.496 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.267983e-03 | 2.486 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.386679e-03 | 2.470 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.386679e-03 | 2.470 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.390404e-03 | 2.470 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.391194e-03 | 2.470 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.703828e-03 | 2.431 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.725613e-03 | 2.429 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.811687e-03 | 2.419 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.904748e-03 | 2.408 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.904748e-03 | 2.408 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.904748e-03 | 2.408 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.904748e-03 | 2.408 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.904748e-03 | 2.408 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.027065e-03 | 2.395 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.311135e-03 | 2.365 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.311135e-03 | 2.365 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.365890e-03 | 2.360 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.474797e-03 | 2.349 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 4.599744e-03 | 2.337 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 4.908740e-03 | 2.309 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.715226e-03 | 2.326 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.960849e-03 | 2.304 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 4.694580e-03 | 2.328 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.707562e-03 | 2.327 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.114297e-03 | 2.291 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.298230e-03 | 2.276 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.298230e-03 | 2.276 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.600379e-03 | 2.252 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.600379e-03 | 2.252 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.609685e-03 | 2.251 | 1 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.822905e-03 | 2.235 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.609685e-03 | 2.251 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 5.598442e-03 | 2.252 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.420675e-03 | 2.266 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.247497e-03 | 2.204 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.260937e-03 | 2.203 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.781624e-03 | 2.169 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.559006e-03 | 2.183 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 6.469984e-03 | 2.189 | 1 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.559006e-03 | 2.183 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.559006e-03 | 2.183 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.559006e-03 | 2.183 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.559006e-03 | 2.183 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.581427e-03 | 2.182 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.559006e-03 | 2.183 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.781624e-03 | 2.169 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.992979e-03 | 2.155 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 7.396695e-03 | 2.131 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.466119e-03 | 2.127 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.960463e-03 | 2.157 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 7.047300e-03 | 2.152 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 7.466119e-03 | 2.127 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 7.324188e-03 | 2.135 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 7.253364e-03 | 2.139 | 1 | 1 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.091896e-03 | 2.149 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 7.091896e-03 | 2.149 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.793471e-03 | 2.108 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.057141e-03 | 2.094 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.384728e-03 | 2.077 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 8.735566e-03 | 2.059 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 8.983962e-03 | 2.047 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 8.983962e-03 | 2.047 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 8.874460e-03 | 2.052 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.664759e-03 | 2.062 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.954358e-03 | 2.048 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.301938e-03 | 2.031 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.576353e-03 | 2.019 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.020699e-02 | 1.991 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.068519e-02 | 1.971 | 1 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.080172e-02 | 1.967 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.105885e-02 | 1.956 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.105885e-02 | 1.956 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.141525e-02 | 1.943 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.141525e-02 | 1.943 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.141525e-02 | 1.943 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.177066e-02 | 1.929 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.177066e-02 | 1.929 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 1.191756e-02 | 1.924 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.191756e-02 | 1.924 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.376006e-02 | 1.861 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.376006e-02 | 1.861 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.376006e-02 | 1.861 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.304137e-02 | 1.885 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.307280e-02 | 1.884 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.250982e-02 | 1.903 | 1 | 1 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.337673e-02 | 1.874 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.356264e-02 | 1.868 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.435734e-02 | 1.843 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.438061e-02 | 1.842 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.438061e-02 | 1.842 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.438061e-02 | 1.842 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.438061e-02 | 1.842 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.438061e-02 | 1.842 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.615143e-02 | 1.792 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.615143e-02 | 1.792 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.630615e-02 | 1.788 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.549884e-02 | 1.810 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.617957e-02 | 1.791 | 1 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.630615e-02 | 1.788 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.501603e-02 | 1.823 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.629857e-02 | 1.788 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.498436e-02 | 1.824 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.461086e-02 | 1.835 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.654778e-02 | 1.781 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.672103e-02 | 1.777 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.687242e-02 | 1.773 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.705817e-02 | 1.768 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.705817e-02 | 1.768 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.705817e-02 | 1.768 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 1.705817e-02 | 1.768 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.917532e-02 | 1.717 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.917532e-02 | 1.717 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.917532e-02 | 1.717 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.878501e-02 | 1.726 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.964836e-02 | 1.707 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.964836e-02 | 1.707 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.964836e-02 | 1.707 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.964836e-02 | 1.707 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.964836e-02 | 1.707 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.964836e-02 | 1.707 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.964836e-02 | 1.707 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.964836e-02 | 1.707 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.964836e-02 | 1.707 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.964836e-02 | 1.707 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.964836e-02 | 1.707 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.964836e-02 | 1.707 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.736311e-02 | 1.760 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.725634e-02 | 1.763 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.908138e-02 | 1.719 | 1 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.760188e-02 | 1.754 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.955093e-02 | 1.709 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.847212e-02 | 1.733 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.932980e-02 | 1.714 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.725634e-02 | 1.763 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.882016e-02 | 1.725 | 1 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.736311e-02 | 1.760 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.955093e-02 | 1.709 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.001940e-02 | 1.699 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.051177e-02 | 1.688 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.062485e-02 | 1.686 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 2.115212e-02 | 1.675 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.161822e-02 | 1.665 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.168330e-02 | 1.664 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.194589e-02 | 1.659 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.364346e-02 | 1.626 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.364346e-02 | 1.626 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.364346e-02 | 1.626 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.451682e-02 | 1.611 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.227612e-02 | 1.652 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.550076e-02 | 1.593 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 2.364346e-02 | 1.626 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.565826e-02 | 1.591 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.550076e-02 | 1.593 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.583389e-02 | 1.588 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.364346e-02 | 1.626 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.264052e-02 | 1.645 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 2.451682e-02 | 1.611 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.349876e-02 | 1.629 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.492313e-02 | 1.603 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.364346e-02 | 1.626 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.364346e-02 | 1.626 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.574605e-02 | 1.589 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.574605e-02 | 1.589 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.325766e-02 | 1.633 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.613325e-02 | 1.583 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.613325e-02 | 1.583 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.613325e-02 | 1.583 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.667009e-02 | 1.574 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.045354e-02 | 1.516 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.045354e-02 | 1.516 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 3.045354e-02 | 1.516 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.045354e-02 | 1.516 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.045354e-02 | 1.516 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.045354e-02 | 1.516 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.045354e-02 | 1.516 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.045354e-02 | 1.516 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.045354e-02 | 1.516 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.045354e-02 | 1.516 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.045354e-02 | 1.516 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.045354e-02 | 1.516 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 3.124615e-02 | 1.505 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.784606e-02 | 1.555 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.784606e-02 | 1.555 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.218567e-02 | 1.492 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.218567e-02 | 1.492 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.218567e-02 | 1.492 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.218567e-02 | 1.492 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.711378e-02 | 1.567 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.714531e-02 | 1.566 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.917262e-02 | 1.535 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.231521e-02 | 1.491 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.231521e-02 | 1.491 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.711378e-02 | 1.567 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.711378e-02 | 1.567 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 3.061135e-02 | 1.514 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.746124e-02 | 1.561 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.941266e-02 | 1.531 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.784606e-02 | 1.555 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.959302e-02 | 1.529 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.091194e-02 | 1.510 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.817555e-02 | 1.550 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.791656e-02 | 1.554 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.049450e-02 | 1.516 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.892451e-02 | 1.539 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.024928e-02 | 1.519 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.141333e-02 | 1.503 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.219512e-02 | 1.492 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.953561e-02 | 1.530 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.001245e-02 | 1.523 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.941266e-02 | 1.531 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.246056e-02 | 1.489 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.295262e-02 | 1.482 | 1 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.319868e-02 | 1.479 | 1 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 3.339502e-02 | 1.476 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.351023e-02 | 1.475 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.351023e-02 | 1.475 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.394259e-02 | 1.469 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.394259e-02 | 1.469 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 3.394259e-02 | 1.469 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 3.394259e-02 | 1.469 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.433460e-02 | 1.464 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.443540e-02 | 1.463 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.443540e-02 | 1.463 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.443540e-02 | 1.463 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.477356e-02 | 1.459 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.480344e-02 | 1.458 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.495405e-02 | 1.457 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.495405e-02 | 1.457 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 4.488726e-02 | 1.348 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 4.488726e-02 | 1.348 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 4.488726e-02 | 1.348 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 4.488726e-02 | 1.348 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 4.488726e-02 | 1.348 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 4.488726e-02 | 1.348 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 3.928295e-02 | 1.406 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.251567e-02 | 1.371 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 4.316448e-02 | 1.365 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 4.316448e-02 | 1.365 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 4.316448e-02 | 1.365 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 4.316448e-02 | 1.365 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 4.316448e-02 | 1.365 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.239249e-02 | 1.373 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.005617e-02 | 1.397 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.879698e-02 | 1.411 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.396718e-02 | 1.357 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.481444e-02 | 1.349 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 4.337770e-02 | 1.363 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.163860e-02 | 1.381 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.163860e-02 | 1.381 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.163860e-02 | 1.381 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.348707e-02 | 1.362 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.169901e-02 | 1.380 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.085277e-02 | 1.389 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 4.083663e-02 | 1.389 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.677647e-02 | 1.434 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.372377e-02 | 1.359 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.303541e-02 | 1.366 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.316448e-02 | 1.365 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.033314e-02 | 1.394 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.316448e-02 | 1.365 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.316448e-02 | 1.365 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.749087e-02 | 1.426 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.742058e-02 | 1.427 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.549980e-02 | 1.342 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 4.549980e-02 | 1.342 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.626780e-02 | 1.335 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.626780e-02 | 1.335 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.659990e-02 | 1.332 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.691897e-02 | 1.329 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 4.692664e-02 | 1.329 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 4.692664e-02 | 1.329 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 4.692664e-02 | 1.329 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.754172e-02 | 1.323 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.793882e-02 | 1.319 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.917421e-02 | 1.308 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.917421e-02 | 1.308 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.966030e-02 | 1.304 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.988198e-02 | 1.302 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 5.181730e-02 | 1.286 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.228262e-02 | 1.282 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 5.273744e-02 | 1.278 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 5.320395e-02 | 1.274 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 5.320395e-02 | 1.274 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 5.320395e-02 | 1.274 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.343547e-02 | 1.272 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.386519e-02 | 1.269 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 5.419937e-02 | 1.266 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 5.457027e-02 | 1.263 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.471407e-02 | 1.262 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 5.471407e-02 | 1.262 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.471407e-02 | 1.262 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.471407e-02 | 1.262 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 5.471407e-02 | 1.262 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 5.471407e-02 | 1.262 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.540458e-02 | 1.256 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.574060e-02 | 1.254 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 5.601265e-02 | 1.252 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.693438e-02 | 1.245 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.702513e-02 | 1.244 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.702690e-02 | 1.244 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.784330e-02 | 1.238 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.784330e-02 | 1.238 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 6.623441e-02 | 1.179 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.623441e-02 | 1.179 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.623441e-02 | 1.179 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 6.882207e-02 | 1.162 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.249313e-02 | 1.204 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 7.444578e-02 | 1.128 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.397445e-02 | 1.131 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 6.784655e-02 | 1.168 | 1 | 1 |
| RUNX2 regulates bone development | R-HSA-8941326 | 6.220497e-02 | 1.206 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 6.685974e-02 | 1.175 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 6.685974e-02 | 1.175 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 6.338893e-02 | 1.198 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.897048e-02 | 1.229 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 7.095447e-02 | 1.149 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.102452e-02 | 1.214 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.102452e-02 | 1.214 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.926860e-02 | 1.227 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.926860e-02 | 1.227 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 6.523327e-02 | 1.186 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 7.758794e-02 | 1.110 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.623441e-02 | 1.179 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.884188e-02 | 1.230 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 6.882207e-02 | 1.162 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.536937e-02 | 1.123 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.536937e-02 | 1.123 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.882207e-02 | 1.162 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 6.368598e-02 | 1.196 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.536937e-02 | 1.123 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 6.483205e-02 | 1.188 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.091851e-02 | 1.149 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.882207e-02 | 1.162 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.884188e-02 | 1.230 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 6.220497e-02 | 1.206 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 7.095447e-02 | 1.149 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 6.468439e-02 | 1.189 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 6.882207e-02 | 1.162 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.249313e-02 | 1.204 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 7.112555e-02 | 1.148 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.113541e-02 | 1.148 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.397445e-02 | 1.131 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 7.032478e-02 | 1.153 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 6.721959e-02 | 1.173 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.411774e-02 | 1.193 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.500773e-02 | 1.187 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 7.032478e-02 | 1.153 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.784655e-02 | 1.168 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 7.073286e-02 | 1.150 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 6.220497e-02 | 1.206 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.506957e-02 | 1.125 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.483205e-02 | 1.188 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 7.769364e-02 | 1.110 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 7.769364e-02 | 1.110 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 8.059578e-02 | 1.094 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 8.059578e-02 | 1.094 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 8.089644e-02 | 1.092 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 8.089644e-02 | 1.092 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 8.089644e-02 | 1.092 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 8.089644e-02 | 1.092 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 8.089644e-02 | 1.092 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.093929e-02 | 1.092 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 8.484155e-02 | 1.071 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.484155e-02 | 1.071 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.511008e-02 | 1.070 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 8.511008e-02 | 1.070 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 8.511008e-02 | 1.070 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.545987e-02 | 1.068 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.545987e-02 | 1.068 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 8.567370e-02 | 1.067 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.698647e-02 | 1.061 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.839307e-02 | 1.054 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 8.856562e-02 | 1.053 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 8.856562e-02 | 1.053 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 8.856562e-02 | 1.053 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.856562e-02 | 1.053 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 8.903827e-02 | 1.050 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 9.070825e-02 | 1.042 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 9.070825e-02 | 1.042 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 9.070825e-02 | 1.042 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 9.070825e-02 | 1.042 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 9.070825e-02 | 1.042 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 9.234509e-02 | 1.035 | 1 | 1 |
| TBC/RABGAPs | R-HSA-8854214 | 9.234509e-02 | 1.035 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 9.328729e-02 | 1.030 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.338219e-02 | 1.030 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.338219e-02 | 1.030 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 9.381951e-02 | 1.028 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 9.396418e-02 | 1.027 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 9.514600e-02 | 1.022 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.514600e-02 | 1.022 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 9.514600e-02 | 1.022 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.582259e-02 | 1.019 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 9.720935e-02 | 1.012 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.017758e-01 | 0.992 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.022024e-01 | 0.991 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 1.022024e-01 | 0.991 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 1.022024e-01 | 0.991 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.022483e-01 | 0.990 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.027368e-01 | 0.988 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.027368e-01 | 0.988 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.051606e-01 | 0.978 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.051690e-01 | 0.978 | 1 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.064105e-01 | 0.973 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.098723e-01 | 0.959 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.102794e-01 | 0.958 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.119469e-01 | 0.951 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.119469e-01 | 0.951 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.141624e-01 | 0.942 | 1 | 1 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.141624e-01 | 0.942 | 1 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.141624e-01 | 0.942 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.141624e-01 | 0.942 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.141732e-01 | 0.942 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.141732e-01 | 0.942 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.141732e-01 | 0.942 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.143585e-01 | 0.942 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.144203e-01 | 0.941 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.144309e-01 | 0.941 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.150879e-01 | 0.939 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 1.150879e-01 | 0.939 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.150879e-01 | 0.939 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 1.150879e-01 | 0.939 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.210017e-01 | 0.917 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.210156e-01 | 0.917 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.218678e-01 | 0.914 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.218678e-01 | 0.914 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.221480e-01 | 0.913 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.224372e-01 | 0.912 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 1.224372e-01 | 0.912 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.224372e-01 | 0.912 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.251560e-01 | 0.903 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.261475e-01 | 0.899 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.261475e-01 | 0.899 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.261475e-01 | 0.899 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.302009e-01 | 0.885 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.302009e-01 | 0.885 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.328928e-01 | 0.876 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.334113e-01 | 0.875 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.334113e-01 | 0.875 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.334113e-01 | 0.875 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.349669e-01 | 0.870 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.349669e-01 | 0.870 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.356355e-01 | 0.868 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 1.540044e-01 | 0.812 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.540044e-01 | 0.812 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.540044e-01 | 0.812 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.540044e-01 | 0.812 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.540044e-01 | 0.812 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.540044e-01 | 0.812 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.450705e-01 | 0.838 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.450705e-01 | 0.838 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.516611e-01 | 0.819 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 1.516611e-01 | 0.819 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.516611e-01 | 0.819 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.516611e-01 | 0.819 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 1.516611e-01 | 0.819 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.440442e-01 | 0.842 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.440442e-01 | 0.842 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.440442e-01 | 0.842 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.440442e-01 | 0.842 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.924055e-01 | 0.716 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.589865e-01 | 0.799 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.438414e-01 | 0.842 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.668215e-01 | 0.778 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.668215e-01 | 0.778 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.498362e-01 | 0.824 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.377574e-01 | 0.861 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.546554e-01 | 0.811 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 1.723760e-01 | 0.764 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.550070e-01 | 0.810 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 1.891455e-01 | 0.723 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.520189e-01 | 0.818 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.634596e-01 | 0.787 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.739229e-01 | 0.760 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.467436e-01 | 0.833 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.875448e-01 | 0.727 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.439082e-01 | 0.842 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.445356e-01 | 0.840 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.005975e-01 | 0.698 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.002449e-01 | 0.698 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.608244e-01 | 0.794 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 1.643993e-01 | 0.784 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.545381e-01 | 0.811 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.865412e-01 | 0.729 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.915888e-01 | 0.718 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.952534e-01 | 0.709 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 1.755075e-01 | 0.756 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.016643e-01 | 0.695 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.016643e-01 | 0.695 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.682194e-01 | 0.774 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.836218e-01 | 0.736 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.439082e-01 | 0.842 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.377574e-01 | 0.861 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 1.391927e-01 | 0.856 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.915888e-01 | 0.718 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 1.755075e-01 | 0.756 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.394555e-01 | 0.856 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.707631e-01 | 0.768 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.725119e-01 | 0.763 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.035983e-01 | 0.691 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.912275e-01 | 0.718 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.553303e-01 | 0.809 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.956396e-01 | 0.709 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.438414e-01 | 0.842 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 1.928767e-01 | 0.715 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.725119e-01 | 0.763 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.634032e-01 | 0.787 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.526643e-01 | 0.816 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 1.516611e-01 | 0.819 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.723760e-01 | 0.764 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 1.723760e-01 | 0.764 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.561713e-01 | 0.806 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.671935e-01 | 0.777 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.926510e-01 | 0.715 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.634766e-01 | 0.787 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.708580e-01 | 0.767 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 1.550070e-01 | 0.810 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.450705e-01 | 0.838 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 1.755075e-01 | 0.756 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.912275e-01 | 0.718 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.926510e-01 | 0.715 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.016643e-01 | 0.695 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.836218e-01 | 0.736 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.915888e-01 | 0.718 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.530140e-01 | 0.815 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.016643e-01 | 0.695 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.366532e-01 | 0.864 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.924055e-01 | 0.716 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.915888e-01 | 0.718 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.415085e-01 | 0.849 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.440442e-01 | 0.842 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 1.498362e-01 | 0.824 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.867054e-01 | 0.729 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.707631e-01 | 0.768 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 2.042585e-01 | 0.690 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.042585e-01 | 0.690 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 2.042585e-01 | 0.690 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 2.042585e-01 | 0.690 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 2.042585e-01 | 0.690 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.064570e-01 | 0.685 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.090428e-01 | 0.680 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 2.090428e-01 | 0.680 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.108574e-01 | 0.676 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.108574e-01 | 0.676 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.108574e-01 | 0.676 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.108574e-01 | 0.676 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.108673e-01 | 0.676 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.111624e-01 | 0.675 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.113413e-01 | 0.675 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 2.113413e-01 | 0.675 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.138604e-01 | 0.670 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.138604e-01 | 0.670 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.153027e-01 | 0.667 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.153027e-01 | 0.667 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.153027e-01 | 0.667 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.153027e-01 | 0.667 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.842989e-01 | 0.546 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.842989e-01 | 0.546 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH3 | R-HSA-5632927 | 2.842989e-01 | 0.546 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.842989e-01 | 0.546 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.842989e-01 | 0.546 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.842989e-01 | 0.546 | 0 | 0 |
| Defective F8 binding to von Willebrand factor | R-HSA-9672393 | 2.842989e-01 | 0.546 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.842989e-01 | 0.546 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.842989e-01 | 0.546 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.842989e-01 | 0.546 | 0 | 0 |
| TWIK-related spinal cord K+ channel (TRESK) | R-HSA-1299344 | 2.842989e-01 | 0.546 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 2.654978e-01 | 0.576 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.654978e-01 | 0.576 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.654978e-01 | 0.576 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.654978e-01 | 0.576 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.654978e-01 | 0.576 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.654978e-01 | 0.576 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 2.654978e-01 | 0.576 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.654978e-01 | 0.576 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.654978e-01 | 0.576 | 0 | 0 |
| FGFR4 mutant receptor activation | R-HSA-1839128 | 3.945326e-01 | 0.404 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 3.945326e-01 | 0.404 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 3.945326e-01 | 0.404 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.945326e-01 | 0.404 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.945326e-01 | 0.404 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 3.945326e-01 | 0.404 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.945326e-01 | 0.404 | 0 | 0 |
| Defective HK1 causes hexokinase deficiency (HK deficiency) | R-HSA-5619056 | 3.945326e-01 | 0.404 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.945326e-01 | 0.404 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.945326e-01 | 0.404 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.945326e-01 | 0.404 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.945326e-01 | 0.404 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.945326e-01 | 0.404 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.945326e-01 | 0.404 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.945326e-01 | 0.404 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.945326e-01 | 0.404 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 3.945326e-01 | 0.404 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.945326e-01 | 0.404 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 3.945326e-01 | 0.404 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.945326e-01 | 0.404 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 2.354719e-01 | 0.628 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.354719e-01 | 0.628 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.354719e-01 | 0.628 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 3.267537e-01 | 0.486 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 3.267537e-01 | 0.486 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.267537e-01 | 0.486 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 3.267537e-01 | 0.486 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 3.267537e-01 | 0.486 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 3.267537e-01 | 0.486 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 3.267537e-01 | 0.486 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 3.267537e-01 | 0.486 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 3.267537e-01 | 0.486 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.799888e-01 | 0.553 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 2.799888e-01 | 0.553 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 2.799888e-01 | 0.553 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.799888e-01 | 0.553 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.799888e-01 | 0.553 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 2.799888e-01 | 0.553 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.799888e-01 | 0.553 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.442016e-01 | 0.612 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 2.442016e-01 | 0.612 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.168931e-01 | 0.664 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 2.455225e-01 | 0.610 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.455225e-01 | 0.610 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.805389e-01 | 0.552 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 2.805389e-01 | 0.552 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.251732e-01 | 0.488 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.251732e-01 | 0.488 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.251732e-01 | 0.488 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.251732e-01 | 0.488 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.251732e-01 | 0.488 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 3.251732e-01 | 0.488 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.865691e-01 | 0.413 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.865691e-01 | 0.413 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 3.865691e-01 | 0.413 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.865691e-01 | 0.413 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.865691e-01 | 0.413 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 3.865691e-01 | 0.413 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 3.865691e-01 | 0.413 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 3.865691e-01 | 0.413 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.160592e-01 | 0.665 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.767538e-01 | 0.558 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 3.176268e-01 | 0.498 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 3.176268e-01 | 0.498 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.401833e-01 | 0.619 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.712808e-01 | 0.567 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.703435e-01 | 0.431 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 2.359088e-01 | 0.627 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.359088e-01 | 0.627 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.087241e-01 | 0.510 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.312064e-01 | 0.636 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.586949e-01 | 0.587 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.996277e-01 | 0.523 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 3.550650e-01 | 0.450 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.550650e-01 | 0.450 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 3.550650e-01 | 0.450 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.162986e-01 | 0.665 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.458495e-01 | 0.609 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 2.738642e-01 | 0.562 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.149226e-01 | 0.382 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 4.149226e-01 | 0.382 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.149226e-01 | 0.382 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 4.149226e-01 | 0.382 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.275689e-01 | 0.643 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.275689e-01 | 0.643 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.659717e-01 | 0.575 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.659717e-01 | 0.575 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.659717e-01 | 0.575 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.659717e-01 | 0.575 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.168402e-01 | 0.499 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.168402e-01 | 0.499 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.168402e-01 | 0.499 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.168402e-01 | 0.499 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.168402e-01 | 0.499 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.584231e-01 | 0.588 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.924874e-01 | 0.406 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.865908e-01 | 0.543 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.576878e-01 | 0.446 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.433535e-01 | 0.464 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.433535e-01 | 0.464 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.185658e-01 | 0.497 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.185658e-01 | 0.497 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.790208e-01 | 0.554 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.163572e-01 | 0.665 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.704603e-01 | 0.568 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.290300e-01 | 0.483 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.870386e-01 | 0.412 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 4.064848e-01 | 0.391 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.064848e-01 | 0.391 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 4.295668e-01 | 0.367 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 4.295668e-01 | 0.367 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.543199e-01 | 0.595 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.842053e-01 | 0.546 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.646036e-01 | 0.438 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.799133e-01 | 0.420 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.799133e-01 | 0.420 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.969925e-01 | 0.401 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.840997e-01 | 0.547 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 4.048531e-01 | 0.393 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 4.238563e-01 | 0.373 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 4.238563e-01 | 0.373 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.247103e-01 | 0.489 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 3.852672e-01 | 0.414 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.112723e-01 | 0.386 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.166485e-01 | 0.380 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.476101e-01 | 0.459 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.212412e-01 | 0.375 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.212412e-01 | 0.375 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.134211e-01 | 0.384 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.252273e-01 | 0.371 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.964909e-01 | 0.402 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 4.278241e-01 | 0.369 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.194549e-01 | 0.377 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.194549e-01 | 0.377 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.305533e-01 | 0.366 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.010744e-01 | 0.521 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.550116e-01 | 0.593 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.550116e-01 | 0.593 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.683366e-01 | 0.434 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.543231e-01 | 0.595 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.543231e-01 | 0.595 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.411684e-01 | 0.467 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.312965e-01 | 0.636 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.162986e-01 | 0.665 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.876071e-01 | 0.541 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.543231e-01 | 0.595 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.512008e-01 | 0.600 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.087241e-01 | 0.510 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.455225e-01 | 0.610 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 2.354719e-01 | 0.628 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.087241e-01 | 0.510 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.679122e-01 | 0.572 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.168931e-01 | 0.664 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.701155e-01 | 0.432 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 4.295668e-01 | 0.367 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 4.193149e-01 | 0.377 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.086262e-01 | 0.511 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 3.814547e-01 | 0.419 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.703435e-01 | 0.431 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 3.550650e-01 | 0.450 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.168402e-01 | 0.499 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.185658e-01 | 0.497 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.945841e-01 | 0.404 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.176268e-01 | 0.498 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.467535e-01 | 0.608 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.382309e-01 | 0.623 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.251732e-01 | 0.488 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.401833e-01 | 0.619 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 3.703435e-01 | 0.431 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.703435e-01 | 0.431 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.218234e-01 | 0.654 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 2.865908e-01 | 0.543 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 4.112723e-01 | 0.386 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.330441e-01 | 0.633 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.964909e-01 | 0.402 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.212988e-01 | 0.655 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.790208e-01 | 0.554 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.022833e-01 | 0.520 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.382309e-01 | 0.623 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.731732e-01 | 0.564 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.767538e-01 | 0.558 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.738642e-01 | 0.562 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.654978e-01 | 0.576 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 3.865691e-01 | 0.413 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.703435e-01 | 0.431 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 2.522365e-01 | 0.598 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.731732e-01 | 0.564 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.823830e-01 | 0.418 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 3.945841e-01 | 0.404 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.221493e-01 | 0.653 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.412822e-01 | 0.467 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.603359e-01 | 0.584 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.799888e-01 | 0.553 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.576878e-01 | 0.446 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 3.290300e-01 | 0.483 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.086262e-01 | 0.511 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.879023e-01 | 0.411 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 3.945841e-01 | 0.404 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 4.297807e-01 | 0.367 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.212412e-01 | 0.375 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.238563e-01 | 0.373 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.907137e-01 | 0.537 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.412822e-01 | 0.467 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.805389e-01 | 0.552 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.550116e-01 | 0.593 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.197737e-01 | 0.495 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 3.261686e-01 | 0.487 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.359088e-01 | 0.627 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 3.717939e-01 | 0.430 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.671040e-01 | 0.573 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 3.267537e-01 | 0.486 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.160592e-01 | 0.665 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 2.712808e-01 | 0.567 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 3.087241e-01 | 0.510 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.996277e-01 | 0.523 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 4.112723e-01 | 0.386 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 3.175625e-01 | 0.498 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 2.401833e-01 | 0.619 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 2.522365e-01 | 0.598 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.201729e-01 | 0.657 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 4.297807e-01 | 0.367 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.738341e-01 | 0.427 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.550650e-01 | 0.450 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.086262e-01 | 0.511 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.359088e-01 | 0.627 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.738341e-01 | 0.427 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.359088e-01 | 0.627 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.865691e-01 | 0.413 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.176268e-01 | 0.498 | 1 | 1 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 3.924874e-01 | 0.406 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 2.777354e-01 | 0.556 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.550626e-01 | 0.450 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 2.436396e-01 | 0.613 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.586949e-01 | 0.587 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.550305e-01 | 0.593 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.865908e-01 | 0.543 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.220508e-01 | 0.654 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 3.251732e-01 | 0.488 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.586949e-01 | 0.587 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.411684e-01 | 0.467 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.086262e-01 | 0.511 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.304065e-01 | 0.481 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.852392e-01 | 0.545 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.842989e-01 | 0.546 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.945326e-01 | 0.404 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.945326e-01 | 0.404 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.945326e-01 | 0.404 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 3.945326e-01 | 0.404 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 3.865691e-01 | 0.413 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 3.865691e-01 | 0.413 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.176268e-01 | 0.498 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 3.087241e-01 | 0.510 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.821127e-01 | 0.550 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.705852e-01 | 0.568 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 4.295668e-01 | 0.367 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.879023e-01 | 0.411 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.073333e-01 | 0.512 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.319257e-01 | 0.365 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.193145e-01 | 0.659 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.166485e-01 | 0.380 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 3.924874e-01 | 0.406 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.924874e-01 | 0.406 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.879023e-01 | 0.411 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.738341e-01 | 0.427 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 4.287325e-01 | 0.368 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 3.865691e-01 | 0.413 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 3.865691e-01 | 0.413 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 3.087241e-01 | 0.510 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.547664e-01 | 0.450 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.354719e-01 | 0.628 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.379537e-01 | 0.471 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.064848e-01 | 0.391 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 3.752768e-01 | 0.426 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.244861e-01 | 0.489 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.945326e-01 | 0.404 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 3.924874e-01 | 0.406 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.576878e-01 | 0.446 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.304065e-01 | 0.481 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.701155e-01 | 0.432 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.166485e-01 | 0.380 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.476101e-01 | 0.459 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.163572e-01 | 0.665 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.271025e-01 | 0.644 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.163754e-01 | 0.381 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 3.267537e-01 | 0.486 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 2.455225e-01 | 0.610 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 3.865691e-01 | 0.413 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.799133e-01 | 0.420 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.938648e-01 | 0.405 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.876903e-01 | 0.541 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 3.865691e-01 | 0.413 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 3.799133e-01 | 0.420 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.969925e-01 | 0.401 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.904369e-01 | 0.408 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.251732e-01 | 0.488 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 3.284916e-01 | 0.483 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 3.411684e-01 | 0.467 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 4.346307e-01 | 0.362 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.374684e-01 | 0.359 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.390484e-01 | 0.357 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.421871e-01 | 0.354 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 4.439350e-01 | 0.353 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 4.439350e-01 | 0.353 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 4.439350e-01 | 0.353 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 4.439350e-01 | 0.353 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 4.439350e-01 | 0.353 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 4.439350e-01 | 0.353 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 4.439350e-01 | 0.353 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 4.439350e-01 | 0.353 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 4.439350e-01 | 0.353 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 4.439350e-01 | 0.353 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.452180e-01 | 0.351 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 4.455407e-01 | 0.351 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 4.455407e-01 | 0.351 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.455407e-01 | 0.351 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.464452e-01 | 0.350 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.469979e-01 | 0.350 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 4.505862e-01 | 0.346 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 4.561074e-01 | 0.341 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.571921e-01 | 0.340 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 4.577285e-01 | 0.339 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.584360e-01 | 0.339 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.584360e-01 | 0.339 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.584360e-01 | 0.339 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.584360e-01 | 0.339 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 4.584360e-01 | 0.339 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 4.592242e-01 | 0.338 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 4.592242e-01 | 0.338 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.619012e-01 | 0.335 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 4.660166e-01 | 0.332 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 4.660166e-01 | 0.332 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 4.660166e-01 | 0.332 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 4.660166e-01 | 0.332 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 4.660166e-01 | 0.332 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 4.660166e-01 | 0.332 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 4.660166e-01 | 0.332 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 4.708931e-01 | 0.327 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.708931e-01 | 0.327 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.708931e-01 | 0.327 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.708931e-01 | 0.327 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 4.712207e-01 | 0.327 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.717119e-01 | 0.326 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.743894e-01 | 0.324 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 4.743894e-01 | 0.324 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.743894e-01 | 0.324 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.758647e-01 | 0.323 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.758647e-01 | 0.323 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.770691e-01 | 0.321 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.809988e-01 | 0.318 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.825110e-01 | 0.316 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.838204e-01 | 0.315 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.849718e-01 | 0.314 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 4.849718e-01 | 0.314 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.869202e-01 | 0.313 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.877932e-01 | 0.312 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 4.877932e-01 | 0.312 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 4.877932e-01 | 0.312 | 0 | 0 |
| Defective F8 cleavage by thrombin | R-HSA-9672391 | 4.877932e-01 | 0.312 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 4.877932e-01 | 0.312 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.877932e-01 | 0.312 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 4.877932e-01 | 0.312 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.877932e-01 | 0.312 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 4.877932e-01 | 0.312 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 4.877932e-01 | 0.312 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.877932e-01 | 0.312 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.877932e-01 | 0.312 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.877932e-01 | 0.312 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 4.877932e-01 | 0.312 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.877932e-01 | 0.312 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 4.877932e-01 | 0.312 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 4.877932e-01 | 0.312 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 4.877932e-01 | 0.312 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 4.877932e-01 | 0.312 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.877932e-01 | 0.312 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.877932e-01 | 0.312 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.910669e-01 | 0.309 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.925859e-01 | 0.308 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.938816e-01 | 0.306 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.938816e-01 | 0.306 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 4.981872e-01 | 0.303 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 4.981872e-01 | 0.303 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 4.981872e-01 | 0.303 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 4.981872e-01 | 0.303 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 4.981872e-01 | 0.303 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 4.981872e-01 | 0.303 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 4.981872e-01 | 0.303 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.981872e-01 | 0.303 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.981872e-01 | 0.303 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 4.981872e-01 | 0.303 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.981872e-01 | 0.303 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.005055e-01 | 0.301 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.005055e-01 | 0.301 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.015921e-01 | 0.300 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 5.015921e-01 | 0.300 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 5.022806e-01 | 0.299 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 5.022806e-01 | 0.299 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.027897e-01 | 0.299 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.027897e-01 | 0.299 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 5.027897e-01 | 0.299 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.032012e-01 | 0.298 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 5.038621e-01 | 0.298 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.041426e-01 | 0.297 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.048674e-01 | 0.297 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.050817e-01 | 0.297 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.230864e-01 | 0.281 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.247567e-01 | 0.280 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 5.247567e-01 | 0.280 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 5.255154e-01 | 0.279 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 5.264220e-01 | 0.279 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 5.264220e-01 | 0.279 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.275231e-01 | 0.278 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.275231e-01 | 0.278 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.288877e-01 | 0.277 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 5.288877e-01 | 0.277 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 5.288877e-01 | 0.277 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.306242e-01 | 0.275 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.306242e-01 | 0.275 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 5.310021e-01 | 0.275 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 5.329139e-01 | 0.273 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.329139e-01 | 0.273 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 5.360890e-01 | 0.271 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.360890e-01 | 0.271 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.360890e-01 | 0.271 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 5.360890e-01 | 0.271 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.374140e-01 | 0.270 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 5.408403e-01 | 0.267 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 5.408403e-01 | 0.267 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 5.408403e-01 | 0.267 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.408403e-01 | 0.267 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.420462e-01 | 0.266 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.433480e-01 | 0.265 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.448422e-01 | 0.264 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 5.465768e-01 | 0.262 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 5.465768e-01 | 0.262 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.486179e-01 | 0.261 | 0 | 0 |
| RSK activation | R-HSA-444257 | 5.489240e-01 | 0.260 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 5.489240e-01 | 0.260 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 5.489240e-01 | 0.260 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 5.489240e-01 | 0.260 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 5.489240e-01 | 0.260 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 5.489240e-01 | 0.260 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 5.489240e-01 | 0.260 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 5.510601e-01 | 0.259 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.524678e-01 | 0.258 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.539878e-01 | 0.256 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 5.540438e-01 | 0.256 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.577462e-01 | 0.254 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.577892e-01 | 0.254 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 5.577892e-01 | 0.254 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 5.626640e-01 | 0.250 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 5.626640e-01 | 0.250 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.626640e-01 | 0.250 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 5.626640e-01 | 0.250 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.626640e-01 | 0.250 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.666933e-01 | 0.247 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 5.666933e-01 | 0.247 | 0 | 0 |
| The IPAF inflammasome | R-HSA-844623 | 5.666933e-01 | 0.247 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 5.666933e-01 | 0.247 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 5.666933e-01 | 0.247 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.666933e-01 | 0.247 | 0 | 0 |
| Phenylketonuria | R-HSA-2160456 | 5.666933e-01 | 0.247 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.666933e-01 | 0.247 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 5.666933e-01 | 0.247 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.666933e-01 | 0.247 | 0 | 0 |
| Defective CYP7B1 causes SPG5A and CBAS3 | R-HSA-5579013 | 5.666933e-01 | 0.247 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 5.666933e-01 | 0.247 | 0 | 0 |
| Defective CYP1B1 causes Glaucoma | R-HSA-5579000 | 5.666933e-01 | 0.247 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 5.666933e-01 | 0.247 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 5.666933e-01 | 0.247 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 5.666933e-01 | 0.247 | 0 | 0 |
| Activation of BMF and translocation to mitochondria | R-HSA-139910 | 5.666933e-01 | 0.247 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 5.666933e-01 | 0.247 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 5.666933e-01 | 0.247 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 5.693416e-01 | 0.245 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 5.693416e-01 | 0.245 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.693416e-01 | 0.245 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 5.693416e-01 | 0.245 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 5.693416e-01 | 0.245 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.701555e-01 | 0.244 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.703943e-01 | 0.244 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.703943e-01 | 0.244 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 5.740989e-01 | 0.241 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 5.744134e-01 | 0.241 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.758396e-01 | 0.240 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 5.785946e-01 | 0.238 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.792278e-01 | 0.237 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.792278e-01 | 0.237 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 5.792278e-01 | 0.237 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.792278e-01 | 0.237 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.792278e-01 | 0.237 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.792278e-01 | 0.237 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.838201e-01 | 0.234 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 5.840346e-01 | 0.234 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 5.841957e-01 | 0.233 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.854191e-01 | 0.233 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.864955e-01 | 0.232 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.875764e-01 | 0.231 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 5.875764e-01 | 0.231 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 5.914234e-01 | 0.228 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 5.914234e-01 | 0.228 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.914234e-01 | 0.228 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.958973e-01 | 0.225 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 5.959412e-01 | 0.225 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 5.959412e-01 | 0.225 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 5.959412e-01 | 0.225 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 5.959412e-01 | 0.225 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 5.959412e-01 | 0.225 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 5.959412e-01 | 0.225 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 5.959412e-01 | 0.225 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 5.959412e-01 | 0.225 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 5.959412e-01 | 0.225 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 5.959412e-01 | 0.225 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 5.959412e-01 | 0.225 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 5.965830e-01 | 0.224 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 5.965830e-01 | 0.224 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 5.985832e-01 | 0.223 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.992571e-01 | 0.222 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.009824e-01 | 0.221 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.012208e-01 | 0.221 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.012208e-01 | 0.221 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.012208e-01 | 0.221 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 6.024748e-01 | 0.220 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 6.024748e-01 | 0.220 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 6.024748e-01 | 0.220 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.036053e-01 | 0.219 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.074310e-01 | 0.217 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.084332e-01 | 0.216 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 6.097683e-01 | 0.215 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.132160e-01 | 0.212 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.155233e-01 | 0.211 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 6.155233e-01 | 0.211 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 6.155233e-01 | 0.211 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.155233e-01 | 0.211 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.155233e-01 | 0.211 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.155233e-01 | 0.211 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 6.155233e-01 | 0.211 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.155233e-01 | 0.211 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.155233e-01 | 0.211 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.155233e-01 | 0.211 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.155233e-01 | 0.211 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.161118e-01 | 0.210 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 6.161118e-01 | 0.210 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 6.191055e-01 | 0.208 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.191055e-01 | 0.208 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 6.216778e-01 | 0.206 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 6.216778e-01 | 0.206 | 0 | 0 |
| Depurination | R-HSA-73927 | 6.256289e-01 | 0.204 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 6.268069e-01 | 0.203 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.282502e-01 | 0.202 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 6.299234e-01 | 0.201 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.301760e-01 | 0.201 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 6.316303e-01 | 0.200 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.316303e-01 | 0.200 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.316303e-01 | 0.200 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.316303e-01 | 0.200 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.316303e-01 | 0.200 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 6.316303e-01 | 0.200 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 6.334435e-01 | 0.198 | 0 | 0 |
| betaKlotho-mediated ligand binding | R-HSA-1307965 | 6.334435e-01 | 0.198 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 6.334435e-01 | 0.198 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 6.334435e-01 | 0.198 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 6.334435e-01 | 0.198 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 6.334435e-01 | 0.198 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 6.334435e-01 | 0.198 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 6.334435e-01 | 0.198 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 6.334435e-01 | 0.198 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 6.334435e-01 | 0.198 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 6.334435e-01 | 0.198 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 6.334435e-01 | 0.198 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 6.334435e-01 | 0.198 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 6.334435e-01 | 0.198 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 6.334435e-01 | 0.198 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 6.334435e-01 | 0.198 | 0 | 0 |
| Interleukin-38 signaling | R-HSA-9007892 | 6.334435e-01 | 0.198 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 6.344453e-01 | 0.198 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 6.381062e-01 | 0.195 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.391807e-01 | 0.194 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.391807e-01 | 0.194 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 6.391807e-01 | 0.194 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 6.391807e-01 | 0.194 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 6.391807e-01 | 0.194 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 6.391807e-01 | 0.194 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.391807e-01 | 0.194 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 6.391807e-01 | 0.194 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 6.391807e-01 | 0.194 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 6.391807e-01 | 0.194 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 6.396961e-01 | 0.194 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.398403e-01 | 0.194 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 6.456431e-01 | 0.190 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.480110e-01 | 0.188 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.496399e-01 | 0.187 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.496399e-01 | 0.187 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.496399e-01 | 0.187 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.496399e-01 | 0.187 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.496399e-01 | 0.187 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.496399e-01 | 0.187 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.518261e-01 | 0.186 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 6.523940e-01 | 0.185 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.581775e-01 | 0.182 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.583888e-01 | 0.182 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.629342e-01 | 0.179 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 6.640039e-01 | 0.178 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.683973e-01 | 0.175 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.695838e-01 | 0.174 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.695838e-01 | 0.174 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 6.695838e-01 | 0.174 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 6.709870e-01 | 0.173 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 6.714377e-01 | 0.173 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.714377e-01 | 0.173 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.776527e-01 | 0.169 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 6.786906e-01 | 0.168 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 6.786906e-01 | 0.168 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 6.786906e-01 | 0.168 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 6.786906e-01 | 0.168 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 6.786906e-01 | 0.168 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 6.786906e-01 | 0.168 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 6.786906e-01 | 0.168 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 6.800876e-01 | 0.167 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 6.800876e-01 | 0.167 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 6.809277e-01 | 0.167 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.815397e-01 | 0.167 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 6.815397e-01 | 0.167 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 6.815397e-01 | 0.167 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 6.815397e-01 | 0.167 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 6.831511e-01 | 0.165 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.846935e-01 | 0.165 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.874732e-01 | 0.163 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.874732e-01 | 0.163 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 6.878021e-01 | 0.163 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.878021e-01 | 0.163 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 6.878021e-01 | 0.163 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 6.899141e-01 | 0.161 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.899141e-01 | 0.161 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.899141e-01 | 0.161 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 6.899141e-01 | 0.161 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 6.899141e-01 | 0.161 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 6.899141e-01 | 0.161 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 6.899141e-01 | 0.161 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 6.899141e-01 | 0.161 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.899141e-01 | 0.161 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 6.899141e-01 | 0.161 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 6.899141e-01 | 0.161 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.899141e-01 | 0.161 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 6.899141e-01 | 0.161 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 6.899141e-01 | 0.161 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 6.899141e-01 | 0.161 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 6.899141e-01 | 0.161 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.899141e-01 | 0.161 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 6.899141e-01 | 0.161 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 6.899141e-01 | 0.161 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.903187e-01 | 0.161 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.921536e-01 | 0.160 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 6.951046e-01 | 0.158 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 7.022216e-01 | 0.154 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.026701e-01 | 0.153 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.026701e-01 | 0.153 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.028041e-01 | 0.153 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.075999e-01 | 0.150 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.112244e-01 | 0.148 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 7.112244e-01 | 0.148 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.112244e-01 | 0.148 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.112244e-01 | 0.148 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 7.112244e-01 | 0.148 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.112244e-01 | 0.148 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 7.112244e-01 | 0.148 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.135081e-01 | 0.147 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.135081e-01 | 0.147 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.145938e-01 | 0.146 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 7.145938e-01 | 0.146 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.145938e-01 | 0.146 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.145938e-01 | 0.146 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.145938e-01 | 0.146 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.145938e-01 | 0.146 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.145938e-01 | 0.146 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.145938e-01 | 0.146 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 7.145938e-01 | 0.146 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 7.155772e-01 | 0.145 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.179778e-01 | 0.144 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 7.233887e-01 | 0.141 | 0 | 0 |
| Protein folding | R-HSA-391251 | 7.245553e-01 | 0.140 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.264261e-01 | 0.139 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.304015e-01 | 0.136 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.304015e-01 | 0.136 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.376253e-01 | 0.132 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.376253e-01 | 0.132 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 7.376878e-01 | 0.132 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 7.376878e-01 | 0.132 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 7.376878e-01 | 0.132 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 7.376878e-01 | 0.132 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 7.376878e-01 | 0.132 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 7.376878e-01 | 0.132 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 7.376878e-01 | 0.132 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 7.376878e-01 | 0.132 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 7.376878e-01 | 0.132 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 7.376878e-01 | 0.132 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 7.376878e-01 | 0.132 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 7.376878e-01 | 0.132 | 0 | 0 |
| Ligand-receptor interactions | R-HSA-5632681 | 7.376878e-01 | 0.132 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 7.376878e-01 | 0.132 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 7.376878e-01 | 0.132 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 7.376878e-01 | 0.132 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 7.376878e-01 | 0.132 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 7.376878e-01 | 0.132 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 7.376878e-01 | 0.132 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 7.376878e-01 | 0.132 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 7.376878e-01 | 0.132 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 7.376878e-01 | 0.132 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.387282e-01 | 0.132 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.423598e-01 | 0.129 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 7.430770e-01 | 0.129 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 7.446275e-01 | 0.128 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 7.446387e-01 | 0.128 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 7.470636e-01 | 0.127 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.470636e-01 | 0.127 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.470636e-01 | 0.127 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.470636e-01 | 0.127 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 7.470636e-01 | 0.127 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.470636e-01 | 0.127 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.470636e-01 | 0.127 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.470636e-01 | 0.127 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.470636e-01 | 0.127 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.470636e-01 | 0.127 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.470773e-01 | 0.127 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.508165e-01 | 0.124 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.531895e-01 | 0.123 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.536637e-01 | 0.123 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.577297e-01 | 0.120 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.601737e-01 | 0.119 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.601737e-01 | 0.119 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.601737e-01 | 0.119 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.641102e-01 | 0.117 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.641102e-01 | 0.117 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.641102e-01 | 0.117 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.645755e-01 | 0.117 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 7.647478e-01 | 0.116 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 7.666920e-01 | 0.115 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 7.666920e-01 | 0.115 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 7.715841e-01 | 0.113 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 7.736507e-01 | 0.111 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 7.736507e-01 | 0.111 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.746001e-01 | 0.111 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.759294e-01 | 0.110 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 7.763057e-01 | 0.110 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 7.763057e-01 | 0.110 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 7.763057e-01 | 0.110 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.763057e-01 | 0.110 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 7.763057e-01 | 0.110 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.763057e-01 | 0.110 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 7.763057e-01 | 0.110 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.781035e-01 | 0.109 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 7.781035e-01 | 0.109 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 7.781035e-01 | 0.109 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 7.781035e-01 | 0.109 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 7.781035e-01 | 0.109 | 0 | 0 |
| Defective factor VIII causes hemophilia A | R-HSA-9662001 | 7.781035e-01 | 0.109 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 7.781035e-01 | 0.109 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 7.781035e-01 | 0.109 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 7.781035e-01 | 0.109 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.791391e-01 | 0.108 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 7.793764e-01 | 0.108 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.793764e-01 | 0.108 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.811871e-01 | 0.107 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 7.811871e-01 | 0.107 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 7.862540e-01 | 0.104 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.874492e-01 | 0.104 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.901317e-01 | 0.102 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.903247e-01 | 0.102 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.960119e-01 | 0.099 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.964637e-01 | 0.099 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.007107e-01 | 0.097 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.007107e-01 | 0.097 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.007107e-01 | 0.097 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 8.007107e-01 | 0.097 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.025437e-01 | 0.096 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.025437e-01 | 0.096 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.025437e-01 | 0.096 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.025437e-01 | 0.096 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.037613e-01 | 0.095 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.088378e-01 | 0.092 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 8.088378e-01 | 0.092 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 8.088378e-01 | 0.092 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.110416e-01 | 0.091 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 8.122941e-01 | 0.090 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 8.122941e-01 | 0.090 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 8.122941e-01 | 0.090 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 8.122941e-01 | 0.090 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 8.122941e-01 | 0.090 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 8.122941e-01 | 0.090 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 8.122941e-01 | 0.090 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 8.122941e-01 | 0.090 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 8.122941e-01 | 0.090 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 8.122941e-01 | 0.090 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 8.122941e-01 | 0.090 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 8.122941e-01 | 0.090 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 8.122941e-01 | 0.090 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 8.122941e-01 | 0.090 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 8.122941e-01 | 0.090 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 8.122941e-01 | 0.090 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.138799e-01 | 0.089 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 8.187985e-01 | 0.087 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.246406e-01 | 0.084 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 8.247563e-01 | 0.084 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 8.249625e-01 | 0.084 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.249625e-01 | 0.084 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.253684e-01 | 0.083 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.260090e-01 | 0.083 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.260090e-01 | 0.083 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.260090e-01 | 0.083 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.263573e-01 | 0.083 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.263573e-01 | 0.083 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.263573e-01 | 0.083 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.263573e-01 | 0.083 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.263573e-01 | 0.083 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.283786e-01 | 0.082 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.300570e-01 | 0.081 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.307026e-01 | 0.081 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.307425e-01 | 0.081 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.355111e-01 | 0.078 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.371090e-01 | 0.077 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.392755e-01 | 0.076 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.398459e-01 | 0.076 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.401218e-01 | 0.076 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 8.412181e-01 | 0.075 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 8.412181e-01 | 0.075 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 8.412181e-01 | 0.075 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 8.412181e-01 | 0.075 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 8.412181e-01 | 0.075 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 8.412181e-01 | 0.075 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 8.412181e-01 | 0.075 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 8.412181e-01 | 0.075 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 8.412181e-01 | 0.075 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 8.412181e-01 | 0.075 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 8.412181e-01 | 0.075 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 8.412181e-01 | 0.075 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 8.412181e-01 | 0.075 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 8.412181e-01 | 0.075 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 8.412181e-01 | 0.075 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 8.412181e-01 | 0.075 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 8.412181e-01 | 0.075 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 8.412181e-01 | 0.075 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 8.412181e-01 | 0.075 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 8.412181e-01 | 0.075 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 8.412181e-01 | 0.075 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.419491e-01 | 0.075 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.420169e-01 | 0.075 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.441005e-01 | 0.074 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.461802e-01 | 0.073 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.469330e-01 | 0.072 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.469330e-01 | 0.072 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.469330e-01 | 0.072 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.474762e-01 | 0.072 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.479465e-01 | 0.072 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.483567e-01 | 0.071 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 8.489884e-01 | 0.071 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.494277e-01 | 0.071 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.519774e-01 | 0.070 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.529897e-01 | 0.069 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.529897e-01 | 0.069 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.529897e-01 | 0.069 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.532903e-01 | 0.069 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.576229e-01 | 0.067 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.586378e-01 | 0.066 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.613583e-01 | 0.065 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.623543e-01 | 0.064 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.623543e-01 | 0.064 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.623543e-01 | 0.064 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 8.623543e-01 | 0.064 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.647880e-01 | 0.063 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 8.655415e-01 | 0.063 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.655415e-01 | 0.063 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 8.655415e-01 | 0.063 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 8.655415e-01 | 0.063 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 8.656866e-01 | 0.063 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 8.656866e-01 | 0.063 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 8.656866e-01 | 0.063 | 0 | 0 |
| Degradation of GABA | R-HSA-916853 | 8.656866e-01 | 0.063 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 8.656866e-01 | 0.063 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 8.656866e-01 | 0.063 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 8.656866e-01 | 0.063 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.680663e-01 | 0.061 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 8.680663e-01 | 0.061 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.700732e-01 | 0.060 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.701501e-01 | 0.060 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.761759e-01 | 0.057 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.764696e-01 | 0.057 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.770134e-01 | 0.057 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.770134e-01 | 0.057 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.780671e-01 | 0.056 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.817316e-01 | 0.055 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 8.825174e-01 | 0.054 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.847319e-01 | 0.053 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.863856e-01 | 0.052 | 0 | 0 |
| OADH complex synthesizes glutaryl-CoA from 2-OA | R-HSA-9858328 | 8.863856e-01 | 0.052 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 8.863856e-01 | 0.052 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.863856e-01 | 0.052 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 8.863856e-01 | 0.052 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.863856e-01 | 0.052 | 0 | 0 |
| Metabolism of serotonin | R-HSA-380612 | 8.863856e-01 | 0.052 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 8.863856e-01 | 0.052 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 8.863856e-01 | 0.052 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 8.863856e-01 | 0.052 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 8.863856e-01 | 0.052 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.863856e-01 | 0.052 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.863856e-01 | 0.052 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 8.863856e-01 | 0.052 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.863856e-01 | 0.052 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.863856e-01 | 0.052 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 8.863856e-01 | 0.052 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 8.863856e-01 | 0.052 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 8.899592e-01 | 0.051 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.902686e-01 | 0.050 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.902686e-01 | 0.050 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.902686e-01 | 0.050 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 8.966671e-01 | 0.047 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.966671e-01 | 0.047 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 8.966671e-01 | 0.047 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.966671e-01 | 0.047 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.966671e-01 | 0.047 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.989908e-01 | 0.046 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.991688e-01 | 0.046 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.008229e-01 | 0.045 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.020768e-01 | 0.045 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.022286e-01 | 0.045 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 9.038957e-01 | 0.044 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 9.038957e-01 | 0.044 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 9.038957e-01 | 0.044 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 9.038957e-01 | 0.044 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 9.038957e-01 | 0.044 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 9.038957e-01 | 0.044 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 9.038957e-01 | 0.044 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 9.038957e-01 | 0.044 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 9.038957e-01 | 0.044 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.047097e-01 | 0.043 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.049556e-01 | 0.043 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.051454e-01 | 0.043 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.095805e-01 | 0.041 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.095805e-01 | 0.041 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 9.095805e-01 | 0.041 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.107279e-01 | 0.041 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.113092e-01 | 0.040 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.120581e-01 | 0.040 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.129981e-01 | 0.040 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.129981e-01 | 0.040 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.129981e-01 | 0.040 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.134071e-01 | 0.039 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 9.187080e-01 | 0.037 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 9.187080e-01 | 0.037 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 9.187080e-01 | 0.037 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 9.187080e-01 | 0.037 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 9.187080e-01 | 0.037 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.209689e-01 | 0.036 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 9.209689e-01 | 0.036 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.209689e-01 | 0.036 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.209689e-01 | 0.036 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.209689e-01 | 0.036 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.209689e-01 | 0.036 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.209689e-01 | 0.036 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.210358e-01 | 0.036 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.226770e-01 | 0.035 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.226770e-01 | 0.035 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.226770e-01 | 0.035 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.238482e-01 | 0.034 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.250517e-01 | 0.034 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.251623e-01 | 0.034 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.261215e-01 | 0.033 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.289854e-01 | 0.032 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.298246e-01 | 0.032 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.309957e-01 | 0.031 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.309957e-01 | 0.031 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 9.309957e-01 | 0.031 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.309957e-01 | 0.031 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.309957e-01 | 0.031 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 9.312381e-01 | 0.031 | 0 | 0 |
| Proline catabolism | R-HSA-70688 | 9.312381e-01 | 0.031 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 9.312381e-01 | 0.031 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 9.312381e-01 | 0.031 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 9.312381e-01 | 0.031 | 0 | 0 |
| Synthesis of GDP-mannose | R-HSA-446205 | 9.312381e-01 | 0.031 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 9.312381e-01 | 0.031 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 9.312381e-01 | 0.031 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 9.312381e-01 | 0.031 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 9.312381e-01 | 0.031 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.313603e-01 | 0.031 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.313603e-01 | 0.031 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.341852e-01 | 0.030 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.345441e-01 | 0.029 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.347015e-01 | 0.029 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.391371e-01 | 0.027 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.391371e-01 | 0.027 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.398099e-01 | 0.027 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.398099e-01 | 0.027 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.398099e-01 | 0.027 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.404966e-01 | 0.027 | 0 | 0 |
| OGDH complex synthesizes succinyl-CoA from 2-OG | R-HSA-9853506 | 9.418374e-01 | 0.026 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 9.418374e-01 | 0.026 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 9.418374e-01 | 0.026 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 9.418374e-01 | 0.026 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 9.418374e-01 | 0.026 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 9.418374e-01 | 0.026 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 9.418374e-01 | 0.026 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 9.418374e-01 | 0.026 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 9.418374e-01 | 0.026 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 9.418374e-01 | 0.026 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 9.418374e-01 | 0.026 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 9.418374e-01 | 0.026 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 9.418374e-01 | 0.026 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 9.418374e-01 | 0.026 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.420853e-01 | 0.026 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 9.420853e-01 | 0.026 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.420853e-01 | 0.026 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.438329e-01 | 0.025 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.460910e-01 | 0.024 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.463444e-01 | 0.024 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.463444e-01 | 0.024 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 9.475470e-01 | 0.023 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.475470e-01 | 0.023 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.475470e-01 | 0.023 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.475470e-01 | 0.023 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.481664e-01 | 0.023 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 9.508034e-01 | 0.022 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 9.508034e-01 | 0.022 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 9.508034e-01 | 0.022 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 9.508034e-01 | 0.022 | 0 | 0 |
| Transport of fatty acids | R-HSA-804914 | 9.508034e-01 | 0.022 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.508034e-01 | 0.022 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 9.508034e-01 | 0.022 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 9.508034e-01 | 0.022 | 0 | 0 |
| Vitamin B2 (riboflavin) metabolism | R-HSA-196843 | 9.508034e-01 | 0.022 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 9.508034e-01 | 0.022 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.508034e-01 | 0.022 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 9.508034e-01 | 0.022 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.508034e-01 | 0.022 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 9.508034e-01 | 0.022 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 9.508034e-01 | 0.022 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.508034e-01 | 0.022 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.522997e-01 | 0.021 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.522997e-01 | 0.021 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.526972e-01 | 0.021 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.536565e-01 | 0.021 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.536565e-01 | 0.021 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.536565e-01 | 0.021 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.543296e-01 | 0.020 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.543296e-01 | 0.020 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.555586e-01 | 0.020 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.564327e-01 | 0.019 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.578350e-01 | 0.019 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 9.583877e-01 | 0.018 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 9.583877e-01 | 0.018 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.583877e-01 | 0.018 | 0 | 0 |
| Events associated with phagocytolytic activity of PMN cells | R-HSA-8941413 | 9.583877e-01 | 0.018 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 9.583877e-01 | 0.018 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.602681e-01 | 0.018 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.602681e-01 | 0.018 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.607979e-01 | 0.017 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.610142e-01 | 0.017 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.627633e-01 | 0.016 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 9.627633e-01 | 0.016 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.627633e-01 | 0.016 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.632219e-01 | 0.016 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.635561e-01 | 0.016 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.635561e-01 | 0.016 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.635561e-01 | 0.016 | 0 | 0 |
| Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | R-HSA-2142816 | 9.648031e-01 | 0.016 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.648031e-01 | 0.016 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.648031e-01 | 0.016 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.648031e-01 | 0.016 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.648031e-01 | 0.016 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.648031e-01 | 0.016 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 9.648031e-01 | 0.016 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.648031e-01 | 0.016 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.648031e-01 | 0.016 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.654614e-01 | 0.015 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.670699e-01 | 0.015 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.670699e-01 | 0.015 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.670699e-01 | 0.015 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.671455e-01 | 0.015 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.671455e-01 | 0.015 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.699982e-01 | 0.013 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.699982e-01 | 0.013 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.699982e-01 | 0.013 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.702298e-01 | 0.013 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.702298e-01 | 0.013 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.702298e-01 | 0.013 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 9.702298e-01 | 0.013 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 9.702298e-01 | 0.013 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.702298e-01 | 0.013 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.702298e-01 | 0.013 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.702298e-01 | 0.013 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.702298e-01 | 0.013 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.702298e-01 | 0.013 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.710373e-01 | 0.013 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.710373e-01 | 0.013 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.722223e-01 | 0.012 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.731660e-01 | 0.012 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.739574e-01 | 0.011 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.739574e-01 | 0.011 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.741989e-01 | 0.011 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.744895e-01 | 0.011 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.744895e-01 | 0.011 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.744895e-01 | 0.011 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.748200e-01 | 0.011 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.748200e-01 | 0.011 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.748200e-01 | 0.011 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.748200e-01 | 0.011 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.748200e-01 | 0.011 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.748851e-01 | 0.011 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.767894e-01 | 0.010 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.770411e-01 | 0.010 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.774093e-01 | 0.010 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.775483e-01 | 0.010 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.787027e-01 | 0.009 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.787027e-01 | 0.009 | 0 | 0 |
| Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) | R-HSA-2142670 | 9.787027e-01 | 0.009 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.787027e-01 | 0.009 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.787027e-01 | 0.009 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.787027e-01 | 0.009 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.787027e-01 | 0.009 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.787027e-01 | 0.009 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.795752e-01 | 0.009 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.795875e-01 | 0.009 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.795875e-01 | 0.009 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.796984e-01 | 0.009 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.804160e-01 | 0.009 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.816926e-01 | 0.008 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.817892e-01 | 0.008 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.819869e-01 | 0.008 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.819869e-01 | 0.008 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.819869e-01 | 0.008 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.819869e-01 | 0.008 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.819869e-01 | 0.008 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.826498e-01 | 0.008 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.830329e-01 | 0.007 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.847648e-01 | 0.007 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 9.847648e-01 | 0.007 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.847648e-01 | 0.007 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.847648e-01 | 0.007 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.851628e-01 | 0.006 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.853086e-01 | 0.006 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.853086e-01 | 0.006 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.855539e-01 | 0.006 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.866307e-01 | 0.006 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.866307e-01 | 0.006 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.869851e-01 | 0.006 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.869851e-01 | 0.006 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.871144e-01 | 0.006 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.871144e-01 | 0.006 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.871144e-01 | 0.006 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.871144e-01 | 0.006 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.882763e-01 | 0.005 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.883930e-01 | 0.005 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.883930e-01 | 0.005 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.890032e-01 | 0.005 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.891018e-01 | 0.005 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.891018e-01 | 0.005 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.891018e-01 | 0.005 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.891018e-01 | 0.005 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.895091e-01 | 0.005 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.896673e-01 | 0.005 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.904932e-01 | 0.004 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.907828e-01 | 0.004 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.907828e-01 | 0.004 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.907828e-01 | 0.004 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.907828e-01 | 0.004 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.907828e-01 | 0.004 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.911744e-01 | 0.004 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.917853e-01 | 0.004 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.917853e-01 | 0.004 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.921243e-01 | 0.003 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.922045e-01 | 0.003 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.922045e-01 | 0.003 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.922045e-01 | 0.003 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.926122e-01 | 0.003 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.929051e-01 | 0.003 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.934071e-01 | 0.003 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.934071e-01 | 0.003 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.934071e-01 | 0.003 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.934071e-01 | 0.003 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.938749e-01 | 0.003 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.938749e-01 | 0.003 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.939640e-01 | 0.003 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.940971e-01 | 0.003 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.944241e-01 | 0.002 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.944241e-01 | 0.002 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.944241e-01 | 0.002 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.944241e-01 | 0.002 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.944241e-01 | 0.002 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.944241e-01 | 0.002 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.944241e-01 | 0.002 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.944241e-01 | 0.002 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.944241e-01 | 0.002 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.946448e-01 | 0.002 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.947144e-01 | 0.002 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.948626e-01 | 0.002 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.951065e-01 | 0.002 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.955214e-01 | 0.002 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.958369e-01 | 0.002 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.959883e-01 | 0.002 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.960119e-01 | 0.002 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.960119e-01 | 0.002 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.960119e-01 | 0.002 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.960119e-01 | 0.002 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.960689e-01 | 0.002 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.963409e-01 | 0.002 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.963409e-01 | 0.002 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.965001e-01 | 0.002 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.966117e-01 | 0.001 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.966273e-01 | 0.001 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.966273e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.967806e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.967806e-01 | 0.001 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.971477e-01 | 0.001 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.971477e-01 | 0.001 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.971557e-01 | 0.001 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.972037e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.972570e-01 | 0.001 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.975878e-01 | 0.001 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.976743e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.978116e-01 | 0.001 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.978351e-01 | 0.001 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.979601e-01 | 0.001 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.979601e-01 | 0.001 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.982712e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.983967e-01 | 0.001 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.984140e-01 | 0.001 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.985412e-01 | 0.001 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.986379e-01 | 0.001 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.986677e-01 | 0.001 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.988141e-01 | 0.001 | 0 | 0 |
| Translation | R-HSA-72766 | 9.988750e-01 | 0.000 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.989568e-01 | 0.000 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.989568e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.991238e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.991278e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.992300e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.992472e-01 | 0.000 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.993692e-01 | 0.000 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.993692e-01 | 0.000 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.993692e-01 | 0.000 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.993692e-01 | 0.000 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.994447e-01 | 0.000 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.994447e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.994652e-01 | 0.000 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.994666e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.995445e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.995586e-01 | 0.000 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.996186e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.996598e-01 | 0.000 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.996775e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.996776e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.996776e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.996776e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.996776e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.997207e-01 | 0.000 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.997273e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.997356e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.997416e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.997470e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.998050e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.998166e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.998187e-01 | 0.000 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.998351e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.998371e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.998604e-01 | 0.000 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.998606e-01 | 0.000 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.999003e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999118e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999170e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999225e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999268e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999345e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999396e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.999398e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999434e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.999491e-01 | 0.000 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.999491e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999655e-01 | 0.000 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.999692e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.999747e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.999747e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999747e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999747e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.999814e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999815e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999816e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.999826e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999855e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999855e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999867e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.999905e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999909e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999913e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.999928e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.999932e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999939e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.999943e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999946e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999947e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999947e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999971e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999978e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.999979e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999979e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999980e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999981e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.999982e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999985e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.999989e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999992e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999993e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999994e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999995e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999996e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999997e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999998e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999999e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999999e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.330669e-16 | 15.477 | 1 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 4.440892e-16 | 15.353 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 5.551115e-16 | 15.256 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.554312e-15 | 14.808 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.554312e-15 | 14.808 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.554312e-15 | 14.808 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.554312e-15 | 14.808 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.330669e-15 | 14.477 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.076916e-14 | 13.968 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 3.819167e-14 | 13.418 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.351275e-14 | 13.272 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.064704e-13 | 12.973 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.342260e-13 | 12.872 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.407763e-13 | 12.851 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.386180e-13 | 12.470 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.285461e-13 | 12.368 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 4.432010e-13 | 12.353 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.346968e-13 | 12.029 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 9.827694e-13 | 12.008 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.093792e-12 | 11.961 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.640466e-12 | 11.785 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.415845e-12 | 11.617 | 1 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.947953e-12 | 11.404 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.713119e-12 | 11.327 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.713119e-12 | 11.327 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.550316e-12 | 11.184 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.873280e-12 | 11.163 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 6.995404e-12 | 11.155 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.701018e-12 | 11.013 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.216582e-11 | 10.915 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.254796e-11 | 10.901 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.087330e-11 | 10.680 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.726652e-11 | 10.564 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 3.805700e-11 | 10.420 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 4.589684e-11 | 10.338 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 6.131451e-11 | 10.212 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 6.507428e-11 | 10.187 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.886525e-11 | 10.162 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.516177e-11 | 10.124 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.976309e-11 | 10.047 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.050915e-10 | 9.978 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.212337e-10 | 9.916 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.342541e-10 | 9.872 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.056545e-10 | 9.515 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.213623e-10 | 9.283 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 5.280518e-10 | 9.277 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 6.421077e-10 | 9.192 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 7.316745e-10 | 9.136 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.025628e-09 | 8.989 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.075040e-09 | 8.969 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.083233e-09 | 8.965 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.168154e-09 | 8.932 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.245166e-09 | 8.905 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.768201e-09 | 8.752 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.823388e-09 | 8.739 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.911126e-09 | 8.719 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.336388e-09 | 8.631 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.446008e-09 | 8.612 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.264502e-09 | 8.486 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.343536e-09 | 8.476 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.382802e-09 | 8.358 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 4.587085e-09 | 8.338 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.795057e-09 | 8.319 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.961299e-09 | 8.225 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 6.065419e-09 | 8.217 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.270033e-09 | 8.082 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.890325e-09 | 8.051 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 9.322805e-09 | 8.030 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.029653e-08 | 7.987 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.937430e-09 | 8.003 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.042934e-08 | 7.982 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.062214e-08 | 7.974 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.155087e-08 | 7.937 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.253604e-08 | 7.902 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.450955e-08 | 7.838 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.467304e-08 | 7.833 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.860501e-08 | 7.730 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.985516e-08 | 7.702 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.999803e-08 | 7.699 | 1 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.898690e-08 | 7.538 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.911218e-08 | 7.536 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.986473e-08 | 7.525 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.568026e-08 | 7.448 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.655715e-08 | 7.437 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 4.116028e-08 | 7.386 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 4.531747e-08 | 7.344 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.612165e-08 | 7.336 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 4.954585e-08 | 7.305 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.129677e-08 | 7.290 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 6.146275e-08 | 7.211 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 6.449145e-08 | 7.190 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 7.156390e-08 | 7.145 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.243629e-08 | 7.140 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.808595e-08 | 7.107 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 7.742450e-08 | 7.111 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 7.503900e-08 | 7.125 | 1 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 7.774525e-08 | 7.109 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.070267e-08 | 7.093 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.775688e-08 | 7.057 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.056875e-07 | 6.976 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.084678e-07 | 6.965 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.215145e-07 | 6.915 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.275280e-07 | 6.894 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.328216e-07 | 6.877 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.362000e-07 | 6.866 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.423137e-07 | 6.847 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.637199e-07 | 6.786 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.637199e-07 | 6.786 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.886566e-07 | 6.724 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.986104e-07 | 6.702 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.253257e-07 | 6.647 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 2.590127e-07 | 6.587 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.833021e-07 | 6.548 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.844786e-07 | 6.546 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.931141e-07 | 6.533 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.136259e-07 | 6.504 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 3.225716e-07 | 6.491 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.524321e-07 | 6.453 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.947921e-07 | 6.404 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 4.097913e-07 | 6.387 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.162386e-07 | 6.381 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 4.271775e-07 | 6.369 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.371544e-07 | 6.359 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.414275e-07 | 6.355 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.938146e-07 | 6.306 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 5.691235e-07 | 6.245 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.620160e-07 | 6.250 | 0 | 0 |
| Depurination | R-HSA-73927 | 5.625984e-07 | 6.250 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.596747e-07 | 6.252 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 5.877827e-07 | 6.231 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 5.877827e-07 | 6.231 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.238869e-07 | 6.205 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.617568e-07 | 6.179 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 8.488291e-07 | 6.071 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.731341e-07 | 6.059 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.783206e-07 | 6.056 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.039053e-06 | 5.983 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.167573e-06 | 5.933 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.169043e-06 | 5.932 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.263708e-06 | 5.898 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.226250e-06 | 5.911 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.325024e-06 | 5.878 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.366866e-06 | 5.864 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.366866e-06 | 5.864 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.467110e-06 | 5.834 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.628229e-06 | 5.788 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.669667e-06 | 5.777 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.685161e-06 | 5.773 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.742785e-06 | 5.759 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.787456e-06 | 5.748 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.926986e-06 | 5.715 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.968002e-06 | 5.706 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.246213e-06 | 5.649 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.290162e-06 | 5.640 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.991265e-06 | 5.524 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.118954e-06 | 5.506 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.185928e-06 | 5.497 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 3.491632e-06 | 5.457 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.835838e-06 | 5.416 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.298254e-06 | 5.367 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.171416e-06 | 5.286 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.567269e-06 | 5.254 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 6.168991e-06 | 5.210 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 6.453875e-06 | 5.190 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 6.453875e-06 | 5.190 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.454876e-06 | 5.190 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.817641e-06 | 5.166 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 7.817164e-06 | 5.107 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.796733e-06 | 5.056 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 8.817721e-06 | 5.055 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 9.436613e-06 | 5.025 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.179373e-05 | 4.928 | 1 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.184233e-05 | 4.927 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.218263e-05 | 4.914 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.300798e-05 | 4.886 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.300798e-05 | 4.886 | 1 | 1 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.317009e-05 | 4.880 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.340564e-05 | 4.873 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.364291e-05 | 4.865 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.455496e-05 | 4.837 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.587585e-05 | 4.799 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.682579e-05 | 4.774 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.682579e-05 | 4.774 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.711504e-05 | 4.767 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.746085e-05 | 4.758 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.989603e-05 | 4.701 | 1 | 1 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.874150e-05 | 4.727 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.070843e-05 | 4.684 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.315001e-05 | 4.635 | 1 | 1 |
| Amyloid fiber formation | R-HSA-977225 | 2.315001e-05 | 4.635 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.471711e-05 | 4.607 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.760299e-05 | 4.559 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.072659e-05 | 4.512 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.158127e-05 | 4.501 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.158127e-05 | 4.501 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.321553e-05 | 4.479 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 3.459608e-05 | 4.461 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.491508e-05 | 4.457 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.854484e-05 | 4.414 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.891306e-05 | 4.410 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.907794e-05 | 4.408 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.127494e-05 | 4.384 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.130619e-05 | 4.384 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.634341e-05 | 4.334 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 4.656204e-05 | 4.332 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.908312e-05 | 4.309 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.355742e-05 | 4.271 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 5.355742e-05 | 4.271 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.916646e-05 | 4.308 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.499636e-05 | 4.260 | 0 | 0 |
| Translation | R-HSA-72766 | 5.513762e-05 | 4.259 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.554885e-05 | 4.255 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 6.167410e-05 | 4.210 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.601525e-05 | 4.180 | 1 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.875770e-05 | 4.163 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.886945e-05 | 4.162 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 8.461492e-05 | 4.073 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 8.461492e-05 | 4.073 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 8.461492e-05 | 4.073 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 8.461492e-05 | 4.073 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 8.848625e-05 | 4.053 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 9.047299e-05 | 4.043 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.148133e-05 | 4.039 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 9.615414e-05 | 4.017 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.615414e-05 | 4.017 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 9.793176e-05 | 4.009 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 9.953345e-05 | 4.002 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.112547e-04 | 3.954 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.113074e-04 | 3.953 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.114652e-04 | 3.953 | 1 | 1 |
| Signaling by VEGF | R-HSA-194138 | 1.118754e-04 | 3.951 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.165645e-04 | 3.933 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.182226e-04 | 3.927 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.208667e-04 | 3.918 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.208667e-04 | 3.918 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.345641e-04 | 3.871 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.238173e-04 | 3.907 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.242288e-04 | 3.906 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.424618e-04 | 3.846 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.276765e-04 | 3.894 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.224955e-04 | 3.912 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.391256e-04 | 3.857 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.537918e-04 | 3.813 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.537918e-04 | 3.813 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.573187e-04 | 3.803 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.043345e-04 | 3.690 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.140366e-04 | 3.670 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.140366e-04 | 3.670 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.140366e-04 | 3.670 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.166094e-04 | 3.664 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.211925e-04 | 3.655 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.211925e-04 | 3.655 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.223290e-04 | 3.653 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.223601e-04 | 3.653 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.823192e-04 | 3.549 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.823192e-04 | 3.549 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.875363e-04 | 3.541 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.875363e-04 | 3.541 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.119034e-04 | 3.506 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.131015e-04 | 3.504 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.131015e-04 | 3.504 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.233258e-04 | 3.490 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.736413e-04 | 3.428 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.751492e-04 | 3.426 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.862253e-04 | 3.413 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 3.868954e-04 | 3.412 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.979112e-04 | 3.400 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 4.048406e-04 | 3.393 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.075767e-04 | 3.390 | 0 | 0 |
| Protein folding | R-HSA-391251 | 4.197020e-04 | 3.377 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.235500e-04 | 3.373 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.235500e-04 | 3.373 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.420478e-04 | 3.355 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.482661e-04 | 3.348 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.550385e-04 | 3.342 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.494273e-04 | 3.260 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.494273e-04 | 3.260 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.012642e-04 | 3.300 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 4.689692e-04 | 3.329 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.151238e-04 | 3.288 | 1 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.585447e-04 | 3.339 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.404549e-04 | 3.267 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.581398e-04 | 3.253 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.102473e-04 | 3.214 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 6.254890e-04 | 3.204 | 1 | 0 |
| Membrane Trafficking | R-HSA-199991 | 6.981371e-04 | 3.156 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.234501e-04 | 3.141 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 7.774002e-04 | 3.109 | 0 | 0 |
| S Phase | R-HSA-69242 | 7.948142e-04 | 3.100 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.417896e-04 | 3.075 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.520191e-04 | 3.070 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 9.171003e-04 | 3.038 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 9.655654e-04 | 3.015 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.000996e-03 | 3.000 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.012517e-03 | 2.995 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.065002e-03 | 2.973 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.126655e-03 | 2.948 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.126655e-03 | 2.948 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.139520e-03 | 2.943 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.159191e-03 | 2.936 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.160759e-03 | 2.935 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.169881e-03 | 2.932 | 1 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.173738e-03 | 2.930 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.210845e-03 | 2.917 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.219856e-03 | 2.914 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.222528e-03 | 2.913 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.284557e-03 | 2.891 | 1 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.356130e-03 | 2.868 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.361908e-03 | 2.866 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.420133e-03 | 2.848 | 1 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.433532e-03 | 2.844 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.451067e-03 | 2.838 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.485286e-03 | 2.828 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.538700e-03 | 2.813 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.561831e-03 | 2.806 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.561831e-03 | 2.806 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.606619e-03 | 2.794 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.682998e-03 | 2.774 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.757635e-03 | 2.755 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.831875e-03 | 2.737 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.875143e-03 | 2.727 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.323747e-03 | 2.634 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.140148e-03 | 2.670 | 1 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 2.426506e-03 | 2.615 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.370099e-03 | 2.625 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.447912e-03 | 2.611 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 2.526867e-03 | 2.597 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.526867e-03 | 2.597 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.535551e-03 | 2.596 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.685204e-03 | 2.571 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.708989e-03 | 2.567 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.764920e-03 | 2.558 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.882113e-03 | 2.540 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 2.886085e-03 | 2.540 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.027433e-03 | 2.519 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.065546e-03 | 2.513 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.165792e-03 | 2.500 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.165792e-03 | 2.500 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.165792e-03 | 2.500 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.340080e-03 | 2.476 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 3.393295e-03 | 2.469 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.498753e-03 | 2.456 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.635869e-03 | 2.439 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.750736e-03 | 2.426 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.750736e-03 | 2.426 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.780686e-03 | 2.422 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.780686e-03 | 2.422 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.820582e-03 | 2.418 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.820582e-03 | 2.418 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.820582e-03 | 2.418 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.836892e-03 | 2.416 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.836892e-03 | 2.416 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.863654e-03 | 2.413 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.863654e-03 | 2.413 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.080482e-03 | 2.389 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.102830e-03 | 2.387 | 1 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.299454e-03 | 2.367 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.299454e-03 | 2.367 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.299454e-03 | 2.367 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 4.299454e-03 | 2.367 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 4.338925e-03 | 2.363 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.477432e-03 | 2.349 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.592141e-03 | 2.338 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.592141e-03 | 2.338 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 4.620903e-03 | 2.335 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.692041e-03 | 2.329 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.753007e-03 | 2.323 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.765335e-03 | 2.322 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 4.765335e-03 | 2.322 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 4.765335e-03 | 2.322 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.813800e-03 | 2.318 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.825758e-03 | 2.316 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.884699e-03 | 2.311 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 5.178419e-03 | 2.286 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.301822e-03 | 2.276 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.436200e-03 | 2.265 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.439158e-03 | 2.264 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.472053e-03 | 2.262 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.476091e-03 | 2.262 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 5.476091e-03 | 2.262 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.548396e-03 | 2.256 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.565239e-03 | 2.255 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 6.803671e-03 | 2.167 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 6.803671e-03 | 2.167 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 6.803671e-03 | 2.167 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 6.803671e-03 | 2.167 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 6.803671e-03 | 2.167 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 6.803671e-03 | 2.167 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 6.803671e-03 | 2.167 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 6.803671e-03 | 2.167 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 6.803671e-03 | 2.167 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 6.803671e-03 | 2.167 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 6.803671e-03 | 2.167 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.833051e-03 | 2.234 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 6.978254e-03 | 2.156 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 6.978254e-03 | 2.156 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.560428e-03 | 2.183 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.226659e-03 | 2.141 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.623056e-03 | 2.250 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.409027e-03 | 2.193 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 7.004650e-03 | 2.155 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.303487e-03 | 2.200 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 7.124921e-03 | 2.147 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.994028e-03 | 2.155 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.623056e-03 | 2.250 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 6.154378e-03 | 2.211 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.936576e-03 | 2.226 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 6.994028e-03 | 2.155 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 7.207979e-03 | 2.142 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 7.004650e-03 | 2.155 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 7.495665e-03 | 2.125 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 7.495665e-03 | 2.125 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 7.516581e-03 | 2.124 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.649556e-03 | 2.116 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.657354e-03 | 2.116 | 1 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 8.011771e-03 | 2.096 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.011771e-03 | 2.096 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.011771e-03 | 2.096 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 8.077044e-03 | 2.093 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.077044e-03 | 2.093 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.088766e-03 | 2.092 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 8.088766e-03 | 2.092 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 8.288070e-03 | 2.082 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 8.509684e-03 | 2.070 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 8.509684e-03 | 2.070 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 8.509684e-03 | 2.070 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 8.689530e-03 | 2.061 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.701583e-03 | 2.060 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 8.701583e-03 | 2.060 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 8.760802e-03 | 2.057 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.869124e-03 | 2.052 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.952692e-03 | 2.048 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.960339e-03 | 2.048 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.768431e-03 | 2.010 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.768431e-03 | 2.010 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 9.776678e-03 | 2.010 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.776678e-03 | 2.010 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.021512e-02 | 1.991 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.025111e-02 | 1.989 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.025111e-02 | 1.989 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.025111e-02 | 1.989 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.025111e-02 | 1.989 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.025111e-02 | 1.989 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.025111e-02 | 1.989 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.038734e-02 | 1.983 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.064433e-02 | 1.973 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.069672e-02 | 1.971 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.069672e-02 | 1.971 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.115761e-02 | 1.952 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.134129e-02 | 1.945 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.136951e-02 | 1.944 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.142477e-02 | 1.942 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.145835e-02 | 1.941 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.200361e-02 | 1.921 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.213312e-02 | 1.916 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.221271e-02 | 1.913 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.239929e-02 | 1.907 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.239929e-02 | 1.907 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.239931e-02 | 1.907 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.239931e-02 | 1.907 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.290215e-02 | 1.889 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.325754e-02 | 1.878 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.334734e-02 | 1.875 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.334734e-02 | 1.875 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.334734e-02 | 1.875 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.334734e-02 | 1.875 | 1 | 1 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.334734e-02 | 1.875 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.353859e-02 | 1.868 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.397969e-02 | 1.855 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.463790e-02 | 1.835 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.463854e-02 | 1.835 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.495436e-02 | 1.825 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.495436e-02 | 1.825 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.495436e-02 | 1.825 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.519355e-02 | 1.818 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.519355e-02 | 1.818 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.527562e-02 | 1.816 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.558140e-02 | 1.807 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.565005e-02 | 1.805 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.565005e-02 | 1.805 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.565005e-02 | 1.805 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.565005e-02 | 1.805 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.580771e-02 | 1.801 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.599956e-02 | 1.796 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.628086e-02 | 1.788 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.628086e-02 | 1.788 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.637225e-02 | 1.786 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.699736e-02 | 1.770 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.755884e-02 | 1.756 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.780356e-02 | 1.749 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.780356e-02 | 1.749 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 1.780356e-02 | 1.749 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.780356e-02 | 1.749 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.787248e-02 | 1.748 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.805949e-02 | 1.743 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.831411e-02 | 1.737 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.831411e-02 | 1.737 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.831411e-02 | 1.737 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.865627e-02 | 1.729 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.882496e-02 | 1.725 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.404644e-02 | 1.619 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.366017e-02 | 1.626 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.827933e-02 | 1.549 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.638608e-02 | 1.579 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.895769e-02 | 1.722 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.108211e-02 | 1.676 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.827933e-02 | 1.549 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.039824e-02 | 1.690 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.583871e-02 | 1.588 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.404644e-02 | 1.619 | 1 | 1 |
| Regulation of Apoptosis | R-HSA-169911 | 2.039824e-02 | 1.690 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.251171e-02 | 1.648 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.998093e-02 | 1.699 | 1 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 2.736675e-02 | 1.563 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.566277e-02 | 1.591 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.108211e-02 | 1.676 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.206565e-02 | 1.656 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.206565e-02 | 1.656 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.971728e-02 | 1.705 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 2.024398e-02 | 1.694 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 2.024398e-02 | 1.694 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.914744e-02 | 1.718 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.914744e-02 | 1.718 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.971728e-02 | 1.705 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.024398e-02 | 1.694 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 2.404644e-02 | 1.619 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.934444e-02 | 1.713 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.151923e-02 | 1.667 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.151923e-02 | 1.667 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.151923e-02 | 1.667 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.325490e-02 | 1.633 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.283730e-02 | 1.641 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.583871e-02 | 1.588 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.583871e-02 | 1.588 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.914744e-02 | 1.718 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.151923e-02 | 1.667 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.834581e-02 | 1.548 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.834581e-02 | 1.548 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.834581e-02 | 1.548 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.873030e-02 | 1.542 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.873030e-02 | 1.542 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.896198e-02 | 1.538 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.896198e-02 | 1.538 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.896198e-02 | 1.538 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.958694e-02 | 1.529 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.968671e-02 | 1.527 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.980368e-02 | 1.526 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.992632e-02 | 1.524 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.005454e-02 | 1.522 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.005454e-02 | 1.522 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.005454e-02 | 1.522 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 3.033605e-02 | 1.518 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.033605e-02 | 1.518 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.152529e-02 | 1.501 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.192382e-02 | 1.496 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 3.195224e-02 | 1.495 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.204936e-02 | 1.494 | 1 | 1 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.204936e-02 | 1.494 | 1 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.204936e-02 | 1.494 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.337694e-02 | 1.477 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.337694e-02 | 1.477 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.345607e-02 | 1.476 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.345607e-02 | 1.476 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.351883e-02 | 1.475 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.351883e-02 | 1.475 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.352834e-02 | 1.475 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.389143e-02 | 1.470 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.452612e-02 | 1.462 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.471004e-02 | 1.460 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.554914e-02 | 1.449 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 3.562882e-02 | 1.448 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.609608e-02 | 1.443 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.609608e-02 | 1.443 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.632185e-02 | 1.440 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 3.632185e-02 | 1.440 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.638542e-02 | 1.439 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.754185e-02 | 1.425 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.754185e-02 | 1.425 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.754185e-02 | 1.425 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.754185e-02 | 1.425 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.758868e-02 | 1.425 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.809304e-02 | 1.419 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.905737e-02 | 1.408 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.920955e-02 | 1.407 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 3.947698e-02 | 1.404 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.982007e-02 | 1.400 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.050619e-02 | 1.392 | 1 | 1 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.061089e-02 | 1.391 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.070009e-02 | 1.390 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 4.134951e-02 | 1.384 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.134951e-02 | 1.384 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 4.188214e-02 | 1.378 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 4.188214e-02 | 1.378 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.188214e-02 | 1.378 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.343396e-02 | 1.362 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.360148e-02 | 1.360 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 4.396931e-02 | 1.357 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.451447e-02 | 1.351 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.451447e-02 | 1.351 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.451447e-02 | 1.351 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 4.483546e-02 | 1.348 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.546341e-02 | 1.342 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.546341e-02 | 1.342 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.555503e-02 | 1.341 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 4.555503e-02 | 1.341 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.555503e-02 | 1.341 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.555503e-02 | 1.341 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.800924e-02 | 1.319 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 4.927123e-02 | 1.307 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 4.927123e-02 | 1.307 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.927123e-02 | 1.307 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.129531e-02 | 1.290 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.145162e-02 | 1.289 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.145162e-02 | 1.289 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.154716e-02 | 1.288 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.228094e-02 | 1.282 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.228094e-02 | 1.282 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.250372e-02 | 1.280 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 5.250372e-02 | 1.280 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 5.250372e-02 | 1.280 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.307569e-02 | 1.275 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 5.369743e-02 | 1.270 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 5.369743e-02 | 1.270 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 5.389208e-02 | 1.268 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.390982e-02 | 1.268 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 5.497085e-02 | 1.260 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.501571e-02 | 1.260 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 5.501571e-02 | 1.260 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.501571e-02 | 1.260 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.501571e-02 | 1.260 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.569181e-02 | 1.254 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 5.576948e-02 | 1.254 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 5.576948e-02 | 1.254 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.576948e-02 | 1.254 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 5.581386e-02 | 1.253 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 5.581386e-02 | 1.253 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.637106e-02 | 1.249 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 5.688557e-02 | 1.245 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.688557e-02 | 1.245 | 1 | 1 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.769174e-02 | 1.239 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 5.769840e-02 | 1.239 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.799112e-02 | 1.237 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.799112e-02 | 1.237 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.799112e-02 | 1.237 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.799112e-02 | 1.237 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.925102e-02 | 1.227 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.981162e-02 | 1.223 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.006279e-02 | 1.221 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 6.010272e-02 | 1.221 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 6.023781e-02 | 1.220 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 6.107427e-02 | 1.214 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 6.107427e-02 | 1.214 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.184745e-02 | 1.209 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.256850e-02 | 1.204 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.298971e-02 | 1.201 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.370680e-02 | 1.196 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.370680e-02 | 1.196 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 6.502098e-02 | 1.187 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.502098e-02 | 1.187 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 6.502098e-02 | 1.187 | 0 | 0 |
| Disease | R-HSA-1643685 | 6.606056e-02 | 1.180 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.634084e-02 | 1.178 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.634084e-02 | 1.178 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 6.722355e-02 | 1.172 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 6.722355e-02 | 1.172 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.722355e-02 | 1.172 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.722355e-02 | 1.172 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.722355e-02 | 1.172 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.758593e-02 | 1.170 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.823535e-02 | 1.166 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 6.859992e-02 | 1.164 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.859992e-02 | 1.164 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 6.859992e-02 | 1.164 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 6.971476e-02 | 1.157 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.971476e-02 | 1.157 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.971476e-02 | 1.157 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 7.054761e-02 | 1.152 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 7.054761e-02 | 1.152 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 7.054761e-02 | 1.152 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.054761e-02 | 1.152 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 7.054761e-02 | 1.152 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.177170e-02 | 1.144 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 7.177170e-02 | 1.144 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.240773e-02 | 1.140 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.254397e-02 | 1.139 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.254397e-02 | 1.139 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.702050e-02 | 1.113 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 7.979529e-02 | 1.098 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 7.979529e-02 | 1.098 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.979529e-02 | 1.098 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.000957e-02 | 1.097 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 8.012230e-02 | 1.096 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.012230e-02 | 1.096 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.056035e-02 | 1.094 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 8.207382e-02 | 1.086 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 8.207382e-02 | 1.086 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.266502e-02 | 1.083 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.509638e-02 | 1.070 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 8.541224e-02 | 1.068 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.024649e-02 | 1.045 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 9.024649e-02 | 1.045 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 9.024649e-02 | 1.045 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 9.024649e-02 | 1.045 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.723534e-01 | 0.764 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.723534e-01 | 0.764 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.723534e-01 | 0.764 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.723534e-01 | 0.764 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.723534e-01 | 0.764 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 1.723534e-01 | 0.764 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 1.723534e-01 | 0.764 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.723534e-01 | 0.764 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.723534e-01 | 0.764 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH3 | R-HSA-5632927 | 1.723534e-01 | 0.764 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.723534e-01 | 0.764 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.112850e-01 | 0.954 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.112850e-01 | 0.954 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.112850e-01 | 0.954 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.112850e-01 | 0.954 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.427015e-01 | 0.846 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.427015e-01 | 0.846 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.427015e-01 | 0.846 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.427015e-01 | 0.846 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.427015e-01 | 0.846 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.427015e-01 | 0.846 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 8.781125e-02 | 1.056 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 8.781125e-02 | 1.056 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 8.781125e-02 | 1.056 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.066534e-01 | 0.972 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.066534e-01 | 0.972 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.269085e-01 | 0.897 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.269085e-01 | 0.897 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.484047e-01 | 0.829 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.081120e-01 | 0.966 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 9.130978e-02 | 1.039 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.237432e-01 | 0.907 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.237432e-01 | 0.907 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.709683e-01 | 0.767 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.709683e-01 | 0.767 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.709683e-01 | 0.767 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.032557e-01 | 0.986 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.402677e-01 | 0.853 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.402677e-01 | 0.853 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.402677e-01 | 0.853 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.640587e-02 | 1.016 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.576123e-01 | 0.802 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.576123e-01 | 0.802 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.576123e-01 | 0.802 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.293103e-01 | 0.888 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.069856e-01 | 0.971 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.069856e-01 | 0.971 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.181373e-01 | 0.928 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.181373e-01 | 0.928 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.298426e-01 | 0.887 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.580168e-01 | 0.801 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.720850e-02 | 1.059 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 1.500131e-01 | 0.824 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.032557e-01 | 0.986 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.640587e-02 | 1.016 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.294762e-01 | 0.888 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.624801e-02 | 1.017 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.081120e-01 | 0.966 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 1.293103e-01 | 0.888 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.548265e-01 | 0.810 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.427015e-01 | 0.846 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.066534e-01 | 0.972 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.237432e-01 | 0.907 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.433514e-01 | 0.844 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 1.549373e-01 | 0.810 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 1.293103e-01 | 0.888 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.246176e-01 | 0.904 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.246176e-01 | 0.904 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 9.403374e-02 | 1.027 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 9.774470e-02 | 1.010 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.237432e-01 | 0.907 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.429824e-01 | 0.845 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.360384e-01 | 0.866 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.402677e-01 | 0.853 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.774470e-02 | 1.010 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.063051e-01 | 0.973 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 1.181373e-01 | 0.928 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.081120e-01 | 0.966 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 1.387331e-01 | 0.858 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.172390e-01 | 0.931 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 1.427015e-01 | 0.846 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 8.781125e-02 | 1.056 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.680552e-01 | 0.775 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.130978e-02 | 1.039 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.402677e-01 | 0.853 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 8.914755e-02 | 1.050 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.075360e-01 | 0.968 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.476881e-01 | 0.831 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.723534e-01 | 0.764 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.723534e-01 | 0.764 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.112850e-01 | 0.954 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.032557e-01 | 0.986 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.576123e-01 | 0.802 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.958945e-02 | 1.048 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 1.419024e-01 | 0.848 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.755775e-02 | 1.058 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.806212e-02 | 1.008 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.066534e-01 | 0.972 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.641350e-02 | 1.063 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.680552e-01 | 0.775 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 1.116113e-01 | 0.952 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 1.617068e-01 | 0.791 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.444644e-01 | 0.840 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 8.880693e-02 | 1.052 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.159331e-01 | 0.936 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.243912e-01 | 0.905 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.032557e-01 | 0.986 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 9.344234e-02 | 1.029 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.118893e-01 | 0.951 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.578791e-01 | 0.802 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.348167e-01 | 0.870 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 1.580168e-01 | 0.801 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 1.427015e-01 | 0.846 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 1.066534e-01 | 0.972 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.578791e-01 | 0.802 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.285204e-01 | 0.891 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 1.500131e-01 | 0.824 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.402677e-01 | 0.853 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.152651e-01 | 0.938 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.433514e-01 | 0.844 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.237432e-01 | 0.907 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.732639e-01 | 0.761 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.732639e-01 | 0.761 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.737958e-01 | 0.760 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.756882e-01 | 0.755 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.756882e-01 | 0.755 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 1.756882e-01 | 0.755 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.756882e-01 | 0.755 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 1.756882e-01 | 0.755 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.756882e-01 | 0.755 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.756882e-01 | 0.755 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 1.756882e-01 | 0.755 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.756995e-01 | 0.755 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.756995e-01 | 0.755 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.769191e-01 | 0.752 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.817383e-01 | 0.741 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.859038e-01 | 0.731 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.890477e-01 | 0.723 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 1.897694e-01 | 0.722 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.944276e-01 | 0.711 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.944276e-01 | 0.711 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.944496e-01 | 0.711 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.944496e-01 | 0.711 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.944496e-01 | 0.711 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 1.958461e-01 | 0.708 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.958461e-01 | 0.708 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.970971e-01 | 0.705 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.988222e-01 | 0.702 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.001855e-01 | 0.699 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.031614e-01 | 0.692 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 2.042094e-01 | 0.690 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.053212e-01 | 0.688 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.053212e-01 | 0.688 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.053212e-01 | 0.688 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.082431e-01 | 0.681 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.097061e-01 | 0.678 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.097061e-01 | 0.678 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.097061e-01 | 0.678 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.097061e-01 | 0.678 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.097061e-01 | 0.678 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.137814e-01 | 0.670 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.186151e-01 | 0.660 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.186151e-01 | 0.660 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.186151e-01 | 0.660 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.189865e-01 | 0.660 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.220360e-01 | 0.654 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.220360e-01 | 0.654 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.247734e-01 | 0.648 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.336134e-01 | 0.632 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.336134e-01 | 0.632 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.336134e-01 | 0.632 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.342355e-01 | 0.630 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.391430e-01 | 0.621 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 2.433706e-01 | 0.614 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.433706e-01 | 0.614 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 2.433706e-01 | 0.614 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.433706e-01 | 0.614 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.433706e-01 | 0.614 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.443009e-01 | 0.612 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 2.443009e-01 | 0.612 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 2.443009e-01 | 0.612 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 2.443009e-01 | 0.612 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.443009e-01 | 0.612 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.443009e-01 | 0.612 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.443009e-01 | 0.612 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 2.443009e-01 | 0.612 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.443009e-01 | 0.612 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 2.457492e-01 | 0.610 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.470545e-01 | 0.607 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.470545e-01 | 0.607 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.470545e-01 | 0.607 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.470545e-01 | 0.607 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.470545e-01 | 0.607 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.470545e-01 | 0.607 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.470545e-01 | 0.607 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.470545e-01 | 0.607 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.470545e-01 | 0.607 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.470545e-01 | 0.607 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.470545e-01 | 0.607 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.470545e-01 | 0.607 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.476112e-01 | 0.606 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.514353e-01 | 0.600 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.531525e-01 | 0.597 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.531525e-01 | 0.597 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.534366e-01 | 0.596 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.671651e-01 | 0.573 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.685421e-01 | 0.571 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.685421e-01 | 0.571 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.685421e-01 | 0.571 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.685421e-01 | 0.571 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 2.685421e-01 | 0.571 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.716294e-01 | 0.566 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 2.716294e-01 | 0.566 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.743348e-01 | 0.562 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.761862e-01 | 0.559 | 0 | 0 |
| RSK activation | R-HSA-444257 | 2.790917e-01 | 0.554 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 2.790917e-01 | 0.554 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.790917e-01 | 0.554 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 2.790917e-01 | 0.554 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 2.790917e-01 | 0.554 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.820988e-01 | 0.550 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.821253e-01 | 0.550 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.843301e-01 | 0.546 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.875994e-01 | 0.541 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.939869e-01 | 0.532 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.939869e-01 | 0.532 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.939869e-01 | 0.532 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.939869e-01 | 0.532 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.939869e-01 | 0.532 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.939869e-01 | 0.532 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 2.953095e-01 | 0.530 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 2.953095e-01 | 0.530 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.953095e-01 | 0.530 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.037608e-01 | 0.517 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.073864e-01 | 0.512 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.105014e-01 | 0.508 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.105014e-01 | 0.508 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 3.125482e-01 | 0.505 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.137616e-01 | 0.503 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 3.137616e-01 | 0.503 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.137616e-01 | 0.503 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 3.137616e-01 | 0.503 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.137616e-01 | 0.503 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.137616e-01 | 0.503 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.137616e-01 | 0.503 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.137616e-01 | 0.503 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.137616e-01 | 0.503 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.150172e-01 | 0.502 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 3.150172e-01 | 0.502 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 3.150172e-01 | 0.502 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.150172e-01 | 0.502 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.150172e-01 | 0.502 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.150172e-01 | 0.502 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.150172e-01 | 0.502 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 3.150172e-01 | 0.502 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.150172e-01 | 0.502 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.150172e-01 | 0.502 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.150172e-01 | 0.502 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.150172e-01 | 0.502 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.150172e-01 | 0.502 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.163509e-01 | 0.500 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.170554e-01 | 0.499 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.170554e-01 | 0.499 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.170554e-01 | 0.499 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.170554e-01 | 0.499 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.170554e-01 | 0.499 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 3.195728e-01 | 0.495 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 3.195728e-01 | 0.495 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.195728e-01 | 0.495 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 3.288297e-01 | 0.483 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 3.288297e-01 | 0.483 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.375086e-01 | 0.472 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.451781e-01 | 0.462 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.451781e-01 | 0.462 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 3.472591e-01 | 0.459 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.472591e-01 | 0.459 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.480492e-01 | 0.458 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 3.480492e-01 | 0.458 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.480492e-01 | 0.458 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 3.480492e-01 | 0.458 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.480492e-01 | 0.458 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.480492e-01 | 0.458 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 3.480492e-01 | 0.458 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.480492e-01 | 0.458 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.480492e-01 | 0.458 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.480492e-01 | 0.458 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 3.480492e-01 | 0.458 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.480492e-01 | 0.458 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 3.587146e-01 | 0.445 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.587146e-01 | 0.445 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 3.608604e-01 | 0.443 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.657450e-01 | 0.437 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 3.696466e-01 | 0.432 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 3.706920e-01 | 0.431 | 0 | 0 |
| PKA activation | R-HSA-163615 | 3.706920e-01 | 0.431 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 3.768492e-01 | 0.424 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.768492e-01 | 0.424 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 3.768492e-01 | 0.424 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 3.768492e-01 | 0.424 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.799046e-01 | 0.420 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.799046e-01 | 0.420 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.799046e-01 | 0.420 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 3.799046e-01 | 0.420 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 3.817411e-01 | 0.418 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.817411e-01 | 0.418 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.817411e-01 | 0.418 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.817411e-01 | 0.418 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.817411e-01 | 0.418 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 3.817411e-01 | 0.418 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.842445e-01 | 0.415 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.862657e-01 | 0.413 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.869883e-01 | 0.412 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.872431e-01 | 0.412 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 3.960141e-01 | 0.402 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.010185e-01 | 0.397 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 4.010185e-01 | 0.397 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.028820e-01 | 0.395 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 4.028820e-01 | 0.395 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 4.082693e-01 | 0.389 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.146658e-01 | 0.382 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.146658e-01 | 0.382 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.146658e-01 | 0.382 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.146658e-01 | 0.382 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.146658e-01 | 0.382 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.146658e-01 | 0.382 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 4.146658e-01 | 0.382 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.146658e-01 | 0.382 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 4.210550e-01 | 0.376 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 4.210550e-01 | 0.376 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 4.210550e-01 | 0.376 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.210550e-01 | 0.376 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.220001e-01 | 0.375 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.220001e-01 | 0.375 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.222376e-01 | 0.374 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.229883e-01 | 0.374 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 4.260210e-01 | 0.371 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 4.261671e-01 | 0.370 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.293380e-01 | 0.367 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.331030e-01 | 0.363 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.331030e-01 | 0.363 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.331030e-01 | 0.363 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.331030e-01 | 0.363 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.331030e-01 | 0.363 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.331030e-01 | 0.363 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.331030e-01 | 0.363 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.331030e-01 | 0.363 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.331030e-01 | 0.363 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.331030e-01 | 0.363 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.331030e-01 | 0.363 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.331030e-01 | 0.363 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.331030e-01 | 0.363 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.337463e-01 | 0.363 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.394239e-01 | 0.357 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 4.399297e-01 | 0.357 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.427978e-01 | 0.354 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 4.457350e-01 | 0.351 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.457350e-01 | 0.351 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.457350e-01 | 0.351 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.466873e-01 | 0.350 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.466873e-01 | 0.350 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.466873e-01 | 0.350 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.466873e-01 | 0.350 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.466873e-01 | 0.350 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.466873e-01 | 0.350 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.466873e-01 | 0.350 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.466873e-01 | 0.350 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.466873e-01 | 0.350 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.466873e-01 | 0.350 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.466873e-01 | 0.350 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 4.466873e-01 | 0.350 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 4.466873e-01 | 0.350 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.466873e-01 | 0.350 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 4.466873e-01 | 0.350 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.466873e-01 | 0.350 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.466873e-01 | 0.350 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.466873e-01 | 0.350 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.466873e-01 | 0.350 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.467664e-01 | 0.350 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 4.490644e-01 | 0.348 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 4.524289e-01 | 0.344 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.575878e-01 | 0.340 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.575878e-01 | 0.340 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.575878e-01 | 0.340 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.575878e-01 | 0.340 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 4.633640e-01 | 0.334 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.633640e-01 | 0.334 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.687553e-01 | 0.329 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 4.687553e-01 | 0.329 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 4.755812e-01 | 0.323 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.777004e-01 | 0.321 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 4.777004e-01 | 0.321 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.777004e-01 | 0.321 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 4.777004e-01 | 0.321 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 4.777004e-01 | 0.321 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 4.777004e-01 | 0.321 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.777004e-01 | 0.321 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.777327e-01 | 0.321 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 4.836553e-01 | 0.315 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 4.842816e-01 | 0.315 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.842816e-01 | 0.315 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 4.842816e-01 | 0.315 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 4.842816e-01 | 0.315 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 4.842816e-01 | 0.315 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.842816e-01 | 0.315 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 4.842816e-01 | 0.315 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 4.842816e-01 | 0.315 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 4.842816e-01 | 0.315 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.842816e-01 | 0.315 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 4.842816e-01 | 0.315 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.842816e-01 | 0.315 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.842816e-01 | 0.315 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 4.849462e-01 | 0.314 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 4.917469e-01 | 0.308 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 4.933741e-01 | 0.307 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 4.937429e-01 | 0.306 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.937429e-01 | 0.306 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 4.937429e-01 | 0.306 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 4.937429e-01 | 0.306 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 4.937429e-01 | 0.306 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 4.937429e-01 | 0.306 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 4.974716e-01 | 0.303 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.009791e-01 | 0.300 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.076262e-01 | 0.294 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.076262e-01 | 0.294 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.076262e-01 | 0.294 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 5.076262e-01 | 0.294 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.076262e-01 | 0.294 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.076262e-01 | 0.294 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 5.168332e-01 | 0.287 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.174663e-01 | 0.286 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.218379e-01 | 0.282 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.232609e-01 | 0.281 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 5.256855e-01 | 0.279 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.301682e-01 | 0.276 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.308427e-01 | 0.275 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.308427e-01 | 0.275 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.308427e-01 | 0.275 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.308427e-01 | 0.275 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.308427e-01 | 0.275 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.308427e-01 | 0.275 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 5.308427e-01 | 0.275 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.308427e-01 | 0.275 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.308427e-01 | 0.275 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.308427e-01 | 0.275 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.308427e-01 | 0.275 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.308427e-01 | 0.275 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.308427e-01 | 0.275 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.308427e-01 | 0.275 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.357909e-01 | 0.271 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.362355e-01 | 0.271 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.364084e-01 | 0.271 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.364084e-01 | 0.271 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.364084e-01 | 0.271 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.364084e-01 | 0.271 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.364084e-01 | 0.271 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.364084e-01 | 0.271 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.364084e-01 | 0.271 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.370799e-01 | 0.270 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.395881e-01 | 0.268 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 5.395881e-01 | 0.268 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 5.425091e-01 | 0.266 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 5.425091e-01 | 0.266 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.427504e-01 | 0.265 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 5.427504e-01 | 0.265 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 5.473966e-01 | 0.262 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 5.479282e-01 | 0.261 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.556136e-01 | 0.255 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 5.615953e-01 | 0.251 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.615953e-01 | 0.251 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 5.615953e-01 | 0.251 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 5.620190e-01 | 0.250 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.620190e-01 | 0.250 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 5.620190e-01 | 0.250 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.640095e-01 | 0.249 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 5.640095e-01 | 0.249 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 5.640095e-01 | 0.249 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.640095e-01 | 0.249 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 5.640095e-01 | 0.249 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 5.640095e-01 | 0.249 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.644859e-01 | 0.248 | 1 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.732026e-01 | 0.242 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.732026e-01 | 0.242 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.732026e-01 | 0.242 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 5.732026e-01 | 0.242 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 5.732026e-01 | 0.242 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 5.732026e-01 | 0.242 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.732026e-01 | 0.242 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.780927e-01 | 0.238 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.797599e-01 | 0.237 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.797599e-01 | 0.237 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.797599e-01 | 0.237 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 5.806310e-01 | 0.236 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.828100e-01 | 0.234 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 5.829512e-01 | 0.234 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.829512e-01 | 0.234 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.851932e-01 | 0.233 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.904082e-01 | 0.229 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.904082e-01 | 0.229 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 5.904082e-01 | 0.229 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.904082e-01 | 0.229 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 5.904082e-01 | 0.229 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 5.904082e-01 | 0.229 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.920226e-01 | 0.228 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 6.036331e-01 | 0.219 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 6.036331e-01 | 0.219 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 6.036331e-01 | 0.219 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 6.072112e-01 | 0.217 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.072112e-01 | 0.217 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.102624e-01 | 0.214 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.117401e-01 | 0.213 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.117401e-01 | 0.213 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.117401e-01 | 0.213 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.117401e-01 | 0.213 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.117401e-01 | 0.213 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.117401e-01 | 0.213 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.117401e-01 | 0.213 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.117401e-01 | 0.213 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.117401e-01 | 0.213 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.117401e-01 | 0.213 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.117401e-01 | 0.213 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.117401e-01 | 0.213 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.137566e-01 | 0.212 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.152053e-01 | 0.211 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 6.152098e-01 | 0.211 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.155966e-01 | 0.211 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.155966e-01 | 0.211 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.155966e-01 | 0.211 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.155966e-01 | 0.211 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 6.155966e-01 | 0.211 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.155966e-01 | 0.211 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.184648e-01 | 0.209 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 6.236244e-01 | 0.205 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.236244e-01 | 0.205 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 6.236244e-01 | 0.205 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 6.266991e-01 | 0.203 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 6.313744e-01 | 0.200 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 6.322193e-01 | 0.199 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 6.322193e-01 | 0.199 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 6.322193e-01 | 0.199 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.322769e-01 | 0.199 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 6.395780e-01 | 0.194 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.395780e-01 | 0.194 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.395780e-01 | 0.194 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 6.395780e-01 | 0.194 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.395780e-01 | 0.194 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 6.395780e-01 | 0.194 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.395780e-01 | 0.194 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 6.429135e-01 | 0.192 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 6.429135e-01 | 0.192 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.440333e-01 | 0.191 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.467999e-01 | 0.189 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.467999e-01 | 0.189 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.467999e-01 | 0.189 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.467999e-01 | 0.189 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.467999e-01 | 0.189 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.467999e-01 | 0.189 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 6.467999e-01 | 0.189 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 6.467999e-01 | 0.189 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 6.467999e-01 | 0.189 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.467999e-01 | 0.189 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.467999e-01 | 0.189 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 6.467999e-01 | 0.189 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.467999e-01 | 0.189 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 6.467999e-01 | 0.189 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.467999e-01 | 0.189 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.467999e-01 | 0.189 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.487296e-01 | 0.188 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.487296e-01 | 0.188 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.487363e-01 | 0.188 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.487363e-01 | 0.188 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.487363e-01 | 0.188 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.487363e-01 | 0.188 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.487363e-01 | 0.188 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 6.491273e-01 | 0.188 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 6.614938e-01 | 0.179 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.614938e-01 | 0.179 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 6.614938e-01 | 0.179 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.623649e-01 | 0.179 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.623649e-01 | 0.179 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 6.623649e-01 | 0.179 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.623649e-01 | 0.179 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 6.623649e-01 | 0.179 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 6.679359e-01 | 0.175 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 6.685730e-01 | 0.175 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 6.685730e-01 | 0.175 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 6.734338e-01 | 0.172 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.748710e-01 | 0.171 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 6.763167e-01 | 0.170 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 6.786958e-01 | 0.168 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 6.786958e-01 | 0.168 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 6.786958e-01 | 0.168 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.786958e-01 | 0.168 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.786958e-01 | 0.168 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 6.786958e-01 | 0.168 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 6.786958e-01 | 0.168 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.786958e-01 | 0.168 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 6.786958e-01 | 0.168 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.786958e-01 | 0.168 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.786958e-01 | 0.168 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 6.786958e-01 | 0.168 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 6.786958e-01 | 0.168 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.802635e-01 | 0.167 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.802635e-01 | 0.167 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.802635e-01 | 0.167 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 6.804997e-01 | 0.167 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.839776e-01 | 0.165 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 6.839776e-01 | 0.165 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.839776e-01 | 0.165 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.839776e-01 | 0.165 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 6.920410e-01 | 0.160 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.932245e-01 | 0.159 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.952648e-01 | 0.158 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.965217e-01 | 0.157 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.033632e-01 | 0.153 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.044422e-01 | 0.152 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.044422e-01 | 0.152 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 7.044422e-01 | 0.152 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.044422e-01 | 0.152 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.077130e-01 | 0.150 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.077130e-01 | 0.150 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.077130e-01 | 0.150 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.077130e-01 | 0.150 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.077130e-01 | 0.150 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.077130e-01 | 0.150 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.077130e-01 | 0.150 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 7.077130e-01 | 0.150 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.077130e-01 | 0.150 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 7.077130e-01 | 0.150 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.077130e-01 | 0.150 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.077130e-01 | 0.150 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.097556e-01 | 0.149 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.116165e-01 | 0.148 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.129753e-01 | 0.147 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.129753e-01 | 0.147 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.228492e-01 | 0.141 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.237897e-01 | 0.140 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.237897e-01 | 0.140 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.237897e-01 | 0.140 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 7.237897e-01 | 0.140 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.237897e-01 | 0.140 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.287312e-01 | 0.137 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.287312e-01 | 0.137 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.341112e-01 | 0.134 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.341112e-01 | 0.134 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.341112e-01 | 0.134 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.341112e-01 | 0.134 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.341112e-01 | 0.134 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.341112e-01 | 0.134 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.341112e-01 | 0.134 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.341112e-01 | 0.134 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.341112e-01 | 0.134 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.341112e-01 | 0.134 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.356539e-01 | 0.133 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.372112e-01 | 0.132 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 7.372112e-01 | 0.132 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 7.376607e-01 | 0.132 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.420551e-01 | 0.130 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.420551e-01 | 0.130 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.420551e-01 | 0.130 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 7.437996e-01 | 0.129 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 7.437996e-01 | 0.129 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.466215e-01 | 0.127 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.501827e-01 | 0.125 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.501827e-01 | 0.125 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.557740e-01 | 0.122 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 7.573737e-01 | 0.121 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.580776e-01 | 0.120 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.581266e-01 | 0.120 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.581266e-01 | 0.120 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 7.581266e-01 | 0.120 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.581266e-01 | 0.120 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.581266e-01 | 0.120 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.581266e-01 | 0.120 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.581928e-01 | 0.120 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.581928e-01 | 0.120 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 7.581928e-01 | 0.120 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.592758e-01 | 0.120 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.592758e-01 | 0.120 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.592758e-01 | 0.120 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.592758e-01 | 0.120 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.592758e-01 | 0.120 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.596487e-01 | 0.119 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 7.691401e-01 | 0.114 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.691401e-01 | 0.114 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 7.719250e-01 | 0.112 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 7.745884e-01 | 0.111 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.746408e-01 | 0.111 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.754916e-01 | 0.110 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.754916e-01 | 0.110 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 7.763834e-01 | 0.110 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.798132e-01 | 0.108 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.799742e-01 | 0.108 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.799742e-01 | 0.108 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 7.799742e-01 | 0.108 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.799742e-01 | 0.108 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.799742e-01 | 0.108 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.799742e-01 | 0.108 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.799742e-01 | 0.108 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.799742e-01 | 0.108 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.799742e-01 | 0.108 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.799742e-01 | 0.108 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.829545e-01 | 0.106 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.907434e-01 | 0.102 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.907434e-01 | 0.102 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.907434e-01 | 0.102 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.907434e-01 | 0.102 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.907434e-01 | 0.102 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.907434e-01 | 0.102 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 7.962095e-01 | 0.099 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.971706e-01 | 0.098 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 7.974709e-01 | 0.098 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.974709e-01 | 0.098 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 7.998496e-01 | 0.097 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.998496e-01 | 0.097 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 7.998496e-01 | 0.097 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.998496e-01 | 0.097 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.998496e-01 | 0.097 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.998496e-01 | 0.097 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.998496e-01 | 0.097 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.000112e-01 | 0.097 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.050731e-01 | 0.094 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.050731e-01 | 0.094 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.050731e-01 | 0.094 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.050731e-01 | 0.094 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.050731e-01 | 0.094 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.072593e-01 | 0.093 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.093197e-01 | 0.092 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.134126e-01 | 0.090 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.178469e-01 | 0.087 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.178469e-01 | 0.087 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.179307e-01 | 0.087 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.179307e-01 | 0.087 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.179307e-01 | 0.087 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.179307e-01 | 0.087 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.179307e-01 | 0.087 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.179307e-01 | 0.087 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.179307e-01 | 0.087 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.179307e-01 | 0.087 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.179307e-01 | 0.087 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.185227e-01 | 0.087 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.185227e-01 | 0.087 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.185227e-01 | 0.087 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.311343e-01 | 0.080 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.311343e-01 | 0.080 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.311343e-01 | 0.080 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.311343e-01 | 0.080 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.343793e-01 | 0.079 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.343793e-01 | 0.079 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.343793e-01 | 0.079 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.343793e-01 | 0.079 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.343793e-01 | 0.079 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.343793e-01 | 0.079 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.413979e-01 | 0.075 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.413979e-01 | 0.075 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.413979e-01 | 0.075 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.429494e-01 | 0.074 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 8.429494e-01 | 0.074 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.429494e-01 | 0.074 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.429494e-01 | 0.074 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.493429e-01 | 0.071 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.493429e-01 | 0.071 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.493429e-01 | 0.071 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.493429e-01 | 0.071 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.493429e-01 | 0.071 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.493429e-01 | 0.071 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.493429e-01 | 0.071 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.493429e-01 | 0.071 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.493429e-01 | 0.071 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.493429e-01 | 0.071 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.493429e-01 | 0.071 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.510010e-01 | 0.070 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.540090e-01 | 0.069 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.600930e-01 | 0.065 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 8.629553e-01 | 0.064 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.629553e-01 | 0.064 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.629553e-01 | 0.064 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.629553e-01 | 0.064 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 8.629553e-01 | 0.064 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 8.629553e-01 | 0.064 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.629553e-01 | 0.064 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.629553e-01 | 0.064 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 8.629553e-01 | 0.064 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.629553e-01 | 0.064 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.643532e-01 | 0.063 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.686945e-01 | 0.061 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.740208e-01 | 0.058 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.740208e-01 | 0.058 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.753385e-01 | 0.058 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.753385e-01 | 0.058 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.753385e-01 | 0.058 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 8.753385e-01 | 0.058 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.753385e-01 | 0.058 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 8.753385e-01 | 0.058 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.753385e-01 | 0.058 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.753385e-01 | 0.058 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.768256e-01 | 0.057 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.830497e-01 | 0.054 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 8.838558e-01 | 0.054 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 8.838558e-01 | 0.054 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 8.866034e-01 | 0.052 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 8.866034e-01 | 0.052 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.866034e-01 | 0.052 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.866034e-01 | 0.052 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.866034e-01 | 0.052 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 8.866034e-01 | 0.052 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.866034e-01 | 0.052 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.870304e-01 | 0.052 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.914763e-01 | 0.050 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.914763e-01 | 0.050 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.966858e-01 | 0.047 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.966858e-01 | 0.047 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 8.968510e-01 | 0.047 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 8.968510e-01 | 0.047 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.968510e-01 | 0.047 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.968510e-01 | 0.047 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.968510e-01 | 0.047 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.968510e-01 | 0.047 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 8.968510e-01 | 0.047 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.968510e-01 | 0.047 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.993356e-01 | 0.046 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.993356e-01 | 0.046 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 8.993356e-01 | 0.046 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.993356e-01 | 0.046 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.035618e-01 | 0.044 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 9.061731e-01 | 0.043 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 9.061731e-01 | 0.043 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 9.061731e-01 | 0.043 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 9.061731e-01 | 0.043 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 9.061731e-01 | 0.043 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.061731e-01 | 0.043 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.061731e-01 | 0.043 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.061731e-01 | 0.043 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.061731e-01 | 0.043 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 9.066615e-01 | 0.043 | 1 | 1 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.066615e-01 | 0.043 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.083712e-01 | 0.042 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.132985e-01 | 0.039 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.134860e-01 | 0.039 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.146532e-01 | 0.039 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.146532e-01 | 0.039 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.146532e-01 | 0.039 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 9.146532e-01 | 0.039 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.146532e-01 | 0.039 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.159097e-01 | 0.038 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.189876e-01 | 0.037 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.223673e-01 | 0.035 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.223673e-01 | 0.035 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.223673e-01 | 0.035 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.231366e-01 | 0.035 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 9.257526e-01 | 0.034 | 1 | 0 |
| Parasite infection | R-HSA-9664407 | 9.260799e-01 | 0.033 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.260799e-01 | 0.033 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.260799e-01 | 0.033 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 9.293846e-01 | 0.032 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.293846e-01 | 0.032 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.357680e-01 | 0.029 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.357680e-01 | 0.029 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.357680e-01 | 0.029 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.357680e-01 | 0.029 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.357680e-01 | 0.029 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.357680e-01 | 0.029 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.357680e-01 | 0.029 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.398436e-01 | 0.027 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.411141e-01 | 0.026 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.415747e-01 | 0.026 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.415747e-01 | 0.026 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.415747e-01 | 0.026 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.415747e-01 | 0.026 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.415747e-01 | 0.026 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.415747e-01 | 0.026 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.446406e-01 | 0.025 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.468567e-01 | 0.024 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.468567e-01 | 0.024 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.468567e-01 | 0.024 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 9.468567e-01 | 0.024 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.468567e-01 | 0.024 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.468567e-01 | 0.024 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.468567e-01 | 0.024 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.496216e-01 | 0.022 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.496216e-01 | 0.022 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.516615e-01 | 0.022 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.516615e-01 | 0.022 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.516615e-01 | 0.022 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.516615e-01 | 0.022 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.517973e-01 | 0.021 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.517973e-01 | 0.021 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.517973e-01 | 0.021 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.529442e-01 | 0.021 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.550426e-01 | 0.020 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.580825e-01 | 0.019 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.609288e-01 | 0.017 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.610021e-01 | 0.017 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.612777e-01 | 0.017 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.612777e-01 | 0.017 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 9.632473e-01 | 0.016 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 9.636243e-01 | 0.016 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.636243e-01 | 0.016 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.669139e-01 | 0.015 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.669139e-01 | 0.015 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.669139e-01 | 0.015 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.669139e-01 | 0.015 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.678842e-01 | 0.014 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.726298e-01 | 0.012 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.732931e-01 | 0.012 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 9.751038e-01 | 0.011 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 9.751038e-01 | 0.011 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 9.751038e-01 | 0.011 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 9.773558e-01 | 0.010 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.788139e-01 | 0.009 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.790291e-01 | 0.009 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 9.794042e-01 | 0.009 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 9.794042e-01 | 0.009 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.794042e-01 | 0.009 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.795115e-01 | 0.009 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.795115e-01 | 0.009 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.812674e-01 | 0.008 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.812674e-01 | 0.008 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.821692e-01 | 0.008 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.829622e-01 | 0.007 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.829622e-01 | 0.007 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.829622e-01 | 0.007 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.835630e-01 | 0.007 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.838368e-01 | 0.007 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.844008e-01 | 0.007 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.845037e-01 | 0.007 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.845037e-01 | 0.007 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.845037e-01 | 0.007 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.845037e-01 | 0.007 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.859059e-01 | 0.006 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.860652e-01 | 0.006 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.871812e-01 | 0.006 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.877708e-01 | 0.005 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.877708e-01 | 0.005 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.881520e-01 | 0.005 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.883412e-01 | 0.005 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.883412e-01 | 0.005 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.883412e-01 | 0.005 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.903560e-01 | 0.004 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.903560e-01 | 0.004 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.907833e-01 | 0.004 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.912289e-01 | 0.004 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.914827e-01 | 0.004 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.920228e-01 | 0.003 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.927449e-01 | 0.003 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.927449e-01 | 0.003 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.927449e-01 | 0.003 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.927449e-01 | 0.003 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.927852e-01 | 0.003 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.930648e-01 | 0.003 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.935480e-01 | 0.003 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.938921e-01 | 0.003 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.945423e-01 | 0.002 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.948320e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.950365e-01 | 0.002 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.954859e-01 | 0.002 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.954859e-01 | 0.002 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.962664e-01 | 0.002 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.962664e-01 | 0.002 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.962664e-01 | 0.002 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.963061e-01 | 0.002 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.966046e-01 | 0.001 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.971322e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.971513e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.973648e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.974973e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.974973e-01 | 0.001 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.975454e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.977421e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.978879e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.980601e-01 | 0.001 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.982400e-01 | 0.001 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.983158e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.985554e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.988054e-01 | 0.001 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.989137e-01 | 0.000 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.991312e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.991617e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.991831e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.991838e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.992522e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.992571e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.993098e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.993631e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.993857e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.994414e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.994414e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.994921e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.994948e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.995381e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.995438e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.997122e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.997389e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.997389e-01 | 0.000 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.997518e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.997841e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.998533e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.998730e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.998780e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999352e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999430e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999439e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999526e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999529e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999572e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999611e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999645e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999764e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999831e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999924e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999932e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999952e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999960e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999978e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999984e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999989e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999991e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999991e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999993e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999998e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999998e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |